<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Aging (Albany NY)</journal-id>
<journal-id journal-id-type="iso-abbrev">Aging (Albany NY)</journal-id>
<journal-id journal-id-type="publisher-id">Aging</journal-id>
<journal-title-group>
<journal-title>Aging (Albany NY)</journal-title>
</journal-title-group>
<issn pub-type="epub">1945-4589</issn>
<publisher>
<publisher-name>Impact Journals</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30677746</article-id>
<article-id pub-id-type="pmc">6366964</article-id>
<article-id pub-id-type="publisher-id">101757</article-id>
<article-id pub-id-type="doi">10.18632/aging.101757</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Iacono</surname>
<given-names>Diego</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feltis</surname>
<given-names>Gloria C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<aff id="aff1"><label>1</label>Neuropathology Research, Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ <addr-line>07927, <country>USA</country></addr-line></aff>
<aff id="aff2"><label>2</label><institution>MidAtlantic Neonatology Associates (MANA)</institution>, <addr-line><city>Morristown</city>, <state>NJ</state> 07960</addr-line>, <country>USA</country></aff>
<aff id="aff3"><label>3</label>Atlantic Neuroscience Institute, Atlantic Health System (AHS), <institution>Overlook Medical Center</institution>, <addr-line><city>Summit</city>, <state>NJ</state> 07901</addr-line>, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Correspondence to: </bold> Diego Iacono; <bold>email: </bold><email xlink:href="diego.iacono@atlantichealth.org">diego.iacono@atlantichealth.org</email>, <email xlink:href="iacono@brinj.org">iacono@brinj.org</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<day>31</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>11</volume>
<issue>2</issue>
<fpage>787</fpage>
<lpage>816</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Iacono and Feltis</copyright-statement>
<license specific-use="CC BY 3.0" xlink:href="http://creativecommons.org/licenses/by/3.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>The central nervous system (CNS) is the cellular substrate for the integration of complex, dynamic, constant, and simultaneous interactions among endogenous and exogenous stimuli across the entire human lifespan. Numerous studies on aging-related brain diseases show that some genes identified as risk factors for some of the most common neurodegenerative diseases - such as the allele 4 of <italic>APOE</italic> gene (<italic>APOE4</italic>) for Alzheimer’s disease (AD) - have a much earlier neuro-anatomical and neuro-physiological impact. The impact of <italic>APOE</italic> polymorphism appears in fact to start as early as youth and early-adult life. Intriguingly, though, those same genes associated with aging-related brain diseases seem to influence different aspects of the brain functioning much earlier actually, that is, even from the neonatal periods and earlier. The <italic>APOE4</italic>, an allele classically associated with later-life neurodegenerative disorders as AD, seems in fact to exert a series of very early effects on phenomena of neuroplasticity and synaptogenesis that begin from the earliest periods of life such as the fetal ones.</p>
<p>We reviewed some of the findings supporting the hypothesis that <italic>APOE</italic> polymorphism is an early modifier of various neurobiological aspects across the entire human lifespan - from the in-utero to the centenarian life - during both normal and pathological conditions of the brain.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd><italic>APOE</italic>-polymorphism</kwd>
<kwd>brain development and aging</kwd>
<kwd>neural cells ratios</kwd>
<kwd>environmental modifiers</kwd>
<kwd>in-utero and centenarian life</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Some genes identified as risk factors for aging-related neurodegenerative diseases - such as the allele 4 of Apolipoprotein E gene (<italic>APOE4</italic>) for Alzheimer’s disease (AD) - can have an early impact on different neuronal and non-neuronal features of the human brain, even starting from the perinatal periods or earlier. The possible early influence of <italic>APOE</italic> polymorphism on various cognitive and non-cognitive aspects through the entire human lifespan [<xref ref-type="bibr" rid="r1">1</xref>–<xref ref-type="bibr" rid="r8">8</xref>] poses the biological rationale for a wider re-consideration on how identical genes - for example, the ones identified as risk factors for aging-related diseases - could differently interact with other genes and environmental factors from the beginning of the human life until the advanced or extreme age.</p>
<p>Essentially, in this context, the main scientific question is: how do these genetic risk factors for late-life brain diseases impact, or have impacted, the general development of the brain and specific cytoarchitectural aspects of neuronal and non-neuronal cells and generate, or have generated, meaningful changes on complex cerebral functions (e.g. episodic memory, visual attention) and ultimately determine divergent clinical outcomes across the entire human lifespan [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>].</p>
<p>It is in fact more and more evident that a series of mutual and long-term interactions between genetic and environmental factors control, or might even determine, quantitative differences between healthy and pathologic neural tissues [<xref ref-type="bibr" rid="r11">11</xref>–<xref ref-type="bibr" rid="r13">13</xref>]. Accordingly, it would be only after a relatively long period of time, normally measured in decades, that global or more selective quantitative differences across different types of neural circuits (e.g. extrapyramidal motor system, limbic system, pyramidal motor system) or brain regions (e.g. hippocampus, amygdala, frontal cortex), would affect specific cerebral functions later in life. Specifically, these cellular quantitative differences could culminate later in life in a more diffuse and irreversibly progressive neurodegenerative process such as dementia (e.g. Alzheimer’s disease [AD], dementia with Lewy bodies [DLB], frontotemporal dementias [FTDs]); in some more selectively distributed deficits (e.g. Parkinson’s disease [PD], progressive supranuclear palsy [PSP]); or in a more focally-distributed functional impairment of a specific neuronal circuitry (e.g. amnestic mild cognitive impairment [a-MCI], essential tremor [ET]).</p>
<p>The concept about gene-environment influence on quantitative ratios between health and pathologic neural tissues implies that when certain specific amounts of neuronal and non-neuronal cells (e.g. glial), which we could term “cellular ratio thresholds” that support the global functioning of the brain (e.g. cardio-respiratory regulation through the cardio-respiratory circuits of the brainstem nuclei), or a cluster of specific cerebral functions (e.g. the executive functions through the signals elaboration in the frontal cortex, or the visual-spatial functions through the temporal lobe activation), or a single cerebral function (e.g. the memory through the hippocampal neuronal firing integration) in a specific individual (a subject carrying a specific set of genes and exposed to either beneficial or detrimental environmental factors along his/her previous life) have been crossed, a neurodegenerative process begins to be clinically manifest and, only in appearance, to be linked to the aging process, but actually being the effect of a long-lasting accrual of various pathogenic and detrimental elements accumulated in the previous decades of his/her life.</p>
<p>Maintaining adequate cellular ratios between healthy and pathologic neural tissues would consist in maintaining enough amounts of still-functioning (normal) <italic>vs.</italic> non-functioning (pathologic) cells able to keep and preserve a normal operational status of the brain. This normal operational status would be the one accounting for keeping motor, sensory, cognitive, emotional, and behavioral skills still functional enough in order to conduct the normal daily functions of life in an independent manner [<xref ref-type="bibr" rid="r14">14</xref>]. Importantly, these functional neural ratios (neuronal and non-neuronal cells) kept below the “dysfunctional cellular ratio thresholds” would not be simply determined by the passive accumulation of a single or multiple brain pathologies (e.g. accumulation of extracellular insoluble β-amyloid in the cerebral cortex or intracellular formation of hyperphosphorylated-tau neurofibrillary tangles as in AD) but also on how certain “predisposing genes” in a specific CNS/brain/person have mutually interacted with a specific group of environmental factors throughout his/her life.</p>
<p>One of the most striking examples of the possibility to maintain normally-functioning neural ratios despite the presence of brain lesions accumulation, it is observation that some older subjects can be categorized as asymptomatic AD subjects (ASYMAD). ASYMAD are cognitively normal older subjects that show, at autopsy, an equivalent or even higher amounts of AD pathology in comparison to those found in age-matched, or even younger subjects, which did receive a clinical diagnosis of AD [<xref ref-type="bibr" rid="r15">15</xref>–<xref ref-type="bibr" rid="r21">21</xref>]. These autopsy-confirmed findings greatly support the hypothesis that genetic or environmental factors might contribute to the clinical silencing of AD pathology, at least in a certain group of older subjects (e.g. the ASYMAD subjects). Moreover, these clinicopathologic discrepancies between brain pathology and clinical manifestations (of absence of them) in AD or generally in dementia, support, among others, the general concept of the “cognitive/brain reserve” [<xref ref-type="bibr" rid="r22">22</xref>–<xref ref-type="bibr" rid="r24">24</xref>].</p>
<p>The cognitive/brain reserve concept, though, needs to necessarily correspond to some biological reservoir of still-functioning cells and neural circuits, which ultimately result from the cumulative balance between beneficial and detrimental genetic and environmental factors that have impacted the architecture of the brain (e.g. synaptic contact distribution in the hippocampus) and that consequently have modified specific brain functions (e.g. memory) across all the previous periods of life [<xref ref-type="bibr" rid="r25">25</xref>]. Additionally, gene-environment interactions accounting for the cognitive/brain reserve capacities in a specific individual across his/her entire lifespan should consider possible prenatal genetic and behavioral factors originating from each parent since the fetal times [<xref ref-type="bibr" rid="r26">26</xref>–<xref ref-type="bibr" rid="r28">28</xref>].</p>
<p><italic>APOE</italic> is one of the best examples that shows how a well-established genetic risk factor for an aging-related disease (AD) exerts its influence throughout the entire human lifespan and is part of complex metabolic and gene-environment interactions, especially in terms of brain cholesterol metabolism and synaptic formation [<xref ref-type="bibr" rid="r29">29</xref>]. The fact that the <italic>APOE</italic> polymorphism (presence of three possible alleles [<italic>APOE2, APOE3, APOE4</italic>] and for each individual the possibility to have only one of the six possible <italic>APOE</italic> genotypes [<italic>APOE2/2, APOE2/3, APOE2/4, APOE3/3, APOE3/4, APOE4/4</italic>]) correlates with different, sometimes divergent, clinical, pathologic, and survival outcomes, implies fundamental questions on which are the specific gene-environmental molecular mechanisms that determine those different effects across the entire human lifespan [<xref ref-type="bibr" rid="r30">30</xref>].</p>
<p>We aimed to briefly review some of the well-established findings on the <italic>APOE</italic> polymorphism associated with different, sometimes paradoxical, effects of this gene on the CNS structures and functions. We aimed to focus on human studies that evidence the effects of <italic>APOE</italic> polymorphism on the development of the brain, on different neuropsychiatric phenotypes, and on some higher cognitive functions present in humans only (e.g. language). Furthermore, we succinctly describe some of the possible molecular mechanistic aspects and biochemical pathways that have been proposed to explain the apparently paradoxical effects of <italic>APOE</italic> across the human lifespan [<xref ref-type="bibr" rid="r31">31</xref>].</p>
</sec>
<sec sec-type="other1">
<title>ApoE (protein)</title>
<p>In humans, the apolipoproteins E (ApoE2, ApoE3 and ApoE4) are molecules expressed in peripheral tissues (liver, spleen, kidneys, and macrophages) [<xref ref-type="bibr" rid="r32">32</xref>,<xref ref-type="bibr" rid="r33">33</xref>] and within the CNS [<xref ref-type="bibr" rid="r34">34</xref>]. ApoE is an essential apolipoprotein for the catabolism of triglyceride-rich lipoprotein constituents and it is found in chylomicron, low- and very low-density lipoproteins (LDLs, VLDLs) [<xref ref-type="bibr" rid="r35">35</xref>]. While liver and macrophages are the primary peripheral tissues where ApoE is produced, astrocytes are the main, and apparently the only cells within the CNS, that produce ApoE. Functionally, in the peripheral tissues, ApoE is part of cholesterol metabolism, while in the CNS it has been recognized as the principal carrier of cholesterol [<xref ref-type="bibr" rid="r36">36</xref>]. ApoE transfers cholesterol to neurons and represents an essential molecule for neuronal growth, synaptic plasticity, and membrane reparative processes [<xref ref-type="bibr" rid="r37">37</xref>]. The transfer of ApoE (cholesterol) to neurons occurs through the interaction of ApoE receptors [<xref ref-type="bibr" rid="r38">38</xref>]. These receptors such as LDLR, VLDLR, ApoER2, and LRP1 receptors belong to the low-density lipoprotein receptor gene family [<xref ref-type="bibr" rid="r39">39</xref>]. While the different chemical differences across the three isoforms of ApoE proteins started to be lately better defined [<xref ref-type="bibr" rid="r40">40</xref>], their different roles and effects in each cellular type remain to be completely understood yet [<xref ref-type="bibr" rid="r41">41</xref>,<xref ref-type="bibr" rid="r42">42</xref>].</p>
</sec>
<sec sec-type="other2">
<title><italic>APOE</italic> (gene)</title>
<p>ApoE, the protein, is codified by a gene localized on the long arm (“q” arm) of the chromosome 19 in the sub-band 32 of region 13 (19q13.32): <italic>APOE</italic> gene (<italic>APOE</italic>). The <italic>APOE</italic> has three alleles (genetic polymorphism): <italic>APOEpsilon</italic>2 (<italic>APOE</italic>2), <italic>APOEpsilon</italic>3 (<italic>APOE</italic>3), and <italic>APOEpsilon</italic>4 (<italic>APOE</italic>4). Each allele codifies to corresponding protein isoforms (ApoE2, ApoE3, ApoE4) that differ in amino acid sequence at the residue 112 (also called “site <italic>A</italic>”) and 158 (also called “site <italic>B</italic>”). Specifically, <italic>APOE</italic>2, <italic>APOE</italic>3, <italic>APOE</italic>4 (the alleles) codify respectively for ApoE2, ApoE3, ApoE4 (the proteins), which at the position 112 and 158 of their amino acidic sequence, contain respectively cysteine/ cysteine, cysteine/arginine, and arginine/arginine [<xref ref-type="bibr" rid="r43">43</xref>]. These amino acid differences in the primary sequence of each ApoE protein determine a different number of charges (0, 1+, 2+) and account for their variant tertiary and quaternary conformations and electrophoretic differences [<xref ref-type="bibr" rid="r44">44</xref>]. Four individual mutations give electrophoretically separated bands at the E2 position. Using the isoelectric focusing techniques [<xref ref-type="bibr" rid="r45">45</xref>] at least four different bands (corresponding to different ApoE2 conformational status) have been identified: E2 (arg158-to-cys) [<xref ref-type="bibr" rid="r46">46</xref>], E2 (lys146-to-gln) [<xref ref-type="bibr" rid="r47">47</xref>], E2 (arg145-to-cys), and E2-Christchurch (arg136-to-ser) [<xref ref-type="bibr" rid="r48">48</xref>]. E2 (arg158-to-cys) is the most common of all four. In general, these “minimal” physical-chemical differences among ApoE proteins determine massive metabolic and structural consequences at tissue and metabolic level, especially within the human CNS [<xref ref-type="bibr" rid="r49">49</xref>,<xref ref-type="bibr" rid="r50">50</xref>].</p>
</sec>
<sec sec-type="other3">
<title>Genetic epidemiology</title>
<p>In the general population, the distribution of <italic>APOE</italic> alleles can vary across different ethnic groups [<xref ref-type="bibr" rid="r51">51</xref>]. These variations seem to be related to different non-genetic factors such as geographical latitude [<xref ref-type="bibr" rid="r52">52</xref>], local temperature and altitude, metabolic rate [<xref ref-type="bibr" rid="r53">53</xref>], hypoxia [<xref ref-type="bibr" rid="r54">54</xref>], “local” availability of lipophilic nutrients [<xref ref-type="bibr" rid="r55">55</xref>], climate [<xref ref-type="bibr" rid="r56">56</xref>] and others [<xref ref-type="bibr" rid="r57">57</xref>–<xref ref-type="bibr" rid="r60">60</xref>].</p>
<p>Notably, from an evolutionary point of view, <italic>APOE</italic>4 has been determined to be the “oldest allele” (which is also the only allele found in non-human primates and other mammals) followed by the <italic>APOE</italic>3, and then by the <italic>APOE</italic>2, which is indeed the “most recent allele” [<xref ref-type="bibr" rid="r61">61</xref>]. <italic>APOE</italic>2 has been estimated to appear in humans only about 80,000 years ago [<xref ref-type="bibr" rid="r62">62</xref>–<xref ref-type="bibr" rid="r64">64</xref>]. The more recent appearance of <italic>APOE</italic>2 in humans could be explained by the relative advantage provided by the corresponding product of this allele (<italic>APOE</italic>2 protein), which seems to increase the neural plasticity, synaptic reparative and clearance capacities of the CNS [<xref ref-type="bibr" rid="r65">65</xref>], as well as human longevity [<xref ref-type="bibr" rid="r66">66</xref>]. Intriguingly, however, while carrying the <italic>APOE</italic>2 could represent a protective factor late in life, especially for delaying dementia and cognitive deficits during aging, this is not necessarily the case early in life, especially during the very early phases of life (see antagonistic pleiotropy paragraph).</p>
</sec>
<sec sec-type="other4">
<title><italic>APOE</italic> and Antagonistic Pleiotropy</title>
<p><italic>APOE</italic> began to appear as one of the best examples of genetic “antagonistic pleiotropy” (AP), a concept applicable to human traits and diseases, and to human cognition, neurodegenerative diseases, and brain diseases in general [<xref ref-type="bibr" rid="r67">67</xref>–<xref ref-type="bibr" rid="r71">71</xref>]. AP is defined as a genetic phenomenon existing when a gene can control for more than one trait (pleiotropy) with at least one possible trait beneficial and another detrimental (antagonistic) to the fitness of that same organism [<xref ref-type="bibr" rid="r72">72</xref>,<xref ref-type="bibr" rid="r73">73</xref>]. Once considered a rare genetic phenomenon, AP seems rather to be a much more frequent event, especially when considering human diseases [<xref ref-type="bibr" rid="r74">74</xref>], and in particular aging-related diseases and human longevity [<xref ref-type="bibr" rid="r75">75</xref>–<xref ref-type="bibr" rid="r77">77</xref>]. Among the <italic>APOE</italic> polymorphism-associated traits that appear to have AP characteristics are included the different biochemical consequences that ApoE2, ApoE3, ApoE4 proteins have on the metabolism of cholesterol, which have important implications, among others, on the metabolism of β-amyloid and synaptogenesis resistance in younger vs. aged mammalians, and could so explain the “paradoxical” beneficial effects of <italic>APOE</italic>4 on specific cognitive skills (e.g. verbal memory in schizophrenic patients [<xref ref-type="bibr" rid="r78">78</xref>], memory performance [<xref ref-type="bibr" rid="r79">79</xref>], and attention in young [<xref ref-type="bibr" rid="r80">80</xref>]), and the observation that <italic>APOE</italic>4 is an advantageous factor on survival and infertility in infectious environments [<xref ref-type="bibr" rid="r81">81</xref>,<xref ref-type="bibr" rid="r82">82</xref>], or that <italic>APOE</italic> alleles are associated with conscientiousness personality-trait in relationship to gray matter volume [<xref ref-type="bibr" rid="r7">7</xref>] and greater cortical connectivity [<xref ref-type="bibr" rid="r83">83</xref>]. <xref ref-type="fig" rid="f1">Figure 1</xref> shows graphs describing the antagonistic pleiotropy concept applied to <italic>APOE</italic> polymorphism.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p><bold>The figure shows the theoretical antagonistic pleotropic (AP) effect of <italic>APOE</italic> gene across the entire human lifespan.</bold> The increased probability of early survival and normal cognition later in life are alternatively correlated with the presence of <italic>APOE4</italic> and <italic>APOE2</italic> allele. However, other genes and environmental factors through their mutual interactions from the in-utero life until centenarian age can probably potentiate the beneficial or detrimental effects on the onset and manifestations of brain diseases and, respectively, reduce or potentiate the genetic predisposition toward more negative or positive clinical outcomes during different periods of life.</p>
</caption>
<graphic xlink:href="aging-11-101757-g001"></graphic>
</fig>
</sec>
<sec sec-type="other5">
<title><italic>APOE</italic> polymorphism in normal and pathologic conditions of the brain across all ages</title>
<p>In general, <italic>APOE</italic>4 and its association with different measurable clinical variables such as dementia severity [<xref ref-type="bibr" rid="r84">84</xref>], neuropsychological scores [<xref ref-type="bibr" rid="r85">85</xref>], pathology burdens [<xref ref-type="bibr" rid="r86">86</xref>], cortical morphometry [<xref ref-type="bibr" rid="r5">5</xref>], morphometric-MRI [<xref ref-type="bibr" rid="r87">87</xref>,<xref ref-type="bibr" rid="r88">88</xref>], functional-MRI [<xref ref-type="bibr" rid="r89">89</xref>–<xref ref-type="bibr" rid="r91">91</xref>], electroencephalographic (EEG) [<xref ref-type="bibr" rid="r92">92</xref>,<xref ref-type="bibr" rid="r93">93</xref>] and magnetoencephalographic (MEG) signals [<xref ref-type="bibr" rid="r94">94</xref>], evoked potentials (EPs) changes [<xref ref-type="bibr" rid="r95">95</xref>,<xref ref-type="bibr" rid="r96">96</xref>], and other methods [<xref ref-type="bibr" rid="r97">97</xref>] has been investigated much more extensively than <italic>APOE</italic>2 [<xref ref-type="bibr" rid="r98">98</xref>–<xref ref-type="bibr" rid="r100">100</xref>]. In fact, studies focusing on <italic>APOE</italic>2 and its association to different clinical and subclinical parameters and possible molecular mechanisms of brain protection have been historically, less numerous than investigations comparing <italic>APOE</italic>4 vs. <italic>APOE</italic>3 for example. Furthermore, although <italic>APOE</italic>4 and <italic>APOE</italic>2 appear to have divergent effects on cognitive outcomes during aging, their corresponding protective or deleterious effects on other periods or conditions of life as brain development, birth prematurity, infancy, childhood cognitive and behavioral outcomes, as well as early-adult and mid-adult life predisposition for neurodegeneration have been generally much less investigated.</p>
<p>We organized the description of the reviewed findings on the effects of <italic>APOE</italic> polymorphism across the human lifespan using a bio-chronological order. We first described the effects of <italic>APOE</italic> polymorphism in normal and pathological conditions of the CNS during in-utero life followed by the neonatal, infancy, teenaging, and adult mid-life, and finally we describe data on <italic>APOE</italic> and the effect on elders and extreme old subjects including octogenarian, nonagenarian and centenarian populations.</p>
<sec>
<title><italic>APOE</italic> and brain during in-utero life (before birth) and in preterm babies (&lt;38 weeks of gestation)</title>
<p>Studies focusing on the possible clinical correlations between <italic>APOE</italic> polymorphism and divergent cognitive or behavioral outcomes of in-utero life, preterm babies, and infant populations are scarce. Due to its historical predominant consideration as a gene negatively associated with later life brain diseases, especially AD, <italic>APOE</italic> and its possible effects on the normal brain development or as a genetic modifier of specific pathologic conditions such as motor-behavioral delay, cerebral palsy, prematurity, and in-utero life brain abnormalities has received little attention until recent times [<xref ref-type="bibr" rid="r101">101</xref>]. In-utero life events imply complex interactions among maternal and fetal <italic>APOE</italic> genotypes, which might determine a highly complex spectrum of different biochemical interactions [<xref ref-type="bibr" rid="r102">102</xref>,<xref ref-type="bibr" rid="r103">103</xref>]. For example, recent findings propose that maternal <italic>APOE</italic> genotype could be a relevant risk factor for poor outcomes at birth, premature delivery, and predisposition for preeclampsia [<xref ref-type="bibr" rid="r27">27</xref>,<xref ref-type="bibr" rid="r104">104</xref>,<xref ref-type="bibr" rid="r105">105</xref>]. These maternal-fetal gene-metabolism interactions during in-utero life seem to potentially determine specific patterns of biochemical imprinting events directly at cerebral level, or alternatively, on different organs and systems such as the vascular system, which could indirectly include the cerebral vasculature [<xref ref-type="bibr" rid="r106">106</xref>,<xref ref-type="bibr" rid="r107">107</xref>]. However, based on more recent observations about AP phenomenon associated with <italic>APOE</italic> polymorphism and on more consolidated data showing that the <italic>APOE</italic>2 is, <italic>per se,</italic> a protective allele against dementia and cognitive decline during aging even independently on the β-amyloid accumulation and “classic” AD pathology [<xref ref-type="bibr" rid="r109">109</xref>], it would be possible in the future to investigate on unprecedented aspects of the cholesterol metabolism related to genetic aspects of <italic>APOE</italic> polymorphism whom influence seem to go well behind specific cognitive aspects and to be actually a “general modulator” of neuronal structures and functions, synaptic formation, brain repair, and neural regenerative mechanisms [<xref ref-type="bibr" rid="r110">110</xref>,<xref ref-type="bibr" rid="r111">111</xref>]. Consequentially, the <italic>APOE</italic> polymorphism appears to acquire an important general role in terms of brain development, impact on neuroreparative capacities and neuroplasticity potentialities across the entire human lifespan. Moreover, coherently with the concept of an early impact of <italic>APOE</italic> on brain structures, Stoknes et al. [<xref ref-type="bibr" rid="r112">112</xref>] have hypothesized that <italic>APOE</italic>2-carriers have a higher risk of death in-utero life following brain injury probably due to an altered or abnormal metabolism of the cholesterol. Other investigators have shown similar results and proposed similar <italic>APOE</italic>-based pathogenetic mechanisms [<xref ref-type="bibr" rid="r113">113</xref>]. These initial observations could explain why some findings show a non-significant association between <italic>APOE</italic> polymorphism and cerebral palsy (CP) simply due the fact that <italic>APOE</italic>2 carriage would represent actually a major risk factors for in-utero life survival (increased prenatal mortality). Recently, another group of investigators showed that <italic>APOE</italic> gene and weight at birth are risk factors for future cardiovascular diseases, and these factors seem to be independent factors as well [<xref ref-type="bibr" rid="r114">114</xref>]. To note, nonetheless, that these latter findings make the possible mechanistic (molecular) correlations among <italic>APOE</italic>, cholesterol metabolism, and vascular diseases much less linear than what could have been expected earlier [<xref ref-type="bibr" rid="r115">115</xref>,<xref ref-type="bibr" rid="r116">116</xref>]. Furthermore, data in support of the interaction between <italic>APOE</italic> alleles and environment suggest that a specific <italic>APOE</italic> genotype is a risk factor able to potentiate the toxic effects of various environmental contaminants. For instance, it has been shown that <italic>APOE</italic>4-carriage implies lower cognitive scores in preterm neonates exposed to higher levels of mercury [<xref ref-type="bibr" rid="r117">117</xref>,<xref ref-type="bibr" rid="r118">118</xref>].</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during normal neonatal (1 day-30 days full-term babies) and infancy (1-12 months full-term babies) periods</title>
<p>Studies on the impact of <italic>APOE</italic> polymorphism on various clinical outcomes in full-term normal neonates and infants are rare [<xref ref-type="bibr" rid="r119">119</xref>–<xref ref-type="bibr" rid="r121">121</xref>]. However, some investigations performed on selected types of neonate populations, suggest that <italic>APOE</italic> has indeed AP features. In fact, an over-representation of <italic>APOE</italic> 4/4 and 2/4 with a reduction in <italic>APOE</italic> 2/3 and 3/3 when compared with adult population [<xref ref-type="bibr" rid="r122">122</xref>] suggests that <italic>APOE</italic>4 is related to an increased risk of premature death. Furthermore, data from the same group of investigators found an over-representation of <italic>APOE</italic>2 in perinatal deaths populations [<xref ref-type="bibr" rid="r123">123</xref>]. This apparent paradoxical inversion of the protective effect of <italic>APOE</italic>2 vs. <italic>APOE</italic>4 in neonates, in contrast with the findings observed in elders, fits very well with the hypothesis that <italic>APOE</italic> has indeed antagonistic pleiotropic properties across the entire human lifespan [<xref ref-type="bibr" rid="r67">67</xref>,<xref ref-type="bibr" rid="r124">124</xref>,<xref ref-type="bibr" rid="r125">125</xref>]. Nevertheless, considering that the distributions of <italic>APOE</italic> alleles in healthy general populations are linked to various types of factors such as ancestry, geography, etc. (see paragraph Genetic epidemiology), much larger population cohorts stratified by the “local” <italic>APOE</italic> frequencies (corrected for all other identified influencing factors) together with a more precise definition of the periods of life to consider (perinatal deaths can have different definition across different countries) and large multi-institutional collaborative investigations are necessary to expand our knowledge on the possible pre-natal or peri-natal effects of <italic>APOE</italic> on early life events as well as on later life physiological or pathological events.</p>
<p>At a more speculative level, we retain that the possible early life effects associated with <italic>APOE</italic> polymorphism could primarily act on the cholesterol metabolism during the development of the brain and other organs and apparatuses (vascular system, liver, lungs, kidneys, etc.). Theoretically, <italic>APOE</italic> could also manifest a protective or detrimental effect on the brain development or its functions through indirect pathways [<xref ref-type="bibr" rid="r126">126</xref>,<xref ref-type="bibr" rid="r127">127</xref>]. Pivotal MRI-imaging studies focusing on morphometric aspects of gray matter (GM) in very preterm infants seem to predict some future aspects of neurodevelopmental outcomes [<xref ref-type="bibr" rid="r128">128</xref>]. While no imaging studies have been performed in large cohorts of normal full-term neonates or infants in the attempt to correlate GM morphometric aspects to <italic>APOE</italic> genotype, a link between <italic>APOE</italic> genotype and cortical thickness using neuroimaging techniques has been shown in young adults [<xref ref-type="bibr" rid="r129">129</xref>].</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during pathological neonatal (1 day-30 days) and infancy (1-12 months) periods</title>
<p>Another example of the possible negative effect of <italic>APOE</italic>2 on brain functions is the detrimental association between <italic>APOE</italic>2 and neurodevelopmental dysfunction observed in neonate and infants after cardiac surgery [<xref ref-type="bibr" rid="r130">130</xref>,<xref ref-type="bibr" rid="r131">131</xref>]. However, this potentially detrimental effect of <italic>APOE</italic>2 early in life could be biased by the higher incidence of neonatal sudden death associated with <italic>APOE</italic>4 or other genetic variants [<xref ref-type="bibr" rid="r132">132</xref>,<xref ref-type="bibr" rid="r133">133</xref>]. In fact, the supposed detrimental <italic>APOE</italic>2 effect in infants after cardiac surgery could be simply due to a possible skewing effect toward <italic>APOE</italic>2 (risk of a reduced survival) in the absence of the chance to test an equivalent number of <italic>APOE</italic>4-carrier subjects with similar conditions underwent to cardiac surgery and subsequently assessed. However, if this after cardiac surgery detrimental <italic>APOE</italic>2-cognitive outcomes association will be confirmed, it will corroborate the hypothesis that <italic>APOE</italic> has AP properties.</p>
<p>To date, the AP properties in humans are not well timed, particularly in relationship to the various phases of the brain development. It has been suggested that the AP effects of the genes related to the brain function could begin to be assessed only after the first year of life. This could be due to the fact, for example, that specific skills (e.g. motor skills) are “localized and matured” in specific circuits of the brain, only after certain periods of the brain development [<xref ref-type="bibr" rid="r134">134</xref>,<xref ref-type="bibr" rid="r135">135</xref>]. Consequently, it would be difficult, or impossible, at clinical level, to evaluate or pre-evaluate the possible future outcomes of each type of motor or non-motor skill until the full genetically-determined neurodevelopmental program has been completed. Furthermore, it is possible to hypothesize that not only there is a life-lasting AP effect of <italic>APOE</italic> across the entire human lifespan, but that this AP effect is present in different areas or brain circuits at different times of the development as well as in the same brain at different ages. In addition, it is not unconceivable to exclude that the AP effects might be additionally modulated by non-genetic factors (e.g. nutrition, environmental toxins, infections, etc.), especially before the conclusion of the major process of maturation of the CNS [<xref ref-type="bibr" rid="r136">136</xref>–<xref ref-type="bibr" rid="r138">138</xref>]. Of course, <italic>APOE</italic> is not the only gene involved in various highly complex phenomena of the human brain maturation but seems to be part of a cluster of genes that reciprocally interact during the different phases of the neurodevelopment [<xref ref-type="bibr" rid="r139">139</xref>]. Accordingly, it would be through these multiple short- and long-term interactions between parental genes and gestational environments that <italic>APOE</italic> polymorphism could influence neurodevelopmental trajectories during early life periods and infancy and later, by pre-establishing a higher risk for “aging-related” conditions, or at least influencing, clinical onset or phenotype in neurodegenerative diseases such as AD, Parkinson’s disease (PD) [<xref ref-type="bibr" rid="r140">140</xref>] or ALS [<xref ref-type="bibr" rid="r141">141</xref>]. Therefore, it is not possible to exclude that those specific metabolic abnormalities or environmental events occurring during the very early period of life could trigger specific biochemical compensatory mechanisms (including synaptic formation and biochemistry) in preterm babies, which are different from those possibly activated during a regular gestation period ending in full-term birth [<xref ref-type="bibr" rid="r142">142</xref>]. For example, there are data showing that children exposed to environmental intoxication can have a different cognitive impact based on the <italic>APOE</italic> genotype [<xref ref-type="bibr" rid="r143">143</xref>], and that these ApoE<italic>-</italic>toxicants interactions can be activated during earlier periods of life and establish the “neural ground” for potential future abnormal reactions in the context of a later normal environment. Finally, other types of illnesses such as intra-uterine infections could directly or indirectly and differently affect cognitive outcomes of children based on their specific <italic>APOE</italic> genotype [<xref ref-type="bibr" rid="r144">144</xref>].</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during normal childhood and teenaging</title>
<p>As investigations on the <italic>APOE</italic> polymorphism get performed considering human subjects with earlier age in life, the possible influence of each <italic>APOE</italic> genotype in these younger populations should consider that <italic>APOE</italic>2 and <italic>APOE</italic>4 can be part of AP phenomena occurring in the same individual (e.g. <italic>APOE</italic>2/E4) and across different individuals (e.g. <italic>APOE</italic>3/E2 vs. <italic>APOE</italic>3/E4) at different ages. The AP effect of <italic>APOE</italic> suggests that it would be fundamental to precisely define the specific periods of life to investigate and in which of those periods AP effects take place [<xref ref-type="bibr" rid="r145">145</xref>]. In fact, during earlier periods of life, the deleterious effects of <italic>APOE</italic>4 vs. <italic>APOE</italic>2 appear to be paradoxically reversed in some cases in respect to older age [<xref ref-type="bibr" rid="r31">31</xref>,<xref ref-type="bibr" rid="r129">129</xref>,<xref ref-type="bibr" rid="r146">146</xref>,<xref ref-type="bibr" rid="r147">147</xref>]. Although studies focusing on the allelic effects of <italic>APOE</italic> on young adults and children are relatively rare, a series of recent analyses evidenced an increased risk for poorer outcomes in <italic>APOE</italic>2- vs. <italic>APOE</italic>4-carriers in pediatric populations [<xref ref-type="bibr" rid="r130">130</xref>]. However, this effect is paradoxical only in appearance if the AP concept is considered. The “switched” effect of <italic>APOE</italic>4 (and alternatively of <italic>APOE</italic>2) during aging (in comparison to earlier periods of life), fits very well with the genetic AP concept for which the function of a gene can change during the time (i.e. from infancy to extreme age) or it can be otherwise activated in presence of different or mutated environmental conditions [<xref ref-type="bibr" rid="r148">148</xref>]. In support of the AP properties of <italic>APOE</italic> alleles, recent imaging studies have demonstrated a negative correlation between <italic>APOE</italic>4 and GM maturation in subjects between 3 and 20 years old [<xref ref-type="bibr" rid="r149">149</xref>]. However, more specific aspects of cortical connectivity and cognition - such as fluid intelligence - resulted to be lower in <italic>APOE</italic>4-carriers vs. non-<italic>APOE</italic>4-carriers [<xref ref-type="bibr" rid="r150">150</xref>]. Yet, in this last study, no direct analyses were performed to compare <italic>APOE</italic>4- vs. <italic>APOE</italic>2-carriers. Other studies, however, have also analyzed the interaction between <italic>APOE</italic> (e.g. non-<italic>APOE</italic>4 carriers) and other genes such as SORL1 showing that is the interaction between these two genes to determine different levels of hippocampal connectivity [<xref ref-type="bibr" rid="r151">151</xref>]. Again, when studying the <italic>APOE</italic> effects across different ages, it looks like of extreme relevance to define in a very precise way, the quantitative parameters or qualitative variables (including other genetic traits or genes) to analyze (e.g. clinical signs or symptoms, cognitive scores, imaging measures, neurophysiological values, etc.) and the specific system, organ, tissue or function to study.</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during pathological conditions of childhood and teenaging</title>
<p>There have been various studies that focused on neurological disorders during childhood and adolescence that attempted to identify possible meaningful correlations between manifestation and progression of a disease, or its variable phenotypic characterization, and the <italic>APOE</italic> genotype. Initial findings by Treble-Barna et al. [<xref ref-type="bibr" rid="r152">152</xref>] suggest an <italic>APOE</italic>-environmental interaction in terms of long-term outcomes in children with a history of traumatic brain injury (TBI). This possible gene-environmental interaction has been further suggested by Kassam et al. [<xref ref-type="bibr" rid="r153">153</xref>] based on meta-analytic results showing that <italic>APOE</italic>4 is undoubtedly associated with a worse prognosis after a TBI in both children and young adults and that this effect might be due to mechanisms quite different from those linked to neurodegeneration during aging.</p>
<p>In support of the hypothesis that <italic>APOE</italic>4-related effects could be linked to different pathomechanisms than the ones leading to neurodegeneration when considering short- or long-term outcomes in the context of the same disease, for example traumatic brain injury (TBI) where there are data showing the possible association between <italic>APOE</italic> and post-concussive syndrome in children, which do not have any significant difference between <italic>APOE</italic>4- vs. non-<italic>APOE</italic>4 carriers, in particular when immediate or short-term outcomes are considered [<xref ref-type="bibr" rid="r154">154</xref>]. By contrast, in other types of brain diseases such as epilepsy, <italic>APOE</italic> genotype resulted to be a strong modifying factor in terms of both neuronal and glial neuropathological changes [<xref ref-type="bibr" rid="r155">155</xref>]. Nonetheless, depending on the specific type of disease associated with seizures or epileptic syndromes, the impact of <italic>APOE</italic> polymorphism seems to vary and it is not always associated with a direct epilepsy-inducing pathogenetic effect [<xref ref-type="bibr" rid="r156">156</xref>], but rather with other clinical aspects such as the age of onset of the disease [<xref ref-type="bibr" rid="r157">157</xref>].</p>
<p>In summary, <italic>APOE</italic> polymorphism during childhood and teenaging does not seem to be necessarily associated with specific structural brain changes but does seem to act in a much more complex way on a series of clinical outcomes characterizing the natural history of a specific disease such as cognitive decline, age of onset, or other associated co-morbidities related to the primary pathologic condition [<xref ref-type="bibr" rid="r113">113</xref>]. Though, earlier in life, the influence of <italic>APOE</italic> genotype seems to operate on a wider set of aspects either at the structural as functional level [<xref ref-type="bibr" rid="r158">158</xref>,<xref ref-type="bibr" rid="r159">159</xref>].</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during normal adulthood (3<sup>rd</sup>-7<sup>th</sup> decade of life)</title>
<p>A series of <italic>APOE</italic>-associated white matter (WM) and gray matter (GM) microstructure differences in adult life have been described and they support the hypothesis that <italic>APOE</italic> polymorphism has indeed an early impact on various neurocytological aspects and different neurophenotypic aspects during normal and pathologic conditions of the CNS. For example, recent cognitive-morphological MRI investigations in normal adult populations described an earlier influence of the <italic>APOE</italic> genotype on specific morphometric aspects of different brain regions as an independent variable that is, as a variable that is not linked to any other known associated genetic or environmental risk factor [<xref ref-type="bibr" rid="r83">83</xref>,<xref ref-type="bibr" rid="r160">160</xref>–<xref ref-type="bibr" rid="r164">164</xref>]. Moreover, functional MRI (fMRI) studies showed significant differences in normal older as well young-adult populations when clustered based on <italic>APOE</italic>4 vs. non-<italic>APOE</italic>4 carriers [<xref ref-type="bibr" rid="r165">165</xref>–<xref ref-type="bibr" rid="r168">168</xref>]. In addition, other factors such as brain metabolism [<xref ref-type="bibr" rid="r169">169</xref>] and vascular reactivity [<xref ref-type="bibr" rid="r170">170</xref>] seem to be associated with an <italic>APOE</italic> genotype, which predisposes to cognitive impairment later in life.</p>
<p>Although studies using normal human brain tissue for comparisons across different <italic>APOE</italic> genotypes are very rare, Love et al. [<xref ref-type="bibr" rid="r171">171</xref>] were able to demonstrate different levels of synaptic proteins in the temporal cortex of normal brains between <italic>APOE</italic>4 vs. non-<italic>APOE</italic>4 carrier subjects.</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during pathological conditions in adulthood (3rd-7th decade of life)</title>
<p>There are different investigations demonstrating that <italic>APOE</italic> genotype can influence the clinical phenotype of brain diseases during adulthood. For example, different levels of neuroinflammation associated with epilepsy were directly correlated with a specific <italic>APOE</italic> genotype in adult patients [<xref ref-type="bibr" rid="r172">172</xref>]. Specifically, <italic>APOE</italic>3 conferred a higher level of protection against neuroinflammatory and neurodegenerative processes associated with epilepsy [<xref ref-type="bibr" rid="r155">155</xref>]. In other brain diseases, such as TBI, it has been shown that different clinical outcomes are present in young adults (in contrast with findings in children) <italic>APOE</italic>4-carriers vs. non-<italic>APOE</italic>4 carriers [<xref ref-type="bibr" rid="r173">173</xref>,<xref ref-type="bibr" rid="r174">174</xref>]. In this case, it has been shown that a specific <italic>APOE</italic> allele can directly influence the reparative capacities of the brain and consequently the clinical outcomes based on a specific allele, the <italic>APOE</italic>4 in this case [<xref ref-type="bibr" rid="r175">175</xref>].</p>
<p>Another fascinating set of data proposed that there is a significant association between sleep disorders and <italic>APOE</italic> genotype [<xref ref-type="bibr" rid="r176">176</xref>,<xref ref-type="bibr" rid="r177">177</xref>], as well as among <italic>APOE</italic>, sleep-wake cycle, and deposition of <italic>β</italic>-amyloid [<xref ref-type="bibr" rid="r178">178</xref>]. This is a further indication that during adult age <italic>APOE</italic>4 confers negative effects to those subjects that have sleep-disordered breathing illnesses. By contrast, it has been evidenced that <italic>APOE</italic>2 confers a higher risk for intracranial hemorrhage in the contest of the natural history of brain arteriovenous malformations in young adults [<xref ref-type="bibr" rid="r179">179</xref>].</p>
<p>Then, importantly, as the mean age of the subjects analyzed in each different clinical or epidemiological study becomes lower, it is valuable to consider the possible AP effect of <italic>APOE</italic> alleles together with a clear distinction of the pathologic conditions to investigate, for example a clear distinction should be kept if a specific study is considering a vascular vs. non-vascular diseases. In fact, as the mean age of the subjects analyzed across different studies lowers also the different type of tissues, organs, or functional systems to target could vary together with the notion that an AP phenomenon can affect different organs or functions at different biological periods of life as well as different areas of the same organ (e.g. the brain) across those different periods of life.</p>
</sec>
<sec>
<title><italic>APOE</italic> and brain during normal aging: successful octogenarians, nonagenarians, and centenarians</title>
<p>To date, <italic>APOE</italic>4 remains the best-established genetic risk factor associated with an increased risk of sporadic late-onset Alzheimer’s disease (LOAD) [<xref ref-type="bibr" rid="r180">180</xref>,<xref ref-type="bibr" rid="r181">181</xref>]. The possibility of <italic>APOE</italic>4 to determine an increased risk for other types of dementias is currently debated and under continued investigation [<xref ref-type="bibr" rid="r182">182</xref>–<xref ref-type="bibr" rid="r186">186</xref>]. While <italic>APOE</italic>4 has a deleterious effect on the onset and progression of AD as well as on cognition during pathological aging [<xref ref-type="bibr" rid="r187">187</xref>], <italic>APOE</italic>2 - the rarest allele of <italic>APOE</italic> gene in Caucasian populations - has been associated with a reduced risk of AD and increased longevity [<xref ref-type="bibr" rid="r77">77</xref>,<xref ref-type="bibr" rid="r188">188</xref>,<xref ref-type="bibr" rid="r189">189</xref>]. However, the detrimental effect of <italic>APOE</italic>4 on cognition (in both homo- and heterozygosis) has been largely confirmed by clinical [<xref ref-type="bibr" rid="r190">190</xref>], neuropsychological [<xref ref-type="bibr" rid="r191">191</xref>], neuroimaging [<xref ref-type="bibr" rid="r192">192</xref>], and neuropathological studies [<xref ref-type="bibr" rid="r193">193</xref>]. Conversely, fewer investigations have focused on the impact of <italic>APOE</italic> in normal brain aging conditions and specifically on <italic>APOE</italic>-related influence on cognition and other brain functions during normal brain aging. Furthermore, for statistical purposes, <italic>APOE</italic>4 effects have been much more frequently contrasted to <italic>APOE</italic>3 (the most frequent <italic>APOE</italic> allele in Caucasian populations) and much less to <italic>APOE</italic>2 due to its lower frequency in most human populations [<xref ref-type="bibr" rid="r194">194</xref>]. Very often, in fact, the rarity of <italic>APOE</italic>2 did not allow performing a correct and reliable statistical approach due to the marked differences in terms of population sample sizes to compare (e.g. numerosity of <italic>APOE</italic>4 vs. <italic>APOE</italic>2 subjects).</p>
<p>Moreover, the harmful effect of <italic>APOE</italic>4 has been associated not only to a higher risk of AD but also to a higher risk or different clinical outcomes for other neurological [<xref ref-type="bibr" rid="r195">195</xref>–<xref ref-type="bibr" rid="r198">198</xref>] and non-neurological conditions [<xref ref-type="bibr" rid="r199">199</xref>–<xref ref-type="bibr" rid="r203">203</xref>]. These latter findings support the hypothesis that <italic>APOE</italic> is very much indeed a possible general modifier of various biological and consequently, clinical phenomena. Curiously, <italic>APOE</italic>4 has also been associated with some apparently paradoxical effects [<xref ref-type="bibr" rid="r204">204</xref>–<xref ref-type="bibr" rid="r207">207</xref>]. For example, the absence of a higher risk for AD or cognitive deficits in some specific human populations has been found [<xref ref-type="bibr" rid="r206">206</xref>,<xref ref-type="bibr" rid="r207">207</xref>]. Nonetheless, the variability of <italic>APOE</italic>4-associated risk across different human populations not only reinforces the concept that <italic>APOE</italic>4 is “just” a risk factor (in contrast to a Mendelian mutation) but also that other environmental and genetic factors are possibly associated with a higher risk of dementia, its onset, and pathogenic progression [<xref ref-type="bibr" rid="r208">208</xref>,<xref ref-type="bibr" rid="r209">209</xref>]. Significantly, the detrimental or beneficial biological mechanisms of <italic>APOE</italic> alleles during premorbid normal adult life periods are far from being completely clarified.</p>
<p>In terms of <italic>APOE</italic> polymorphism-associated changes during normal aging, some studies have shown that <italic>APOE</italic>4 (vs. <italic>APOE</italic>3) is associated with a cortical thinning in a series of specific brain regions (e.g. medial and inferior temporal regions, including entorhinal cortex) [<xref ref-type="bibr" rid="r210">210</xref>]. These thinner cortical regions are the same cerebral regions more frequently affected in AD and particularly vulnerable to the AD pathology accumulation (e.g. β-amyloid accumulation). Interestingly, though, the <italic>APOE</italic>4-associated thinning of those AD-vulnerable cortical regions seems to be, per se, independent from the extracellular β<italic>-</italic>amyloid accumulation, especially when cognitively normal vs. early mild cognitive impairment (EMCI) or AD subjects are taken in account [<xref ref-type="bibr" rid="r210">210</xref>]. This newer perspective on <italic>APOE</italic>4 that is, a genetic factor having its own impact independently from β-amyloid accumulation (or other pathologies?) seems to confirm a direct and autonomous influence of <italic>APOE</italic>4 on the cortical architecture in specific regions of the brain [<xref ref-type="bibr" rid="r211">211</xref>,<xref ref-type="bibr" rid="r212">212</xref>].</p>
<p>The pathogenetic “independency” of <italic>APOE</italic> could be probably linked to basic cholesterol metabolic mechanisms related of the three different <italic>APOE</italic> alleles, their final protein products and cellular localizations [<xref ref-type="bibr" rid="r213">213</xref>]. In addition, the possible association among <italic>APOE</italic> genotypes, specific brain areas architecture and related brain functions, seems to go behind pure cognitive aspects and involve other non-cognitive functions such as the motor skills for example [<xref ref-type="bibr" rid="r214">214</xref>].</p>
<p>Finally, it is relevant to consider that the effect of <italic>APOE</italic>4 on the pathology and progression of AD, and probably on human cognition in general, appears to be mitigated by a series of other possible beneficial environmental factors [<xref ref-type="bibr" rid="r215">215</xref>]. However, it is not completely known which could be the possible environmental factors that could alternatively (beneficial or detrimental) potentiate the opposite effects of <italic>APOE</italic>4 and <italic>APOE</italic>2 during normal life conditions.</p>
<p>This brief description of some most recent neuroimaging and population-based studies of the <italic>APOE</italic> impact in humans illustrates either the complexity and intrinsic plastic capacities of the human brain to produce different clinical outcomes as consequence of the mutual interplay among genetic risk factors (e.g. <italic>APOE</italic>4, is not a determinant of disease) on the neural tissue (e.g. cortical thinning), independent pathogenetic factors (different for example, from β-amyloid extracellular accumulation or intracellular phosphorylated-tau formation) and other possible environmental variables, which are not identified or completely investigated yet such as lifestyle, nutritional habits, stress, or history of infectious diseases. Moreover, it is important to mention that there are recent findings from relatively large cohort studies that enrolled cognitively normal centenarians, which started to investigate cognitive aspects related to <italic>APOE</italic> genotype at a very advanced age and started to show unexpected and interesting results. For example, <italic>APOE</italic>4 in centenarians seems to be positively correlated with negative rather than positive affect in interaction with life events [<xref ref-type="bibr" rid="r216">216</xref>].</p>
<p>In general, these new findings seem to reinforce the concept that <italic>APOE</italic> not only influences some cognitive aspects until very late in life, until the 10<sup>th</sup> of life or later, but that there are much tighter possible links among cognition, emotions, and longevity in the human species [<xref ref-type="bibr" rid="r217">217</xref>].</p>
</sec>
<sec>
<title><italic>APOE</italic> during pathological aging: Alzheimer’s Disease and other dementias in elders</title>
<p>In the context of neurodegenerative diseases, and dementia in particular, extensive analyses have shown that <italic>APOE</italic> genotype influences cognitive and non-cognitive phenotypes of subjects with a clinical diagnosis of MCI or AD (clinically probable AD). For example, <italic>APOE</italic>4 has been found to cluster at least two different groups of cognitive outcomes among subjects with dementia [<xref ref-type="bibr" rid="r5">5</xref>]. Moreover, in behavioral terms, <italic>APOE</italic>4 has been associated with different compartmental subtypes of AD [<xref ref-type="bibr" rid="r218">218</xref>]. Other investigations have further demonstrated that <italic>APOE</italic>4 can generate different endophenotypes in terms of neuropathology. For example, Murray et al. [<xref ref-type="bibr" rid="r219">219</xref>] were able to distinguish different subtypes of AD when <italic>APOE</italic>4 was clustered together with age of onset of the disease. However, in other non-AD dementias it seems that the detrimental link between <italic>APOE</italic>4 and cognitive decline is much more complex than in AD [<xref ref-type="bibr" rid="r220">220</xref>,<xref ref-type="bibr" rid="r221">221</xref>]. Moreover, previous and more recent investigations began showing that in the context of non-AD dementias such as FTD or cognitive decline in ALS, the modifying action of <italic>APOE</italic> polymorphism can be rather different from what is observed in classical AD [<xref ref-type="bibr" rid="r222">222</xref>,<xref ref-type="bibr" rid="r223">223</xref>]. For example, cognitive dysfunctions in ALS are associated with <italic>APOE</italic> genotype and other genes as well, such as SCNA gene. In this case, it seems that both genes cooperate for a higher risk of dementia in ALS only when related to the presence of Lewy bodies - a typical neuropathological feature of dementia with Lewy bodies (DLB) [<xref ref-type="bibr" rid="r224">224</xref>,<xref ref-type="bibr" rid="r225">225</xref>]. These recent findings support the possible mutual interactions between <italic>APOE</italic> and other genes and other non-genetic factors and that these more complex molecular interactions can produce different clinical phenotypes during the manifestations of age-related neurodegenerative diseases and probably earlier in life as well [<xref ref-type="bibr" rid="r226">226</xref>,<xref ref-type="bibr" rid="r227">227</xref>].</p>
</sec>
</sec>
<sec sec-type="cases">
<title>The “special” case of <italic>APOE</italic>2 and neurodegeneration during aging</title>
<p>As described earlier in this review, only few studies have focused on the relative impact, including possible molecular mechanisms, of <italic>APOE</italic>4 vs. <italic>APOE</italic>2 in terms of different cognitive outcomes during normal or cognitively successful aging [<xref ref-type="bibr" rid="r228">228</xref>–<xref ref-type="bibr" rid="r231">231</xref>]. Those few studies that have attempted to verify the possible associations between cognitively normal older subjects and <italic>APOE</italic> polymorphism have shown that the protective effect of <italic>APOE</italic>2 is not directly associated with mechanisms linked, for example, to the extracellular β-amyloid accumulation into the brain or to the alterations of synaptic and neuroinflammatory levels in the CNS [<xref ref-type="bibr" rid="r232">232</xref>,<xref ref-type="bibr" rid="r233">233</xref>]. These latter observations are of special interest since they could open other and different views on the possible protective mechanisms of <italic>APOE</italic>2 independent on the “classic” AD pathology [<xref ref-type="bibr" rid="r234">234</xref>,<xref ref-type="bibr" rid="r235">235</xref>]. These more recent findings allow hypothesizing that the protective effects of <italic>APOE</italic>2 on the brain and its functions are intrinsic to the molecular features of <italic>APOE</italic> alleles and its protein products. In fact, the beneficial effects of <italic>APOE</italic>2 later in life can be only partially, or indirectly, related to the reduction of those pathologic factors currently considered as the “pathogenetic” causes of AD: extracellular accumulation of β-amyloid pathology, hyperphosphorylated-tau formation and spreading, increased levels of neuroinflammation and synaptic loss [<xref ref-type="bibr" rid="r236">236</xref>,<xref ref-type="bibr" rid="r237">237</xref>]. Therefore, these more recent findings imply that also other factors linked to the intrinsic molecular advantage of <italic>APOE</italic>2 need to be taken in account [<xref ref-type="bibr" rid="r228">228</xref>,<xref ref-type="bibr" rid="r238">238</xref>,<xref ref-type="bibr" rid="r239">239</xref>]. However, the new molecular aspects of <italic>APOE</italic>2 need future confirmation by analyzing data from very large prospective studies aiming to measure the real effect of <italic>APOE</italic>2 protein in a large multi-factorial statistical model that would include both biological (genetic) and non-biological (environmental) factors [<xref ref-type="bibr" rid="r240">240</xref>,<xref ref-type="bibr" rid="r241">241</xref>]. These studies should include human brain donations to increase the chance to quantifying ratios between residual (normal/still-functional) and pathologic tissues (dysfunctional neuronal or non-neuronal) that could directly derive from the action of <italic>APOE</italic>2 vs. <italic>APOE</italic>4 on the neural tissue through probably its biochemical interaction with cholesterol metabolism. Therefore, it could be possible to hypothesize that the <italic>APOE</italic>2-related action on the cholesterol metabolism would be capable to delay the cognitive decline during normal aging by specific molecular mechanisms that could be modulated using pharmacological compounds or non-pharmacological treatments, or alternatively, offer the opportunity to potentiate their beneficial action in a more preventive or protective manner. Unfortunately, the specific <italic>APOE</italic>2 molecular mechanisms are currently not completely known [<xref ref-type="bibr" rid="r242">242</xref>]. Nonetheless, some molecular mechanisms have been proposed based on new and unexpected metabolic links between different biochemical pathways. For example, new possible links between homeostatic pathways of iron and lipids metabolism [<xref ref-type="bibr" rid="r243">243</xref>] or between <italic>APOE</italic>2 and disease-onset of other mutations through the interaction of <italic>APOE</italic>2 and genes involved in cellular proliferation, protein degradation, apoptotic and immune dysregulation processes has been shown [<xref ref-type="bibr" rid="r244">244</xref>]. Moreover, differential phenomena of neuroplasticity as based on <italic>APOE</italic>4 vs. <italic>APOE</italic>3 have been proposed [<xref ref-type="bibr" rid="r245">245</xref>]. Furthermore, as for possible differences across the three <italic>APOE</italic> proteins, recent pilot investigations started to show that <italic>APOE</italic> genotypes is associated with different plasmatic levels of <italic>APOE</italic>2 vs. <italic>APOE</italic>3 and <italic>APOE</italic>4 proteins as hourly measured in human subjects [<xref ref-type="bibr" rid="r246">246</xref>]. These newer biochemical findings on <italic>APOE</italic> have been made possible by recent methodological advancement especially those based on mass spectrometry [<xref ref-type="bibr" rid="r247">247</xref>] and highly complex techniques [<xref ref-type="bibr" rid="r248">248</xref>].</p>
</sec>
<sec sec-type="other6">
<title><italic>APOE</italic>, higher cognitive functions, and modulatory effects of personality-traits</title>
<p><italic>APOE</italic>2 in older subjects, even in the presence of high levels AD pathology and clinically silent dementia, have shown a significant association with higher language skills acquired early in life [<xref ref-type="bibr" rid="r249">249</xref>]. Furthermore, recently, MRI findings showed that specific spectroscopy signals are associated with cognitive and language development at term-equivalent period in some of the identical brain areas (e.g. hippocampus) that are later often affected by aging-related diseases such as AD [<xref ref-type="bibr" rid="r250">250</xref>,<xref ref-type="bibr" rid="r251">251</xref>]. However, it is not known, yet, if these imaging findings are also directly linked to <italic>APOE</italic> or to other genetic polymorphisms. Nonetheless, it is highly possible that language skills, as well as other higher cognitive human functions, could be connected to more specific gene-environmental interactions during either in-utero life and during the very first months or years of life as based on a cluster of genes, including <italic>APOE</italic>, whose function or dysfunction, directly predispose an individual to a higher risk of neurological and psychiatric risk later in life due to the very early impact of those gene-environmental interactions on specific brain structures and functions “already set up for” at birth or earlier. These early gene-environmental neurobiological phenomena could predispose to specific types of neurophenotypes later in life during the youth, middle-age or aging of that individual [<xref ref-type="bibr" rid="r253">253</xref>].</p>
<p>Intriguingly, <italic>APOE</italic> genotype seems to be associated or interacting with specific traits of personality [<xref ref-type="bibr" rid="r254">254</xref>], and even with GM volumes in specific areas of the brain that can have a modulatory effect on cognition. Among the personality traits that seem to be associated with an <italic>APOE</italic>-personality modulatory interaction there is the conscientiousness [<xref ref-type="bibr" rid="r7">7</xref>]. Although many of these studies were limited by the relatively small number of subjects analyzed, they do represent initial and important findings of the more plastic relationship between <italic>APOE</italic> and personality-based behavioral aspects that could represent useful clinical tools in establishing a higher risk of dementia before any clinical manifestation [<xref ref-type="bibr" rid="r255">255</xref>,<xref ref-type="bibr" rid="r256">256</xref>].</p>
</sec>
<sec sec-type="other7">
<title>FUTURE PERSPECTIVES</title>
<p>This necessarily succinct review focusing on the possible types of impact of <italic>APOE</italic> polymorphism on human brain structures, cerebral functions, and brain illnesses across different ages in normal and pathological conditions of the brain and possible modulatory effects of specific personality traits (e.g. conscientiousness, neuroticism) suggests that future larger longitudinal investigations would need to consider numerous genetic and environmental variables to fully identify the molecular mechanisms of <italic>APOE</italic> as well as the interactions between the <italic>APOE</italic> with other genes and other aspects such as environmental imprinting (nutritional, educational, behavioral, etc.) during the early phase of life [<xref ref-type="bibr" rid="r257">257</xref>,<xref ref-type="bibr" rid="r258">258</xref>].</p>
<p><italic>APOE</italic> started to appear a gene associated with relevant antagonistic pleiotropic phenomena and it seems to be involved in different human diseases, not only brain diseases [<xref ref-type="bibr" rid="r259">259</xref>]. <italic>APOE</italic> appears, in fact, to have an important and modifying impact on lung diseases [<xref ref-type="bibr" rid="r200">200</xref>], infectious diseases [<xref ref-type="bibr" rid="r202">202</xref>,<xref ref-type="bibr" rid="r260">260</xref>], and on very specific pathologic processes [<xref ref-type="bibr" rid="r203">203</xref>]. Finally, <italic>APOE</italic> seems to be involved in the different behavioral outcomes and personality-traits modulatory effects whose molecular mechanisms still need to be completely elucidated [<xref ref-type="bibr" rid="r261">261</xref>].</p>
<p>Future studies, possibly stratified by individual <italic>APOE</italic> genotype, should be able to identify the precise molecular mechanisms by which a specific compound could modify or halt the detrimental effects of <italic>APOE</italic>4 during late-life period or, by “paradoxical” contrast, enhance its effects during the early or very early phases of life. Different types of molecules with possible pharmacological actions on the <italic>APOE</italic> gene products, and especially on <italic>APOE</italic>4 gene product, are under constant investigation [<xref ref-type="bibr" rid="r262">262</xref>,<xref ref-type="bibr" rid="r263">263</xref>], using newer technological sequencing and computational advancements that better inform us on the possible genome-based mechanisms of health maintenance [<xref ref-type="bibr" rid="r264">264</xref>,<xref ref-type="bibr" rid="r265">265</xref>]. Moreover, <italic>APOE</italic>4 has been identified as a ligand for the LDL receptors (LDLRs) family and that ApoE receptor 2 (ApoEr2) [<xref ref-type="bibr" rid="r266">266</xref>], together with VLDL receptor (VLDLR), have major impacts on brain development and adult synaptic plasticity [<xref ref-type="bibr" rid="r267">267</xref>,<xref ref-type="bibr" rid="r268">268</xref>]. ApoEr2 acts through the activation of Reelin [<xref ref-type="bibr" rid="r269">269</xref>–<xref ref-type="bibr" rid="r271">271</xref>], whose function could be modulated by specific compounds that secondarily would act or reduce the <italic>APOE</italic>4 detrimental effects on the CNS in general, or on dementia being the main genetic risk factor for AD [<xref ref-type="bibr" rid="r272">272</xref>,<xref ref-type="bibr" rid="r273">273</xref>].</p>
<p>Finally, new and exciting facets of CNS biology and aging such as those related to the glymphatic system [<xref ref-type="bibr" rid="r274">274</xref>], or the CNS-associated lymphatic system [<xref ref-type="bibr" rid="r275">275</xref>], have recently opened new ways to better understand the CNS biology, its clearance capacities, as well as the possibility to associate these new discoveries with acquired knowledge about <italic>APOE</italic>, its pathogenic contribution to neuropathology of dementia, and the effects of <italic>APOE</italic> alleles across the entire human lifespan.</p>
</sec>
<sec sec-type="other8">
<title>BOX 1. POSSIBLE <italic>APOE</italic>-LINKED BIOLOGICAL TRAITS ASSOCIATED WITH ANTAGONISTIC PLEIOTROPY FEATURES</title>
<p>Although this review aimed to describe the findings about different functional brain outcomes, in normal and pathological conditions of the brain, associated or influenced by the <italic>APOE</italic> allelic polymorphism in humans, we also briefly describe some of the possible <italic>APOE</italic>-molecular and non-molecular traits that could be associated with the proposed AP features of <italic>APOE</italic>. There is a plethora of animal studies (experiments employing transgenic animals, mainly rodents) that define various genetic (<italic>APOE</italic>), metabolic (ApoE proteins), and ApoE receptors (intracellular functional consequences) molecular aspects that would be impossible to describe here in an exhaustive way. For this reason, we preferred to focus on those possible <italic>APOE</italic>-traits that seem to have some antagonistic pleiotropic (AP) features across the lifespan in mammalians.</p>
<p>We retain that the following “<italic>APOE-</italic>linked traits” are among the most suitable candidates able to explain the antagonistic pleiotropic effects of the <italic>APOE</italic> polymorphism:</p>
<sec>
<title><italic>APOE4</italic>-carrier as “Higher β-amyloid accumulator subject”</title>
<p>Using different animal models and different biochemical approaches, it has been demonstrated that <italic>APOE</italic>4-animals have a reduced capacity to catabolize and consequently to reduce, the progressive accumulation of 1-42 β-amyloid, one of the main constituents of extracellular β-amyloid accumulation [<xref ref-type="bibr" rid="r276">276</xref>–<xref ref-type="bibr" rid="r278">278</xref>]. Furthermore, <italic>APOE</italic>4 seems also to indirectly exacerbate tau-mediated neurodegeneration [<xref ref-type="bibr" rid="r279">279</xref>]. Moreover, the <italic>APOE</italic>4 seems to determine this reduction of catabolic 1-42 β-amyloid (as well as of other forms of β-amyloid [<xref ref-type="bibr" rid="r280">280</xref>,<xref ref-type="bibr" rid="r281">281</xref>]) in a regionally-based manner [<xref ref-type="bibr" rid="r282">282</xref>–<xref ref-type="bibr" rid="r284">284</xref>]. If these deleterious effects of <italic>APOE</italic>4 on the β-amyloid metabolism during aging or adult life are deleterious as well for the brain or other tissues in early life is not known or, by contrast, if <italic>APOE</italic>2 has a beneficial effect in early-life is not completely understood [<xref ref-type="bibr" rid="r285">285</xref>,<xref ref-type="bibr" rid="r286">286</xref>]. Curiously, however, newer investigations both in animals and humans showed a “paradoxical” (due to actually to the AP?) effect of <italic>APOE</italic>2, specifically in case of <italic>APOE</italic>2 homozygosis (<italic>APOE</italic>2/E2) [<xref ref-type="bibr" rid="r287">287</xref>]. Zhao and colleagues, for example, show increased levels of tau lesions in cases of Progressive Supranuclear Palsy (PSP), a typical tauopathy, when associated with <italic>APOE</italic>2 homozygosis.</p>
</sec>
<sec>
<title><italic>APOE4</italic>-carrier as “Lower synaptic/spine replacement/ repairing capacity subject”</title>
<p>A consistent series of experiments either in-vitro and in-vivo aiming to compare the formation of synapses or the capacity to repair synapses in the presence of <italic>APOE4</italic> vs. <italic>APOE</italic>3 or <italic>APOE</italic>2 have now consolidated the evidence that <italic>APOE</italic> polymorphism is indeed directly linked to differential capacities of the brain, both in terms of synapses formation and repair, when one of those three alleles are expressed. For example, in the specific context of AD - where entorhinal cortex lesions represent some of the very initial pathogenetic events ending in the synaptic loss subjacent memory impairment - it has been demonstrated that <italic>APOE</italic>4 is associated to a reduced capacity to form new synapses as measured by GAP-43 and synaptophysin proteins, which are typical molecular markers of neo-synaptogenesis [<xref ref-type="bibr" rid="r288">288</xref>,<xref ref-type="bibr" rid="r289">289</xref>]. Furthermore, other investigators have demonstrated that <italic>APOE</italic>4 is specifically associated with a reduced capacity to produce spine and consequently contribute to the dendritic complexity [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r290">290</xref>]. Although these animal models show the detrimental effect of <italic>APOE</italic>4 on the synaptic compartment, which is coherent with the <italic>APOE</italic>4 effect later in life, paradoxically, or better in antagonistic pleiotropic terms, there are studies in humans showing a higher performance of specific cognitive tasks in younger subjects when carrying <italic>APOE</italic>4 in comparison to <italic>APOE</italic>2 [<xref ref-type="bibr" rid="r291">291</xref>–<xref ref-type="bibr" rid="r293">293</xref>]. However, some new recent studies in humans show that even in the presence of <italic>APOE</italic>4 there are some morphometric alterations of the dendritic spines (e.g. in the frontal cortex), which could support the maintenance of normal cognitive functions despite the presence of AD pathology or aging [<xref ref-type="bibr" rid="r294">294</xref>].</p>
</sec>
<sec>
<title><italic>APOE4</italic>-carrier and personality-traits, “Higher genetic-personality-trait susceptible subject”</title>
<p>The neurohistologic structure as the neuronal and synaptic complexity associated to the different traits of personality defined in humans is not completely known [<xref ref-type="bibr" rid="r295">295</xref>]. The attempt to link specific connectomics aspects to each specific type of personality or behavior is still in its infancy [<xref ref-type="bibr" rid="r296">296</xref>–<xref ref-type="bibr" rid="r298">298</xref>]. However, initial studies are showing interesting findings when introducing the <italic>APOE</italic> polymorphism factor in the analyses of possible connectomics changes in <italic>APOE</italic>4 carrier individuals. Some recent studies [<xref ref-type="bibr" rid="r300">300</xref>,<xref ref-type="bibr" rid="r301">301</xref>] show that the default-mode network in <italic>APOE</italic>4 subjects differs from non-<italic>APOE</italic>4 in a way that <italic>APOE</italic>4 seems to establish the functional communications across different brain regions (connectomics), which could predispose to some cognitive disadvantage across the entire lifespan. Moreover, some investigations pointed out that there is indeed an association between cognition measurements and personality traits [<xref ref-type="bibr" rid="r302">302</xref>,<xref ref-type="bibr" rid="r303">303</xref>]. If these links are also based, influenced, or modulated by a specific genotype, such <italic>APOE</italic>4 vs. <italic>APOE</italic>2 is under investigation. However, initial studies, show that specific personality factors (e.g. neuroticism and extraversion) can actually moderate the cognitive outcomes in <italic>APOE</italic>4 carriers [<xref ref-type="bibr" rid="r255">255</xref>,<xref ref-type="bibr" rid="r261">261</xref>].</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="COI-statement">
<p><bold>CONFLICTS OF INTEREST:</bold> The authors have nothing to disclose and do not have any conflict of interests.</p>
</fn>
<fn fn-type="financial-disclosure">
<p><bold>FUNDING:</bold> This manuscript was supported by intramural funds of the Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ, USA.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="r1">
<label>1</label>
<mixed-citation publication-type="journal"><string-name><surname>Dumanis</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Tesoriero</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Babus</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Trotter</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Ladu</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Weeber</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Turner</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Rebeck</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Hoe</surname>
<given-names>HS</given-names></string-name>. <article-title>ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.</article-title>
<source/>J Neurosci. <year>2009</year>; <volume>29</volume>:<fpage>15317</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4026-09.2009</pub-id><pub-id pub-id-type="pmid">19955384</pub-id></mixed-citation>
</ref>
<ref id="r2">
<label>2</label>
<mixed-citation publication-type="journal"><string-name><surname>Jain</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Knoferle</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>. <article-title>Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development.</article-title>
<source/>PLoS One. <year>2013</year>; <volume>8</volume>:<fpage>e59478</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059478</pub-id><pub-id pub-id-type="pmid">23527202</pub-id></mixed-citation>
</ref>
<ref id="r3">
<label>3</label>
<mixed-citation publication-type="journal"><string-name><surname>Simonovitch</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schmukler</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bespalko</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Iram</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Frenkel</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Holtzman</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Masliah</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Michaelson</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Pinkas-Kramarski</surname>
<given-names>R</given-names></string-name>. <article-title>Impaired autophagy in APOE4 a strocytes.</article-title>
<source/>J Alzheimers Dis. <year>2016</year>; <volume>51</volume>:<fpage>915</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-151101</pub-id><pub-id pub-id-type="pmid">26923027</pub-id></mixed-citation>
</ref>
<ref id="r4">
<label>4</label>
<mixed-citation publication-type="journal"><string-name><surname>Levi</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Lütjohann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Devir</surname>
<given-names>A</given-names></string-name>, <string-name><surname>von Bergmann</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hartmann</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Michaelson</surname>
<given-names>DM</given-names></string-name>. <article-title>Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation.</article-title>
<source/>J Neurochem. <year>2005</year>; <volume>95</volume>:<fpage>987</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03441.x</pub-id><pub-id pub-id-type="pmid">16190879</pub-id></mixed-citation>
</ref>
<ref id="r5">
<label>5</label>
<mixed-citation publication-type="journal"><string-name><surname>Scheltens</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Tijms</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Koene</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Barkhof</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Teunissen</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Wolfsgruber</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wagner</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kornhuber</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Peters</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Cohn-Sheehy</surname>
<given-names>BI</given-names></string-name>, <string-name><surname>Rabinovici</surname>
<given-names>GD</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>BL</given-names></string-name>, <string-name><surname>Kramer</surname>
<given-names>JH</given-names></string-name>, <etal>et al</etal>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>, and <collab>German Dementia Competence Network</collab>, and <collab>University of California San Francisco Memory and Aging Center</collab>, and <collab>Amsterdam Dementia Cohort</collab>. <article-title>Cognitive subtypes of probable Alzheimer’s disease robustly identified in four cohorts.</article-title>
<source/>Alzheimers Dement. <year>2017</year>; <volume>13</volume>:<fpage>1226</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2017.03.002</pub-id><pub-id pub-id-type="pmid">28427934</pub-id></mixed-citation>
</ref>
<ref id="r6">
<label>6</label>
<mixed-citation publication-type="journal"><string-name><surname>Gardener</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Rainey-Smith</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Sohrabi</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Weinborn</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Verdile</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Fernando</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Harrington</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Burnham</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Taddei</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Masters</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Macaulay</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Rowe</surname>
<given-names>CC</given-names></string-name>, <etal>et al</etal>, and <collab>AIBL Research Group</collab>. <article-title>Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>58</volume>:<fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-161158</pub-id><pub-id pub-id-type="pmid">28387666</pub-id></mixed-citation>
</ref>
<ref id="r7">
<label>7</label>
<mixed-citation publication-type="journal"><string-name><surname>Kunz</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Reuter</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Axmacher</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Montag</surname>
<given-names>C</given-names></string-name>. <article-title>Conscientiousness is negatively associated with grey matter volume in young APOE ɛ4-carriers.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>56</volume>:<fpage>1135</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160854</pub-id><pub-id pub-id-type="pmid">28106551</pub-id></mixed-citation>
</ref>
<ref id="r8">
<label>8</label>
<mixed-citation publication-type="journal"><string-name><surname>Håkansson</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Soininen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Winblad</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kivipelto</surname>
<given-names>M</given-names></string-name>. <article-title>Feelings of hopelessness in midlife and cognitive health in later life: a prospective population-based cohort.</article-title>
<source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0140261</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0140261</pub-id><pub-id pub-id-type="pmid">26460971</pub-id></mixed-citation>
</ref>
<ref id="r9">
<label>9</label>
<mixed-citation publication-type="journal"><string-name><surname>Khan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Giampietro</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Banaschewski</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Barker</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Bokde</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Büchel</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Conrod</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Flor</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Frouin</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Garavan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Gowland</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Heinz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ittermann</surname>
<given-names>B</given-names></string-name>, <etal>et al</etal>, and <collab>Alzheimer–s Disease Neuroimaging Initiative</collab>, and <collab>AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group</collab>, and <collab>IMAGEN consortium</collab>. <article-title>A multi-cohort study of ApoE ɛ4 and Amyloid-β effects on the hippocampus in Alzheimer’s Disease.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>56</volume>:<fpage>1159</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-161097</pub-id><pub-id pub-id-type="pmid">28157104</pub-id></mixed-citation>
</ref>
<ref id="r10">
<label>10</label>
<mixed-citation publication-type="journal"><string-name><surname>Krell-Roesch</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vemuri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pink</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>RO</given-names></string-name>, <string-name><surname>Stokin</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Mielke</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Christianson</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Knopman</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Kremers</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Geda</surname>
<given-names>YE</given-names></string-name>. <article-title>Association between mentally stimulating activities in late life and the outcome of incident mild cognitive impairment, with an analysis of the APOE ε4 genotype.</article-title>
<source/>JAMA Neurol. <year>2017</year>; <volume>74</volume>:<fpage>332</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.3822</pub-id><pub-id pub-id-type="pmid">28135351</pub-id></mixed-citation>
</ref>
<ref id="r11">
<label>11</label>
<mixed-citation publication-type="journal"><string-name><surname>Pappas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chaiworapongsa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Romero</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Korzeniewski</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Cortez</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Bhatti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gomez-Lopez</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hassan</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Shankaran</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tarca</surname>
<given-names>AL</given-names></string-name>. <article-title>Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.</article-title>
<source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0118573</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0118573</pub-id><pub-id pub-id-type="pmid">25822971</pub-id></mixed-citation>
</ref>
<ref id="r12">
<label>12</label>
<mixed-citation publication-type="journal"><string-name><surname>Eidem</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Ackerman</surname>
<given-names>WE</given-names>
<suffix>4th</suffix></string-name>, <string-name><surname>McGary</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Abbot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rokas</surname>
<given-names>A</given-names></string-name>. <article-title>Gestational tissue transcriptomics in term and preterm human pregnancies: a systematic review and meta-analysis.</article-title>
<source/>BMC Med Genomics. <year>2015</year>; <volume>8</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s12920-015-0099-8</pub-id><pub-id pub-id-type="pmid">26044726</pub-id></mixed-citation>
</ref>
<ref id="r13">
<label>13</label>
<mixed-citation publication-type="journal"><string-name><surname>Tilley</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Joseph</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Kuban</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Dammann</surname>
<given-names>OU</given-names></string-name>, <string-name><surname>O’Shea</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Fry</surname>
<given-names>RC</given-names></string-name>. <article-title>Genomic biomarkers of prenatal intrauterine inflammation in umbilical cord tissue predict later life neurological outcomes.</article-title>
<source/>PLoS One. <year>2017</year>; <volume>12</volume>:<fpage>e0176953</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0176953</pub-id><pub-id pub-id-type="pmid">28493900</pub-id></mixed-citation>
</ref>
<ref id="r14">
<label>14</label>
<mixed-citation publication-type="journal"><string-name><surname>Prizer</surname>
<given-names>LP</given-names></string-name>, <string-name><surname>Zimmerman</surname>
<given-names>S</given-names></string-name>. <article-title>Progressive support for activities of daily living for persons living with dementia.</article-title>
<source/>Gerontologist. <year>2018</year> (<issue>suppl_1</issue>); <volume>58</volume>:<fpage>S74</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1093/geront/gnx103</pub-id><pub-id pub-id-type="pmid">29361063</pub-id></mixed-citation>
</ref>
<ref id="r15">
<label>15</label>
<mixed-citation publication-type="journal"><string-name><surname>Katzman</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Terry</surname>
<given-names>R</given-names></string-name>, <string-name><surname>DeTeresa</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Fuld</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Renbing</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Peck</surname>
<given-names>A</given-names></string-name>. <article-title>Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.</article-title>
<source/>Ann Neurol. <year>1988</year>; <volume>23</volume>:<fpage>138</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410230206</pub-id><pub-id pub-id-type="pmid">2897823</pub-id></mixed-citation>
</ref>
<ref id="r16">
<label>16</label>
<mixed-citation publication-type="journal"><string-name><surname>Crystal</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Dickson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fuld</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Masur</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mehler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Masdeu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kawas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Aronson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wolfson</surname>
<given-names>L</given-names></string-name>. <article-title>Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease.</article-title>
<source/>Neurology. <year>1988</year>; <volume>38</volume>:<fpage>1682</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.38.11.1682</pub-id><pub-id pub-id-type="pmid">3185902</pub-id></mixed-citation>
</ref>
<ref id="r17">
<label>17</label>
<mixed-citation publication-type="journal"><string-name><surname>Troncoso</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Dal Forno</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kawas</surname>
<given-names>CH</given-names></string-name>. <article-title>Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.</article-title>
<source/>Neurobiol Aging. <year>1996</year>; <volume>17</volume>:<fpage>365</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/0197-4580(96)00028-0</pub-id><pub-id pub-id-type="pmid">8725897</pub-id></mixed-citation>
</ref>
<ref id="r18">
<label>18</label>
<mixed-citation publication-type="journal"><string-name><surname>Price</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>JC</given-names></string-name>. <article-title>Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease.</article-title>
<source/>Ann Neurol. <year>1999</year>; <volume>45</volume>:<fpage>358</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8249(199903)45:3&lt;358::AID-ANA12&gt;3.0.CO;2-X</pub-id><pub-id pub-id-type="pmid">10072051</pub-id></mixed-citation>
</ref>
<ref id="r19">
<label>19</label>
<mixed-citation publication-type="journal"><string-name><surname>Knopman</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Parisi</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Salviati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Floriach-Robert</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Boeve</surname>
<given-names>BF</given-names></string-name>, <string-name><surname>Ivnik</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Dickson</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>McDonald</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Braak</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>RC</given-names></string-name>. <article-title>Neuropathology of cognitively normal elderly.</article-title>
<source/>J Neuropathol Exp Neurol. <year>2003</year>; <volume>62</volume>:<fpage>1087</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/62.11.1087</pub-id><pub-id pub-id-type="pmid">14656067</pub-id></mixed-citation>
</ref>
<ref id="r20">
<label>20</label>
<mixed-citation publication-type="journal"><string-name><surname>Iacono</surname>
<given-names>D</given-names></string-name>, <string-name><surname>O’Brien</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Resnick</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Zonderman</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Pletnikova</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Rudow</surname>
<given-names>G</given-names></string-name>, <string-name><surname>An</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>West</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Crain</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Troncoso</surname>
<given-names>JC</given-names></string-name>. <article-title>Neuronal hypertrophy in asymptomatic Alzheimer disease.</article-title>
<source/>J Neuropathol Exp Neurol. <year>2008</year>; <volume>67</volume>:<fpage>578</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181772794</pub-id><pub-id pub-id-type="pmid">18520776</pub-id></mixed-citation>
</ref>
<ref id="r21">
<label>21</label>
<mixed-citation publication-type="journal"><string-name><surname>Monsell</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Mock</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Fardo</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Bertelsen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cairns</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Roe</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Ellingson</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Goate</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kukull</surname>
<given-names>WA</given-names></string-name>. <article-title>Genetic comparison of symptomatic and asymptomatic persons with Alzheimer Disease neuropathology.</article-title>
<source/>Alzheimer Dis Assoc Disord. <year>2017</year>; <volume>31</volume>:<fpage>232</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1097/WAD.0000000000000179</pub-id><pub-id pub-id-type="pmid">27849641</pub-id></mixed-citation>
</ref>
<ref id="r22">
<label>22</label>
<mixed-citation publication-type="journal"><string-name><surname>Stern</surname>
<given-names>Y</given-names></string-name>. <article-title>What is cognitive reserve? Theory and research application of the reserve concept.</article-title>
<source/>J Int Neuropsychol Soc. <year>2002</year>; <volume>8</volume>:<fpage>448</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1017/S1355617702813248</pub-id><pub-id pub-id-type="pmid">11939702</pub-id></mixed-citation>
</ref>
<ref id="r23">
<label>23</label>
<mixed-citation publication-type="journal"><string-name><surname>Stern</surname>
<given-names>Y</given-names></string-name>. <article-title>Cognitive reserve in ageing and Alzheimer’s disease.</article-title>
<source/>Lancet Neurol. <year>2012</year>; <volume>11</volume>:<fpage>1006</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70191-6</pub-id><pub-id pub-id-type="pmid">23079557</pub-id></mixed-citation>
</ref>
<ref id="r24">
<label>24</label>
<mixed-citation publication-type="journal"><string-name><surname>Honer</surname>
<given-names>WG</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Sawada</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Thornton</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Leurgans</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>DA</given-names></string-name>. <article-title>Cognitive reserve, presynaptic proteins and dementia in the elderly.</article-title>
<source/>Transl Psychiatry. <year>2012</year>; <volume>2</volume>:<fpage>e114</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2012.38</pub-id><pub-id pub-id-type="pmid">22832958</pub-id></mixed-citation>
</ref>
<ref id="r25">
<label>25</label>
<mixed-citation publication-type="journal"><string-name><surname>Neltner</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Abner</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Jicha</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Schmitt</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Poon</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Marla</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Davey</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Jazwinski</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>D</given-names></string-name>, <etal>et al</etal>. <article-title>Brain pathologies in extreme old age.</article-title>
<source/>Neurobiol Aging. <year>2016</year>; <volume>37</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.10.009</pub-id><pub-id pub-id-type="pmid">26597697</pub-id></mixed-citation>
</ref>
<ref id="r26">
<label>26</label>
<mixed-citation publication-type="journal"><string-name><surname>Descamps</surname>
<given-names>OS</given-names></string-name>, <string-name><surname>Bruniaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guilmot</surname>
<given-names>PF</given-names></string-name>, <string-name><surname>Tonglet</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Heller</surname>
<given-names>FR</given-names></string-name>. <article-title>Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children.</article-title>
<source/>J Lipid Res. <year>2005</year>; <volume>46</volume>:<fpage>2405</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M500223-JLR200</pub-id><pub-id pub-id-type="pmid">16106048</pub-id></mixed-citation>
</ref>
<ref id="r27">
<label>27</label>
<mixed-citation publication-type="journal"><string-name><surname>Steffen</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Cooper</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Caprau</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Simhan</surname>
<given-names>HN</given-names></string-name>, <string-name><surname>Dagle</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Marazita</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>JC</given-names></string-name>. <article-title>Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.</article-title>
<source/>J Perinatol. <year>2007</year>; <volume>27</volume>:<fpage>672</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jp.7211806</pub-id><pub-id pub-id-type="pmid">17855807</pub-id></mixed-citation>
</ref>
<ref id="r28">
<label>28</label>
<mixed-citation publication-type="journal"><string-name><surname>Procopciuc</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Caracostea</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zaharie</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Stamatian</surname>
<given-names>F</given-names></string-name>. <article-title>Newborn APOE genotype influences maternal lipid profile and the severity of high-risk pregnancy - preeclampsia: interaction with maternal genotypes as a modulating risk factor in preeclampsia.</article-title>
<source/>Hypertens Pregnancy. <year>2015</year>; <volume>34</volume>:<fpage>271</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.3109/10641955.2015.1009541</pub-id><pub-id pub-id-type="pmid">25806651</pub-id></mixed-citation>
</ref>
<ref id="r29">
<label>29</label>
<mixed-citation publication-type="journal"><string-name><surname>Mauch</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Nägler</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Schumacher</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Göritz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Müller</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Otto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pfrieger</surname>
<given-names>FW</given-names></string-name>. <article-title>CNS synaptogenesis promoted by glia-derived cholesterol.</article-title>
<source/>Science. <year>2001</year>; <volume>294</volume>:<fpage>1354</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1126/science.294.5545.1354</pub-id><pub-id pub-id-type="pmid">11701931</pub-id></mixed-citation>
</ref>
<ref id="r30">
<label>30</label>
<mixed-citation publication-type="journal"><string-name><surname>Tamnes</surname>
<given-names>CK</given-names></string-name>, <string-name><surname>Walhovd</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Dale</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Østby</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Grydeland</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Richardson</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Westlye</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Roddey</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Hagler</surname>
<given-names>DJ</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Due-Tønnessen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Holland</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fjell</surname>
<given-names>AM</given-names></string-name>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>. <article-title>Brain development and aging: overlapping and unique patterns of change.</article-title>
<source/>Neuroimage. <year>2013</year>; <volume>68</volume>:<fpage>63</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.11.039</pub-id><pub-id pub-id-type="pmid">23246860</pub-id></mixed-citation>
</ref>
<ref id="r31">
<label>31</label>
<mixed-citation publication-type="journal"><string-name><surname>Lancaster</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rusted</surname>
<given-names>J</given-names></string-name>. <article-title>The APOE paradox: do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline.</article-title>
<source/>Neurobiol Aging. <year>2016</year>; <volume>48</volume>:<fpage>114</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.08.015</pub-id><pub-id pub-id-type="pmid">27661410</pub-id></mixed-citation>
</ref>
<ref id="r32">
<label>32</label>
<mixed-citation publication-type="journal"><string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.</article-title>
<source/>Science. <year>1988</year>; <volume>240</volume>:<fpage>622</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1126/science.3283935</pub-id><pub-id pub-id-type="pmid">3283935</pub-id></mixed-citation>
</ref>
<ref id="r33">
<label>33</label>
<mixed-citation publication-type="journal"><string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Rall</surname>
<given-names>SC</given-names>
<suffix>Jr</suffix></string-name>. <article-title>Apolipoprotein E: far more than a lipid transport protein.</article-title>
<source/>Annu Rev Genomics Hum Genet. <year>2000</year>; <volume>1</volume>:<fpage>507</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.1.1.507</pub-id><pub-id pub-id-type="pmid">11701639</pub-id></mixed-citation>
</ref>
<ref id="r34">
<label>34</label>
<mixed-citation publication-type="journal"><string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism.</article-title>
<source/>Arterioscler Thromb Vasc Biol. <year>2016</year>; <volume>36</volume>:<fpage>1305</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307023</pub-id><pub-id pub-id-type="pmid">27174096</pub-id></mixed-citation>
</ref>
<ref id="r35">
<label>35</label>
<mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases.</article-title>
<source/>Neurobiol Dis. <year>2014</year>; <volume>72</volume>:<fpage>3</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.08.025</pub-id><pub-id pub-id-type="pmid">25173806</pub-id></mixed-citation>
</ref>
<ref id="r36">
<label>36</label>
<mixed-citation publication-type="journal"><string-name><surname>Hauser</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Narayanaswami</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>RO</given-names></string-name>. <article-title>Apolipoprotein E: from lipid transport to neurobiology.</article-title>
<source/>Prog Lipid Res. <year>2011</year>; <volume>50</volume>:<fpage>62</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.plipres.2010.09.001</pub-id><pub-id pub-id-type="pmid">20854843</pub-id></mixed-citation>
</ref>
<ref id="r37">
<label>37</label>
<mixed-citation publication-type="journal"><string-name><surname>Holtzman</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>. <article-title>Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.</article-title>
<source/>Cold Spring Harb Perspect Med. <year>2012</year>; <volume>2</volume>:<fpage>a006312</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a006312</pub-id><pub-id pub-id-type="pmid">22393530</pub-id></mixed-citation>
</ref>
<ref id="r38">
<label>38</label>
<mixed-citation publication-type="journal"><string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>. <article-title>Apolipoprotein E receptors in the nervous system.</article-title>
<source/>Curr Opin Lipidol. <year>2009</year>; <volume>20</volume>:<fpage>190</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1097/MOL.0b013e32832d3a10</pub-id><pub-id pub-id-type="pmid">19433918</pub-id></mixed-citation>
</ref>
<ref id="r39">
<label>39</label>
<mixed-citation publication-type="journal"><string-name><surname>Lane-Donovan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Philips</surname>
<given-names>GT</given-names></string-name>, <string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>. <article-title>More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.</article-title>
<source/>Neuron. <year>2014</year>; <volume>83</volume>:<fpage>771</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.08.005</pub-id><pub-id pub-id-type="pmid">25144875</pub-id></mixed-citation>
</ref>
<ref id="r40">
<label>40</label>
<mixed-citation publication-type="journal"><string-name><surname>Jones</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Rozkalne</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Spires-Jones</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Hshieh</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>von Armin</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Mielke</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bacskai</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Hyman</surname>
<given-names>BT</given-names></string-name>. <article-title>Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brain.</article-title>
<source/>PLoS One. <year>2011</year>; <volume>6</volume>:<fpage>e14586</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0014586</pub-id><pub-id pub-id-type="pmid">21297948</pub-id></mixed-citation>
</ref>
<ref id="r41">
<label>41</label>
<mixed-citation publication-type="journal"><string-name><surname>Simon</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Girod</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fonbonne</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salvador</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Clément</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lantéri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Amouyel</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lambert</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Lemoine</surname>
<given-names>J</given-names></string-name>. <article-title>Total ApoE and ApoE4 isoform assays in an Alzheimer’s disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides.</article-title>
<source/>Mol Cell Proteomics. <year>2012</year>; <volume>11</volume>:<fpage>1389</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M112.018861</pub-id><pub-id pub-id-type="pmid">22918225</pub-id></mixed-citation>
</ref>
<ref id="r42">
<label>42</label>
<mixed-citation publication-type="journal"><string-name><surname>Frieden</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Garai</surname>
<given-names>K</given-names></string-name>. <article-title>Concerning the structure of apoE.</article-title>
<source/>Protein Sci. <year>2013</year>; <volume>22</volume>:<fpage>1820</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1002/pro.2379</pub-id><pub-id pub-id-type="pmid">24115173</pub-id></mixed-citation>
</ref>
<ref id="r43">
<label>43</label>
<mixed-citation publication-type="journal"><string-name><surname>Weisgraber</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Rall</surname>
<given-names>SC</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.</article-title>
<source/>J Biol Chem. <year>1981</year>; <volume>256</volume>:<fpage>9077</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">7263700</pub-id></mixed-citation>
</ref>
<ref id="r44">
<label>44</label>
<mixed-citation publication-type="journal"><string-name><surname>Weisgraber</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Rall</surname>
<given-names>SC</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Innerarity</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Kuusi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ehnholm</surname>
<given-names>C</given-names></string-name>. <article-title>A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.</article-title>
<source/>J Clin Invest. <year>1984</year>; <volume>73</volume>:<fpage>1024</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1172/JCI111287</pub-id><pub-id pub-id-type="pmid">6323533</pub-id></mixed-citation>
</ref>
<ref id="r45">
<label>45</label>
<mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>PY</given-names></string-name>, <string-name><surname>Costumbrado</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>YH</given-names></string-name>. <article-title>Agarose gel electrophoresis for the separation of DNA fragments.</article-title>
<source/>J Vis Exp. <year>2012; 62;</year><fpage>3923</fpage>. <pub-id pub-id-type="doi">10.3791/3923</pub-id><pub-id pub-id-type="pmid">22546956</pub-id></mixed-citation>
</ref>
<ref id="r46">
<label>46</label>
<mixed-citation publication-type="journal"><string-name><surname>Weisgraber</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Newhouse</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Tuan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Nestruck</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Davignon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.</article-title>
<source/>Arteriosclerosis. <year>1989</year>; <volume>9</volume>:<fpage>50</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.9.1.50</pub-id><pub-id pub-id-type="pmid">2912421</pub-id></mixed-citation>
</ref>
<ref id="r47">
<label>47</label>
<mixed-citation publication-type="journal"><string-name><surname>Rall</surname>
<given-names>SC</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Weisgraber</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Innerarity</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Bersot</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Blum</surname>
<given-names>CB</given-names></string-name>. <article-title>Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.</article-title>
<source/>J Clin Invest. <year>1983</year>; <volume>72</volume>:<fpage>1288</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1172/JCI111085</pub-id><pub-id pub-id-type="pmid">6313758</pub-id></mixed-citation>
</ref>
<ref id="r48">
<label>48</label>
<mixed-citation publication-type="journal"><string-name><surname>Wardell</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Brennan</surname>
<given-names>SO</given-names></string-name>, <string-name><surname>Janus</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Fraser</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Carrell</surname>
<given-names>RW</given-names></string-name>. <article-title>Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.</article-title>
<source/>J Clin Invest. <year>1987</year>; <volume>80</volume>:<fpage>483</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1172/JCI113096</pub-id><pub-id pub-id-type="pmid">3038959</pub-id></mixed-citation>
</ref>
<ref id="r49">
<label>49</label>
<mixed-citation publication-type="journal"><string-name><surname>Utermann</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Weisgraber</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Weber</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.</article-title>
<source/>J Lipid Res. <year>1984</year>; <volume>25</volume>:<fpage>378</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">6726088</pub-id></mixed-citation>
</ref>
<ref id="r50">
<label>50</label>
<mixed-citation publication-type="journal"><string-name><surname>Kara</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Marks</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Fan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Klickstein</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Roe</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Krogh</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Wegmann</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Maesako</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Mylvaganam</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Berezovska</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Hudry</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hyman</surname>
<given-names>BT</given-names></string-name>. <article-title>Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay.</article-title>
<source/>J Biol Chem. <year>2017</year>; <volume>292</volume>:<fpage>14720</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.784264</pub-id><pub-id pub-id-type="pmid">28684412</pub-id></mixed-citation>
</ref>
<ref id="r51">
<label>51</label>
<mixed-citation publication-type="journal"><string-name><surname>Farrer</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Cupples</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Haines</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Hyman</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kukull</surname>
<given-names>WA</given-names></string-name>, <string-name><surname>Mayeux</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Myers</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Pericak-Vance</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Risch</surname>
<given-names>N</given-names></string-name>, <string-name><surname>van Duijn</surname>
<given-names>CM</given-names></string-name>, and <collab>APOE and Alzheimer Disease Meta Analysis Consortium</collab>. <article-title>Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis.</article-title>
<source/>JAMA. <year>1997</year>; <volume>278</volume>:<fpage>1349</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1001/jama.1997.03550160069041</pub-id><pub-id pub-id-type="pmid">9343467</pub-id></mixed-citation>
</ref>
<ref id="r52">
<label>52</label>
<mixed-citation publication-type="journal"><string-name><surname>Gerdes</surname>
<given-names>LU</given-names></string-name>. <article-title>The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations.</article-title>
<source/>Clin Chem Lab Med. <year>2003</year>; <volume>41</volume>:<fpage>628</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1515/CCLM.2003.094</pub-id><pub-id pub-id-type="pmid">12812258</pub-id></mixed-citation>
</ref>
<ref id="r53">
<label>53</label>
<mixed-citation publication-type="journal"><string-name><surname>Eisenberg</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Kuzawa</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>MG</given-names></string-name>. <article-title>Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history.</article-title>
<source/>Am J Phys Anthropol. <year>2010</year>; <volume>143</volume>:<fpage>100</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/ajpa.21298</pub-id><pub-id pub-id-type="pmid">20734437</pub-id></mixed-citation>
</ref>
<ref id="r54">
<label>54</label>
<mixed-citation publication-type="journal"><string-name><surname>Beall</surname>
<given-names>CM</given-names></string-name>. <article-title>Two routes to functional adaptation: tibetan and Andean high-altitude natives.</article-title>
<source/>Proc Natl Acad Sci USA. <year>2007</year> (<issue>Suppl 1</issue>); <volume>104</volume>:<fpage>8655</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0701985104</pub-id><pub-id pub-id-type="pmid">17494744</pub-id></mixed-citation>
</ref>
<ref id="r55">
<label>55</label>
<mixed-citation publication-type="journal"><string-name><surname>Egert</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rimbach</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Huebbe</surname>
<given-names>P</given-names></string-name>. <article-title>ApoE genotype: from geographic distribution to function and responsiveness to dietary factors.</article-title>
<source/>Proc Nutr Soc. <year>2012</year>; <volume>71</volume>:<fpage>410</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1017/S0029665112000249</pub-id><pub-id pub-id-type="pmid">22564824</pub-id></mixed-citation>
</ref>
<ref id="r56">
<label>56</label>
<mixed-citation publication-type="journal"><string-name><surname>Trumble</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Stieglitz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Blackwell</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Allayee</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Beheim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Finch</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Gurven</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kaplan</surname>
<given-names>H</given-names></string-name>. <article-title>Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden.</article-title>
<source/>FASEB J. <year>2017</year>; <volume>31</volume>:<fpage>1508</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201601084R</pub-id><pub-id pub-id-type="pmid">28031319</pub-id></mixed-citation>
</ref>
<ref id="r57">
<label>57</label>
<mixed-citation publication-type="journal"><string-name><surname>Eisenberg</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Kuzawa</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>MG</given-names></string-name>. <article-title>Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history.</article-title>
<source/>Am J Phys Anthropol. <year>2010</year>; <volume>143</volume>:<fpage>100</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/ajpa.21298</pub-id><pub-id pub-id-type="pmid">20734437</pub-id></mixed-citation>
</ref>
<ref id="r58">
<label>58</label>
<mixed-citation publication-type="journal"><string-name><surname>Kern</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mehlig</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kern</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zetterberg</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Thelle</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Skoog</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Lissner</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blennow</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Börjesson-Hanson</surname>
<given-names>A</given-names></string-name>. <article-title>The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth.</article-title>
<source/>Am J Epidemiol. <year>2015</year>; <volume>181</volume>:<fpage>214</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwu442</pub-id><pub-id pub-id-type="pmid">25609095</pub-id></mixed-citation>
</ref>
<ref id="r59">
<label>59</label>
<mixed-citation publication-type="journal"><string-name><surname>Heffernan</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Chidgey</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Masters</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>BR</given-names></string-name>. <article-title>The neurobiology and age-related prevalence of the ε4 allele of Apolipoprotein E in Alzheimer’s Disease cohorts.</article-title>
<source/>J Mol Neurosci. <year>2016</year>; <volume>60</volume>:<fpage>316</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-016-0804-x</pub-id><pub-id pub-id-type="pmid">27498201</pub-id></mixed-citation>
</ref>
<ref id="r60">
<label>60</label>
<mixed-citation publication-type="journal"><string-name><surname>Sawyer</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Sekar</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Osborne</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kittner</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Moomaw</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Flaherty</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Langefeld</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Rosand</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Woo</surname>
<given-names>D</given-names></string-name>. <article-title>Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage.</article-title>
<source/>Neurology. <year>2018</year>; <volume>91</volume>:<fpage>e410</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000005908</pub-id><pub-id pub-id-type="pmid">29959260</pub-id></mixed-citation>
</ref>
<ref id="r61">
<label>61</label>
<mixed-citation publication-type="journal"><string-name><surname>McIntosh</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dickson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Anestis</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Watts</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Webster</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Fontenot</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Bradley</surname>
<given-names>BJ</given-names></string-name>. <article-title>The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes).</article-title>
<source/>PLoS One. <year>2012</year>; <volume>7</volume>:<fpage>e47760</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047760</pub-id><pub-id pub-id-type="pmid">23112842</pub-id></mixed-citation>
</ref>
<ref id="r62">
<label>62</label>
<mixed-citation publication-type="journal"><string-name><surname>Fullerton</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Nickerson</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Stengârd</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Salomaa</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Vartiainen</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Perola</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Boerwinkle</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sing</surname>
<given-names>CF</given-names></string-name>. <article-title>Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.</article-title>
<source/>Am J Hum Genet. <year>2000</year>; <volume>67</volume>:<fpage>881</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1086/303070</pub-id><pub-id pub-id-type="pmid">10986041</pub-id></mixed-citation>
</ref>
<ref id="r63">
<label>63</label>
<mixed-citation publication-type="journal"><string-name><surname>Hanlon</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Rubinsztein</surname>
<given-names>DC</given-names></string-name>. <article-title>Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans.</article-title>
<source/>Atherosclerosis. <year>1995</year>; <volume>112</volume>:<fpage>85</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9150(94)05402-5</pub-id><pub-id pub-id-type="pmid">7772071</pub-id></mixed-citation>
</ref>
<ref id="r64">
<label>64</label>
<mixed-citation publication-type="journal"><string-name><surname>Huebbe</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rimbach</surname>
<given-names>G</given-names></string-name>. <article-title>Evolution of human apolipoprotein E (APOE) isoforms: gene structure, protein function and interaction with dietary factors.</article-title>
<source/>Ageing Res Rev. <year>2017</year>; <volume>37</volume>:<fpage>146</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2017.06.002</pub-id><pub-id pub-id-type="pmid">28647612</pub-id></mixed-citation>
</ref>
<ref id="r65">
<label>65</label>
<mixed-citation publication-type="journal"><string-name><surname>Conejero-Goldberg</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gomar</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Bobes-Bascaran</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hyde</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Kleinman</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Herman</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Goldberg</surname>
<given-names>TE</given-names></string-name>. <article-title>APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms.</article-title>
<source/>Mol Psychiatry. <year>2014</year>; <volume>19</volume>:<fpage>1243</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.194</pub-id><pub-id pub-id-type="pmid">24492349</pub-id></mixed-citation>
</ref>
<ref id="r66">
<label>66</label>
<mixed-citation publication-type="journal"><string-name><surname>Sebastiani</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gurinovich</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nygaard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sasaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sweigart</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bae</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Villa</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Atzmon</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arai</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Barzilai</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Puca</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>. <article-title>APOE alleles and extreme human longevity.</article-title>
<source/>J Gerontol A Biol Sci Med Sci. <year>2019</year>; <volume>74</volume>:<comment>E44-51</comment>. <pub-id pub-id-type="doi">10.1093/gerona/gly174</pub-id><pub-id pub-id-type="pmid">30060062</pub-id></mixed-citation>
</ref>
<ref id="r67">
<label>67</label>
<mixed-citation publication-type="journal"><string-name><surname>Rodríguez</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Marigorta</surname>
<given-names>UM</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Spataro</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bosch</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Navarro</surname>
<given-names>A</given-names></string-name>. <article-title>Antagonistic pleiotropy and mutation accumulation influence human senescence and disease.</article-title>
<source/>Nat Ecol Evol. <year>2017</year>; <volume>1</volume>:<fpage>55</fpage>. <pub-id pub-id-type="doi">10.1038/s41559-016-0055</pub-id><pub-id pub-id-type="pmid">28812720</pub-id></mixed-citation>
</ref>
<ref id="r68">
<label>68</label>
<mixed-citation publication-type="journal"><string-name><surname>Bennet</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Reynolds</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Gatz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Blennow</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pedersen</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>Prince</surname>
<given-names>JA</given-names></string-name>. <article-title>Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF amyloid-β42, and dementia.</article-title>
<source/>J Alzheimers Dis. <year>2010</year>; <volume>22</volume>:<fpage>129</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100864</pub-id><pub-id pub-id-type="pmid">20847432</pub-id></mixed-citation>
</ref>
<ref id="r69">
<label>69</label>
<mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Andres</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sadino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Nakama</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ernst</surname>
<given-names>T</given-names></string-name>. <article-title>Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.</article-title>
<source/>Neuroimage. <year>2011</year>; <volume>58</volume>:<fpage>1017</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.07.010</pub-id><pub-id pub-id-type="pmid">21803164</pub-id></mixed-citation>
</ref>
<ref id="r70">
<label>70</label>
<mixed-citation publication-type="journal"><string-name><surname>Tuminello</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SD</given-names></string-name>. <article-title>The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations.</article-title>
<source/>Int J Alzheimers Dis. <year>2011</year>; <volume>2011</volume>:<fpage>726197</fpage>. <pub-id pub-id-type="doi">10.4061/2011/726197</pub-id><pub-id pub-id-type="pmid">21423560</pub-id></mixed-citation>
</ref>
<ref id="r71">
<label>71</label>
<mixed-citation publication-type="journal"><string-name><surname>Maxwell</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Ballantyne</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Cheverud</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Guild</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Ndumele</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Boerwinkle</surname>
<given-names>E</given-names></string-name>. <article-title>APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions.</article-title>
<source/>Genetics. <year>2013</year>; <volume>195</volume>:<fpage>1397</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.113.157719</pub-id><pub-id pub-id-type="pmid">24097412</pub-id></mixed-citation>
</ref>
<ref id="r72">
<label>72</label>
<mixed-citation publication-type="journal"><string-name><surname>Williams</surname>
<given-names>GC</given-names></string-name>. <article-title>Pleiotropy, natural selection, and the evolution of senescence.</article-title>
<source/>Evolution. <year>1957</year>; <volume>11</volume>:<fpage>398</fpage>–<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1111/j.1558-5646.1957.tb02911.x</pub-id></mixed-citation>
</ref>
<ref id="r73">
<label>73</label>
<mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>BY</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>. <article-title>Genomic patterns of pleiotropy and the evolution of complexity.</article-title>
<source/>Proc Natl Acad Sci USA. <year>2010</year>; <volume>107</volume>:<fpage>18034</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1004666107</pub-id><pub-id pub-id-type="pmid">20876104</pub-id></mixed-citation>
</ref>
<ref id="r74">
<label>74</label>
<mixed-citation publication-type="journal"><string-name><surname>Carter</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>AQ</given-names></string-name>. <article-title>Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles.</article-title>
<source/>BMC Med Genet. <year>2011</year>; <volume>12</volume>:<fpage>160</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2350-12-160</pub-id><pub-id pub-id-type="pmid">22151998</pub-id></mixed-citation>
</ref>
<ref id="r75">
<label>75</label>
<mixed-citation publication-type="journal"><string-name><surname>Joshi</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Fischer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Schraut</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Campbell</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Esko</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>JF</given-names></string-name>. <article-title>Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan.</article-title>
<source/>Nat Commun. <year>2016</year>; <volume>7</volume>:<fpage>11174</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11174</pub-id><pub-id pub-id-type="pmid">27029810</pub-id></mixed-citation>
</ref>
<ref id="r76">
<label>76</label>
<mixed-citation publication-type="journal"><string-name><surname>Drenos</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Kirkwood</surname>
<given-names>TB</given-names></string-name>. <article-title>Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E.</article-title>
<source/>PLoS One. <year>2010</year>; <volume>5</volume>:<fpage>e10022</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010022</pub-id><pub-id pub-id-type="pmid">20368805</pub-id></mixed-citation>
</ref>
<ref id="r77">
<label>77</label>
<mixed-citation publication-type="journal"><string-name><surname>Garatachea</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Marín</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Santos-Lozano</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sanchis-Gomar</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Emanuele</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lucia</surname>
<given-names>A</given-names></string-name>. <article-title>The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis.</article-title>
<source/>Rejuvenation Res. <year>2015</year>; <volume>18</volume>:<fpage>3</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2014.1605</pub-id><pub-id pub-id-type="pmid">25385258</pub-id></mixed-citation>
</ref>
<ref id="r78">
<label>78</label>
<mixed-citation publication-type="journal"><string-name><surname>Vila-Rodriguez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lang</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Baitz</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Gicas</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Thorton</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Ehmann</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>GN</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Torres</surname>
<given-names>IJ</given-names></string-name>, <string-name><surname>Kopala</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>MacEwan</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Müller</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Honer</surname>
<given-names>WG</given-names></string-name>. <article-title>Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?</article-title>
<source/>Neuropsychiatr Dis Treat. <year>2017</year>; <volume>13</volume>:<fpage>2945</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S150488</pub-id><pub-id pub-id-type="pmid">29263671</pub-id></mixed-citation>
</ref>
<ref id="r79">
<label>79</label>
<mixed-citation publication-type="journal"><string-name><surname>Jochemsen</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Muller</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van der Graaf</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Geerlings</surname>
<given-names>MI</given-names></string-name>. <article-title>APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study.</article-title>
<source/>Neurobiol Aging. <year>2012</year>; <volume>33</volume>:<fpage>832.e15</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.07.016</pub-id><pub-id pub-id-type="pmid">21908077</pub-id></mixed-citation>
</ref>
<ref id="r80">
<label>80</label>
<mixed-citation publication-type="journal"><string-name><surname>Rusted</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>King</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Dowell</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tofts</surname>
<given-names>PS</given-names></string-name>. <article-title>APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures.</article-title>
<source/>Neuroimage. <year>2013</year>; <volume>65</volume>:<fpage>364</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.10.010</pub-id><pub-id pub-id-type="pmid">23063453</pub-id></mixed-citation>
</ref>
<ref id="r81">
<label>81</label>
<mixed-citation publication-type="journal"><string-name><surname>van Exel</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Koopman</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Bodegom</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Meij</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Knijff</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ziem</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Finch</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Westendorp</surname>
<given-names>RG</given-names></string-name>. <article-title>Effect of APOE ε4 allele on survival and fertility in an adverse environment.</article-title>
<source/>PLoS One. <year>2017</year>; <volume>12</volume>:<fpage>e0179497</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0179497</pub-id><pub-id pub-id-type="pmid">28683096</pub-id></mixed-citation>
</ref>
<ref id="r82">
<label>82</label>
<mixed-citation publication-type="journal"><string-name><surname>Jasienska</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ellison</surname>
<given-names>PT</given-names></string-name>, <string-name><surname>Galbarczyk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jasienski</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kalemba-Drozdz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kapiszewska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nenko</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Thune</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ziomkiewicz</surname>
<given-names>A</given-names></string-name>. <article-title>Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: a case of antagonistic pleiotropy?</article-title>
<source/>Proc Biol Sci. <year>2015</year>; <volume>282</volume>:<fpage>20142395</fpage>. <pub-id pub-id-type="doi">10.1098/rspb.2014.2395</pub-id><pub-id pub-id-type="pmid">25673673</pub-id></mixed-citation>
</ref>
<ref id="r83">
<label>83</label>
<mixed-citation publication-type="journal"><string-name><surname>Dowell</surname>
<given-names>NG</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Tofts</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>King</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rusted</surname>
<given-names>JM</given-names></string-name>. <article-title>Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers.</article-title>
<source/>NMR Biomed. <year>2016</year>; <volume>29</volume>:<fpage>614</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/nbm.3502</pub-id><pub-id pub-id-type="pmid">26929040</pub-id></mixed-citation>
</ref>
<ref id="r84">
<label>84</label>
<mixed-citation publication-type="journal"><string-name><surname>Falahati</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Muehlboeck</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Eriksdotter</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Simmons</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wahlund</surname>
<given-names>LO</given-names></string-name>, <string-name><surname>Westman</surname>
<given-names>E</given-names></string-name>. <article-title>Monitoring disease progression in mild cognitive impairment: associations between atrophy patterns, cognition, APOE and amyloid.</article-title>
<source/>Neuroimage Clin. <year>2017</year>; <volume>16</volume>:<fpage>418</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2017.08.014</pub-id><pub-id pub-id-type="pmid">28879083</pub-id></mixed-citation>
</ref>
<ref id="r85">
<label>85</label>
<mixed-citation publication-type="journal"><string-name><surname>Jefferson</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Beiser</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Seshadri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wolf</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Au</surname>
<given-names>R</given-names></string-name>. <article-title>APOE and mild cognitive impairment: the Framingham Heart Study.</article-title>
<source/>Age Ageing. <year>2015</year>; <volume>44</volume>:<fpage>307</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/ageing/afu183</pub-id><pub-id pub-id-type="pmid">25497326</pub-id></mixed-citation>
</ref>
<ref id="r86">
<label>86</label>
<mixed-citation publication-type="journal"><string-name><surname>Sabbagh</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Malek-Ahmadi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dugger</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sue</surname>
<given-names>LI</given-names></string-name>, <string-name><surname>Serrano</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jacobson</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Beach</surname>
<given-names>TG</given-names></string-name>. <article-title>The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease.</article-title>
<source/>BMC Neurol. <year>2013</year>; <volume>13</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2377-13-44</pub-id><pub-id pub-id-type="pmid">23663404</pub-id></mixed-citation>
</ref>
<ref id="r87">
<label>87</label>
<mixed-citation publication-type="journal"><string-name><surname>Lim</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Williamson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Laws</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Villemagne</surname>
<given-names>VL</given-names></string-name>, <string-name><surname>Bourgeat</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Fowler</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rainey-Smith</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Salvado</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Martins</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Rowe</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Masters</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Maruff</surname>
<given-names>P</given-names></string-name>, and <collab>AIBL Research Group</collab>. <article-title>Effect of APOE genotype on amyloid deposition, brain volume, and memory in cognitively normal older individuals.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>58</volume>:<fpage>1293</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-170072</pub-id><pub-id pub-id-type="pmid">28550258</pub-id></mixed-citation>
</ref>
<ref id="r88">
<label>88</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Meng</surname>
<given-names>XF</given-names></string-name>, <string-name><surname>Risacher</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Saykin</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>L</given-names></string-name>. <article-title>APOE genotype and neuroimaging markers of Alzheimer’s disease: systematic review and meta-analysis.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2015</year>; <volume>86</volume>:<fpage>127</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2014-307719</pub-id><pub-id pub-id-type="pmid">24838911</pub-id></mixed-citation>
</ref>
<ref id="r89">
<label>89</label>
<mixed-citation publication-type="journal"><string-name><surname>Goveas</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Franczak</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Antuono</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>SJ</given-names></string-name>. <article-title>Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults.</article-title>
<source/>PLoS One. <year>2013</year>; <volume>8</volume>:<fpage>e55902</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0055902</pub-id><pub-id pub-id-type="pmid">23424640</pub-id></mixed-citation>
</ref>
<ref id="r90">
<label>90</label>
<mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Roe</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Brier</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Benzinger</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Ances</surname>
<given-names>BM</given-names></string-name>. <article-title>The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging.</article-title>
<source/>Alzheimer Dis Assoc Disord. <year>2014</year>; <volume>28</volume>:<fpage>122</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1097/WAD.0b013e318299d096</pub-id><pub-id pub-id-type="pmid">24830360</pub-id></mixed-citation>
</ref>
<ref id="r91">
<label>91</label>
<mixed-citation publication-type="journal"><string-name><surname>Liang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>. <article-title>Neuroimaging Initiative AD. Frequency specific effects of ApoE ε4 allele on resting-state networks in nondemented elders.</article-title>
<source/>BioMed Res Int. <year>2017</year>; <volume>2017</volume>:<fpage>9823501</fpage>
<pub-id pub-id-type="doi">10.1155/2017/9823501</pub-id><pub-id pub-id-type="pmid">28396874</pub-id></mixed-citation>
</ref>
<ref id="r92">
<label>92</label>
<mixed-citation publication-type="journal"><string-name><surname>de Waal</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stam</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Blankenstein</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Pijnenburg</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Scheltens</surname>
<given-names>P</given-names></string-name>, <string-name><surname>van der Flier</surname>
<given-names>WM</given-names></string-name>. <article-title>EEG abnormalities in early and late onset Alzheimer’s disease: understanding heterogeneity.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2011</year>; <volume>82</volume>:<fpage>67</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2010.216432</pub-id><pub-id pub-id-type="pmid">20935323</pub-id></mixed-citation>
</ref>
<ref id="r93">
<label>93</label>
<mixed-citation publication-type="journal"><string-name><surname>Galluzzi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marizzoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Babiloni</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Albani</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Antelmi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bagnoli</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bartres-Faz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cordone</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Didic</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Farotti</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fiedler</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Forloni</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Girtler</surname>
<given-names>N</given-names></string-name>, <etal>et al</etal>, and <collab>PharmaCog Consortium</collab>. <article-title>Clinical and biomarker profiling of prodromal Alzheimer’s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’.</article-title>
<source/>J Intern Med. <year>2016</year>; <volume>279</volume>:<fpage>576</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12482</pub-id><pub-id pub-id-type="pmid">26940242</pub-id></mixed-citation>
</ref>
<ref id="r94">
<label>94</label>
<mixed-citation publication-type="journal"><string-name><surname>Cuesta</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Garcés</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Castellanos</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>López</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Aurtenetxe</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bajo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Pineda-Pardo</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Bruña</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marín</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Delgado</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barabash</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ancín</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Cabranes</surname>
<given-names>JA</given-names></string-name>, <etal>et al</etal>. <article-title>Influence of the APOE ε4 allele and mild cognitive impairment diagnosis in the disruption of the MEG resting state functional connectivity in sources space.</article-title>
<source/>J Alzheimers Dis. <year>2015</year>; <volume>44</volume>:<fpage>493</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-141872</pub-id><pub-id pub-id-type="pmid">25281603</pub-id></mixed-citation>
</ref>
<ref id="r95">
<label>95</label>
<mixed-citation publication-type="journal"><string-name><surname>Kowalewski</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>C</given-names></string-name>. <article-title>Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.</article-title>
<source/>Brain Res. <year>2012</year>; <volume>1442</volume>:<fpage>55</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2011.12.030</pub-id><pub-id pub-id-type="pmid">22305338</pub-id></mixed-citation>
</ref>
<ref id="r96">
<label>96</label>
<mixed-citation publication-type="journal"><string-name><surname>Corby</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Morgan</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>C</given-names></string-name>. <article-title>Abnormal event-related potentials in young and middle-aged adults with the ApoE ε4 allele.</article-title>
<source/>Int J Psychophysiol. <year>2012</year>; <volume>83</volume>:<fpage>276</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2011.11.001</pub-id><pub-id pub-id-type="pmid">22100309</pub-id></mixed-citation>
</ref>
<ref id="r97">
<label>97</label>
<mixed-citation publication-type="journal"><string-name><surname>Tensil</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hessler</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Gutsmiedl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Riedl</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Grimmer</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Diehl-Schmid</surname>
<given-names>J</given-names></string-name>. <article-title>Sex Differences in Neuropsychological Test Performance in Alzheimer’s Disease and the Influence of the ApoE Genotype.</article-title>
<source/>Alzheimer Dis Assoc Disord. <year>2018</year>; <volume>32</volume>:<fpage>145</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1097/WAD.0000000000000229</pub-id><pub-id pub-id-type="pmid">29189302</pub-id></mixed-citation>
</ref>
<ref id="r98">
<label>98</label>
<mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>. <article-title>Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer’s disease.</article-title>
<source/>Oncotarget. <year>2016</year>; <volume>7</volume>:<fpage>58789</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.11289</pub-id><pub-id pub-id-type="pmid">27542235</pub-id></mixed-citation>
</ref>
<ref id="r99">
<label>99</label>
<mixed-citation publication-type="journal"><string-name><surname>Shinohara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kanekiyo</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Linthicum</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shinohara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Frisch-Daiello</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Fryer</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>. <article-title>APOE2 eases cognitive decline during Aging: clinical and preclinical evaluations.</article-title>
<source/>Ann Neurol. <year>2016</year>; <volume>79</volume>:<fpage>758</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24628</pub-id><pub-id pub-id-type="pmid">26933942</pub-id></mixed-citation>
</ref>
<ref id="r100">
<label>100</label>
<mixed-citation publication-type="journal"><string-name><surname>Konishi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bhat</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Banner</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Poirier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Joober</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bohbot</surname>
<given-names>VD</given-names></string-name>. <article-title>APOE2 Is associated with spatial navigational strategies and increased gray matter in the hippocampus.</article-title>
<source/>Front Hum Neurosci. <year>2016</year>; <volume>10</volume>:<fpage>349</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2016.00349</pub-id><pub-id pub-id-type="pmid">27468260</pub-id></mixed-citation>
</ref>
<ref id="r101">
<label>101</label>
<mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Douet</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bloss</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pritchett</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jernigan</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Akshoomoff</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Frazier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Amaral</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Gruen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WE</given-names></string-name>, <etal>et al</etal>, and <collab>Pediatric Imaging, Neurocognition, and Genetics (PING) Study Consortium</collab>. <article-title>Gray matter maturation and cognition in children with different APOE ε genotypes.</article-title>
<source/>Neurology. <year>2016</year>; <volume>87</volume>:<fpage>585</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000002939</pub-id><pub-id pub-id-type="pmid">27412137</pub-id></mixed-citation>
</ref>
<ref id="r102">
<label>102</label>
<mixed-citation publication-type="journal"><string-name><surname>Herrmann</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Hanf</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kaffarnik</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Motzny</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Reissner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Steinmetz</surname>
<given-names>A</given-names></string-name>. <article-title>The influence of apolipoprotein E polymorphism on plasma concentrations of apolipoprotein B and A-I during the first year of life.</article-title>
<source/>Pediatrics. <year>1994</year>; <volume>93</volume>:<fpage>296</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">8121744</pub-id></mixed-citation>
</ref>
<ref id="r103">
<label>103</label>
<mixed-citation publication-type="journal"><string-name><surname>Kallio</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Salmenperä</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Siimes</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Perheentupa</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gylling</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Miettinen</surname>
<given-names>TA</given-names></string-name>. <article-title>Apoprotein E phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding.</article-title>
<source/>J Lipid Res. <year>1997</year>; <volume>38</volume>:<fpage>759</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">9144090</pub-id></mixed-citation>
</ref>
<ref id="r104">
<label>104</label>
<mixed-citation publication-type="journal"><string-name><surname>Jacobs</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Harville</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>TN</given-names></string-name>, <string-name><surname>Bazzano</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>. <article-title>Maternal apolipoprotein E genotype as a potential risk factor for poor birth outcomes: The Bogalusa Heart Study.</article-title>
<source/>J Perinatol. <year>2016</year>; <volume>36</volume>:<fpage>432</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/jp.2016.4</pub-id><pub-id pub-id-type="pmid">26890557</pub-id></mixed-citation>
</ref>
<ref id="r105">
<label>105</label>
<mixed-citation publication-type="journal"><string-name><surname>Atkinson</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Blumenstein</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Black</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Kasabov</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Cooper</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>North</surname>
<given-names>RA</given-names></string-name>, and <collab>SCOPE Consortium</collab>. <article-title>An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia.</article-title>
<source/>J Lipid Res. <year>2009</year>; <volume>50</volume>:<fpage>71</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M800296-JLR200</pub-id><pub-id pub-id-type="pmid">18725658</pub-id></mixed-citation>
</ref>
<ref id="r106">
<label>106</label>
<mixed-citation publication-type="journal"><string-name><surname>Alkemade</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>van Vliet</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Henneman</surname>
<given-names>P</given-names></string-name>, <string-name><surname>van Dijk</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Hierck</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>van Munsteren</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Scheerman</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Goeman</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Havekes</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Gittenberger-de Groot</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>van den Elsen</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>DeRuiter</surname>
<given-names>MC</given-names></string-name>. <article-title>Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature.</article-title>
<source/>Am J Pathol. <year>2010</year>; <volume>176</volume>:<fpage>542</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.090031</pub-id><pub-id pub-id-type="pmid">20035052</pub-id></mixed-citation>
</ref>
<ref id="r107">
<label>107</label>
<mixed-citation publication-type="journal"><string-name><surname>Steinmetz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Thiemann</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Czekelius</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kaffarnik</surname>
<given-names>H</given-names></string-name>. <article-title>Polymorphism of apolipoprotein E influences levels of serum apolipoproteins E and B in the human neonate.</article-title>
<source/>Eur J Clin Invest. <year>1989</year>; <volume>19</volume>:<fpage>390</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2362.1989.tb00247.x</pub-id><pub-id pub-id-type="pmid">2506056</pub-id></mixed-citation>
</ref>
<ref id="r108">
<label>108</label>
<mixed-citation publication-type="journal"><string-name><surname>Sinclair</surname>
<given-names>LI</given-names></string-name>, <string-name><surname>Pleydell-Pearce</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>IN</given-names></string-name>. <article-title>Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life.</article-title>
<source/>Neurobiol Learn Mem. <year>2017</year>; <volume>146</volume>:<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2017.10.008</pub-id><pub-id pub-id-type="pmid">29032015</pub-id></mixed-citation>
</ref>
<ref id="r109">
<label>109</label>
<mixed-citation publication-type="journal"><string-name><surname>Comley</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Fuller</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Wishart</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Mutsaers</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Ribchester</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Parson</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Horsburgh</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gillingwater</surname>
<given-names>TH</given-names></string-name>. <article-title>ApoE isoform-specific regulation of regeneration in the peripheral nervous system.</article-title>
<source/>Hum Mol Genet. <year>2011</year>; <volume>20</volume>:<fpage>2406</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr147</pub-id><pub-id pub-id-type="pmid">21478199</pub-id></mixed-citation>
</ref>
<ref id="r110">
<label>110</label>
<mixed-citation publication-type="journal"><string-name><surname>Lorber</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Chew</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Hauck</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Chong</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Fawcett</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>KR</given-names></string-name>. <article-title>Retinal glia promote dorsal root ganglion axon regeneration.</article-title>
<source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0115996</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0115996</pub-id><pub-id pub-id-type="pmid">25816134</pub-id></mixed-citation>
</ref>
<ref id="r111">
<label>111</label>
<mixed-citation publication-type="journal"><string-name><surname>Rozenbaum</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rajman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rishal</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Koppel</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Koley</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Medzihradszky</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Oses-Prieto</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Kawaguchi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Amieux</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Burlingame</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Coppola</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Fainzilber</surname>
<given-names>M</given-names></string-name>. <article-title>Translatome regulation in neuronal injury and axon regrowth.</article-title>
<source/>eNeuro. <year>2018</year>; <volume>5</volume>:<fpage>ENEURO.0276-17.2018</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0276-17.2018</pub-id><pub-id pub-id-type="pmid">29756027</pub-id></mixed-citation>
</ref>
<ref id="r112">
<label>112</label>
<mixed-citation publication-type="journal"><string-name><surname>Stoknes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lien</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Bao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Blackman</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Lie</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Vik</surname>
<given-names>T</given-names></string-name>. <article-title>Child apolipoprotein E gene variants and risk of cerebral palsy: estimation from case-parent triads.</article-title>
<source/>Eur J Paediatr Neurol. <year>2015</year>; <volume>19</volume>:<fpage>286</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2014.12.017</pub-id><pub-id pub-id-type="pmid">25596901</pub-id></mixed-citation>
</ref>
<ref id="r113">
<label>113</label>
<mixed-citation publication-type="journal"><string-name><surname>Lien</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gordish-Dressman</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Skranes</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Blackman</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Vik</surname>
<given-names>T</given-names></string-name>. <article-title>Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E.</article-title>
<source/>Acta Paediatr. <year>2015</year>; <volume>104</volume>:<fpage>701</fpage>–<lpage>06</lpage>. <pub-id pub-id-type="doi">10.1111/apa.12983</pub-id><pub-id pub-id-type="pmid">25703783</pub-id></mixed-citation>
</ref>
<ref id="r114">
<label>114</label>
<mixed-citation publication-type="journal"><string-name><surname>Norda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rausch</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Orlikowsky</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hütten</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schulz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Göpel</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pecks</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Apolipoprotein</surname>
<given-names>E</given-names></string-name>. <article-title>Apolipoprotein E genotype in very preterm neonates with intrauterine growth restriction: an analysis of the German Neonatal Network Cohort.</article-title>
<source/>BioMed Res Int. <year>2017</year>; <volume>2017</volume>:<fpage>2837027</fpage>. <pub-id pub-id-type="doi">10.1155/2017/2837027</pub-id><pub-id pub-id-type="pmid">28480219</pub-id></mixed-citation>
</ref>
<ref id="r115">
<label>115</label>
<mixed-citation publication-type="journal"><string-name><surname>Kypreos</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Karagiannides</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fotiadou</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Karavia</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Brinkmeier</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Giakoumi</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Tsompanidi</surname>
<given-names>EM</given-names></string-name>. <article-title>Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.</article-title>
<source/>FEBS J. <year>2009</year>; <volume>276</volume>:<fpage>5720</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07301.x</pub-id><pub-id pub-id-type="pmid">19754875</pub-id></mixed-citation>
</ref>
<ref id="r116">
<label>116</label>
<mixed-citation publication-type="journal"><string-name><surname>Cotten</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Goldstein</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>McDonald</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Goldberg</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Salhab</surname>
<given-names>WA</given-names></string-name>, <string-name><surname>Carlo</surname>
<given-names>WA</given-names></string-name>, <string-name><surname>Tyson</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Finer</surname>
<given-names>NN</given-names></string-name>, <string-name><surname>Walsh</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Ehrenkranz</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Laptook</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Guillet</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Schibler</surname>
<given-names>K</given-names></string-name>, <etal>et al</etal>, and <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>. <article-title>Apolipoprotein E genotype and outcome in infants with hypoxic-ischemic encephalopathy.</article-title>
<source/>Pediatr Res. <year>2014</year>; <volume>75</volume>:<fpage>424</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.235</pub-id><pub-id pub-id-type="pmid">24322171</pub-id></mixed-citation>
</ref>
<ref id="r117">
<label>117</label>
<mixed-citation publication-type="journal"><string-name><surname>Ng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Hsieh</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>PC</given-names></string-name>. <article-title>Mercury, APOE, and children’s neurodevelopment.</article-title>
<source/>Neurotoxicology. <year>2013</year>; <volume>37</volume>:<fpage>85</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2013.03.012</pub-id><pub-id pub-id-type="pmid">23603214</pub-id></mixed-citation>
</ref>
<ref id="r118">
<label>118</label>
<mixed-citation publication-type="journal"><string-name><surname>Snoj Tratnik</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Falnoga</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Trdin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mazej</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fajon</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Miklavčič</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kobal</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Osredkar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sešek Briški</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Krsnik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Neubauer</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kodrič</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stropnik</surname>
<given-names>S</given-names></string-name>, <etal>et al</etal>. <article-title>Prenatal mercury exposure, neurodevelopment and apolipoprotein E genetic polymorphism.</article-title>
<source/>Environ Res. <year>2017</year>; <volume>152</volume>:<fpage>375</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.envres.2016.08.035</pub-id><pub-id pub-id-type="pmid">27616663</pub-id></mixed-citation>
</ref>
<ref id="r119">
<label>119</label>
<mixed-citation publication-type="journal"><string-name><surname>Dean</surname>
<given-names>DC</given-names>
<suffix>3rd</suffix></string-name>, <string-name><surname>Jerskey</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Protas</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Thiyyagura</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Roontiva</surname>
<given-names>A</given-names></string-name>, <string-name><surname>O’Muircheartaigh</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Dirks</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Waskiewicz</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lehman</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Siniard</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Turk</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Hua</surname>
<given-names>X</given-names></string-name>, <etal>et al</etal>. <article-title>Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.</article-title>
<source/>JAMA Neurol. <year>2014</year>; <volume>71</volume>:<fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.4544</pub-id><pub-id pub-id-type="pmid">24276092</pub-id></mixed-citation>
</ref>
<ref id="r120">
<label>120</label>
<mixed-citation publication-type="journal"><string-name><surname>Knickmeyer</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Geng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Woolson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hamer</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Konneker</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Styner</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gilmore</surname>
<given-names>JH</given-names></string-name>. <article-title>Common variants in psychiatric risk genes predict brain structure at birth.</article-title>
<source/>Cereb Cortex. <year>2014</year>; <volume>24</volume>:<fpage>1230</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhs401</pub-id><pub-id pub-id-type="pmid">23283688</pub-id></mixed-citation>
</ref>
<ref id="r121">
<label>121</label>
<mixed-citation publication-type="journal"><string-name><surname>Korja</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ylijoki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lapinleimu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Pohjola</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Matomäki</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kuśmierek</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mahlman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rikalainen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Parkkola</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kaukola</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lehtonen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hallman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Haataja</surname>
<given-names>L</given-names></string-name>. <article-title>Apolipoprotein E, brain injury and neurodevelopmental outcome of children.</article-title>
<source/>Genes Brain Behav. <year>2013</year>; <volume>12</volume>:<fpage>348</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1111/gbb.12024</pub-id><pub-id pub-id-type="pmid">23387365</pub-id></mixed-citation>
</ref>
<ref id="r122">
<label>122</label>
<mixed-citation publication-type="journal"><string-name><surname>Becher</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>McIntosh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Keeling</surname>
<given-names>JW</given-names></string-name>. <article-title>Distribution of apolipoprotein E alleles in a Scottish healthy newborn population.</article-title>
<source/>Biol Neonate. <year>2005</year>; <volume>88</volume>:<fpage>164</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1159/000086205</pub-id><pub-id pub-id-type="pmid">15942165</pub-id></mixed-citation>
</ref>
<ref id="r123">
<label>123</label>
<mixed-citation publication-type="journal"><string-name><surname>Becher</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Keeling</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>McIntosh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wyatt</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>J</given-names></string-name>. <article-title>The distribution of apolipoprotein E alleles in Scottish perinatal deaths.</article-title>
<source/>J Med Genet. <year>2006</year>; <volume>43</volume>:<fpage>414</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2005.033936</pub-id><pub-id pub-id-type="pmid">16183800</pub-id></mixed-citation>
</ref>
<ref id="r124">
<label>124</label>
<mixed-citation publication-type="journal"><string-name><surname>Everman</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Morgan</surname>
<given-names>TJ</given-names></string-name>. <article-title>Antagonistic pleiotropy and mutation accumulation contribute to age-related decline in stress response.</article-title>
<source/>Evolution. <year>2018</year>; <volume>72</volume>:<fpage>303</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/evo.13408</pub-id><pub-id pub-id-type="pmid">29214647</pub-id></mixed-citation>
</ref>
<ref id="r125">
<label>125</label>
<mixed-citation publication-type="journal"><string-name><surname>Maklakov</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Rowe</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Friberg</surname>
<given-names>U</given-names></string-name>. <article-title>Why organisms age: evolution of senescence under positive pleiotropy?</article-title>
<source/>BioEssays. <year>2015</year>; <volume>37</volume>:<fpage>802</fpage>–<lpage>07</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201500025</pub-id><pub-id pub-id-type="pmid">25900580</pub-id></mixed-citation>
</ref>
<ref id="r126">
<label>126</label>
<mixed-citation publication-type="journal"><string-name><surname>Blackman</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Gordish-Dressman</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Matsumoto</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Sinkin</surname>
<given-names>RA</given-names></string-name>. <article-title>The apolipoprotein gene and recovery from brain injury among extremely preterm infants.</article-title>
<source/>Neonatology. <year>2014</year>; <volume>105</volume>:<fpage>227</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1159/000357700</pub-id><pub-id pub-id-type="pmid">24503939</pub-id></mixed-citation>
</ref>
<ref id="r127">
<label>127</label>
<mixed-citation publication-type="journal"><string-name><surname>Bell</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Becher</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Keeling</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>McIntosh</surname>
<given-names>N</given-names></string-name>. <article-title>The neuropathology of stillbirth - correlation with apolipoprotein genotype in a Scottish population based study.</article-title>
<source/>Early Hum Dev. <year>2015</year>; <volume>91</volume>:<fpage>139</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2014.12.008</pub-id><pub-id pub-id-type="pmid">25617864</pub-id></mixed-citation>
</ref>
<ref id="r128">
<label>128</label>
<mixed-citation publication-type="journal"><string-name><surname>Woodward</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Austin</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Howard</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Inder</surname>
<given-names>TE</given-names></string-name>. <article-title>Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.</article-title>
<source/>N Engl J Med. <year>2006</year>; <volume>355</volume>:<fpage>685</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa053792</pub-id><pub-id pub-id-type="pmid">16914704</pub-id></mixed-citation>
</ref>
<ref id="r129">
<label>129</label>
<mixed-citation publication-type="journal"><string-name><surname>Shaw</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lerch</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Pruessner</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>KN</given-names></string-name>, <string-name><surname>Rose</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Greenstein</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Clasen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rapoport</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Giedd</surname>
<given-names>JN</given-names></string-name>. <article-title>Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study.</article-title>
<source/>Lancet Neurol. <year>2007</year>; <volume>6</volume>:<fpage>494</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(07)70106-0</pub-id><pub-id pub-id-type="pmid">17509484</pub-id></mixed-citation>
</ref>
<ref id="r130">
<label>130</label>
<mixed-citation publication-type="journal"><string-name><surname>Gaynor</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Arrington</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Atz</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Bellinger</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Burt</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Ghanayem</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Jacobs</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Mahle</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Marino</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>SG</given-names></string-name>, <etal>et al</etal>. <article-title>Validation of association of the apolipoprotein E ε2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants.</article-title>
<source/>J Thorac Cardiovasc Surg. <year>2014</year>; <volume>148</volume>:<fpage>2560</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2014.07.052</pub-id><pub-id pub-id-type="pmid">25282659</pub-id></mixed-citation>
</ref>
<ref id="r131">
<label>131</label>
<mixed-citation publication-type="journal"><string-name><surname>Zeltser</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Jarvik</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Bernbaum</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wernovsky</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Nord</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Gerdes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zackai</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Clancy</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nicolson</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Spray</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Gaynor</surname>
<given-names>JW</given-names></string-name>. <article-title>Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot.</article-title>
<source/>J Thorac Cardiovasc Surg. <year>2008</year>; <volume>135</volume>:<fpage>91</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2007.04.074</pub-id><pub-id pub-id-type="pmid">18179924</pub-id></mixed-citation>
</ref>
<ref id="r132">
<label>132</label>
<mixed-citation publication-type="journal"><string-name><surname>Becher</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Keeling</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wyatt</surname>
<given-names>B</given-names></string-name>, <string-name><surname>McIntosh</surname>
<given-names>N</given-names></string-name>. <article-title>Apolipoprotein E e4 and its prevalence in early childhood death due to sudden infant death syndrome or to recognised causes.</article-title>
<source/>Early Hum Dev. <year>2008</year>; <volume>84</volume>:<fpage>549</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2008.01.002</pub-id><pub-id pub-id-type="pmid">18280677</pub-id></mixed-citation>
</ref>
<ref id="r133">
<label>133</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hua</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jian-Ping</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>L</given-names></string-name>. <article-title>Association between the lipid levels and single nucleotide polymorphisms of ABCA1, APOE and HMGCR genes in subjects with spontaneous preterm delivery.</article-title>
<source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0135785</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0135785</pub-id><pub-id pub-id-type="pmid">26301579</pub-id></mixed-citation>
</ref>
<ref id="r134">
<label>134</label>
<mixed-citation publication-type="journal"><string-name><surname>Sarnat</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>Philippart</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Flores-Sarnat</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>XC</given-names></string-name>. <article-title>Timing in neural maturation: arrest, delay, precociousness, and temporal determination of malformations.</article-title>
<source/>Pediatr Neurol. <year>2015</year>; <volume>52</volume>:<fpage>473</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2015.01.020</pub-id><pub-id pub-id-type="pmid">25797487</pub-id></mixed-citation>
</ref>
<ref id="r135">
<label>135</label>
<mixed-citation publication-type="journal"><string-name><surname>Ben-Ari</surname>
<given-names>Y</given-names></string-name>. <article-title>Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders.</article-title>
<source/>Trends Neurosci. <year>2008</year>; <volume>31</volume>:<fpage>626</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.09.002</pub-id><pub-id pub-id-type="pmid">18951639</pub-id></mixed-citation>
</ref>
<ref id="r136">
<label>136</label>
<mixed-citation publication-type="journal"><string-name><surname>Avelar</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Perfeito</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gordo</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>MG</given-names></string-name>. <article-title>Genome architecture is a selectable trait that can be maintained by antagonistic pleiotropy.</article-title>
<source/>Nat Commun. <year>2013</year>; <volume>4</volume>:<fpage>2235</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms3235</pub-id><pub-id pub-id-type="pmid">23974178</pub-id></mixed-citation>
</ref>
<ref id="r137">
<label>137</label>
<mixed-citation publication-type="journal"><string-name><surname>Maharjan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>McKenzie</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Yeung</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ferenci</surname>
<given-names>T</given-names></string-name>. <article-title>The basis of antagonistic pleiotropy in hfq mutations that have opposite effects on fitness at slow and fast growth rates.</article-title>
<source/>Heredity (Edinb). <year>2013</year>; <volume>110</volume>:<fpage>10</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1038/hdy.2012.46</pub-id><pub-id pub-id-type="pmid">23169561</pub-id></mixed-citation>
</ref>
<ref id="r138">
<label>138</label>
<mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Metcalfe</surname>
<given-names>NB</given-names></string-name>, <string-name><surname>Velando</surname>
<given-names>A</given-names></string-name>. <article-title>A benign juvenile environment reduces the strength of antagonistic pleiotropy and genetic variation in the rate of senescence.</article-title>
<source/>J Anim Ecol. <year>2016</year>; <volume>85</volume>:<fpage>705</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1111/1365-2656.12468</pub-id><pub-id pub-id-type="pmid">26559495</pub-id></mixed-citation>
</ref>
<ref id="r139">
<label>139</label>
<mixed-citation publication-type="journal"><string-name><surname>Ruiz</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Labayen</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ortega</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Moreno</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>González-Lamuño</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Martí</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nova</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Fuentes</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Redondo-Figuero</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Martínez</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Sjöström</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Castillo</surname>
<given-names>MJ</given-names></string-name>, and <collab>AVENA Study Group</collab>. <article-title>Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study.</article-title>
<source/>BMC Med Genet. <year>2008</year>; <volume>9</volume>:<fpage>98</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2350-9-98</pub-id><pub-id pub-id-type="pmid">19000312</pub-id></mixed-citation>
</ref>
<ref id="r140">
<label>140</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Hauser</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Booze</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Walter</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Nance</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Hubble</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Koller</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Pahwa</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Stern</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Hiner</surname>
<given-names>BC</given-names></string-name>, <etal>et al</etal>. <article-title>Apolipoprotein E controls the risk and age at onset of Parkinson disease.</article-title>
<source/>Neurology. <year>2004</year>; <volume>62</volume>:<fpage>2005</fpage>–<lpage>09</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000128089.53030.AC</pub-id><pub-id pub-id-type="pmid">15184605</pub-id></mixed-citation>
</ref>
<ref id="r141">
<label>141</label>
<mixed-citation publication-type="journal"><string-name><surname>Chiò</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brunetti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barberis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iazzolino</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Montuschi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ilardi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cammarosano</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Canosa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Moglia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Calvo</surname>
<given-names>A</given-names></string-name>. <article-title>The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis.</article-title>
<source/>JAMA Neurol. <year>2016</year>; <volume>73</volume>:<fpage>425</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2015.4773</pub-id><pub-id pub-id-type="pmid">26903389</pub-id></mixed-citation>
</ref>
<ref id="r142">
<label>142</label>
<mixed-citation publication-type="journal"><string-name><surname>Pecks</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Mohaupt</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Hütten</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Maass</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rath</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Escher</surname>
<given-names>G</given-names></string-name>. <article-title>Cholesterol acceptor capacity is preserved by different mechanisms in preterm and term fetuses.</article-title>
<source/>Biochim Biophys Acta. <year>2014</year>; <volume>1841</volume>:<fpage>251</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2013.11.008</pub-id><pub-id pub-id-type="pmid">24291326</pub-id></mixed-citation>
</ref>
<ref id="r143">
<label>143</label>
<mixed-citation publication-type="journal"><string-name><surname>Wright</surname>
<given-names>RO</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Silverman</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Tsaih</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bellinger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Palazuelos</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Hernandez-Avila</surname>
<given-names>M</given-names></string-name>. <article-title>Apolipoprotein E genotype predicts 24-month bayley scales infant development score.</article-title>
<source/>Pediatr Res. <year>2003</year>; <volume>54</volume>:<fpage>819</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000090927.53818.DE</pub-id><pub-id pub-id-type="pmid">12930912</pub-id></mixed-citation>
</ref>
<ref id="r144">
<label>144</label>
<mixed-citation publication-type="journal"><string-name><surname>Oriá</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Patrick</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lorntz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>de Castro Costa</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Brito</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Barrett</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Lima</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Guerrant</surname>
<given-names>RL</given-names></string-name>. <article-title>APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil.</article-title>
<source/>Pediatr Res. <year>2005</year>; <volume>57</volume>:<fpage>310</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000148719.82468.CA</pub-id><pub-id pub-id-type="pmid">15611352</pub-id></mixed-citation>
</ref>
<ref id="r145">
<label>145</label>
<mixed-citation publication-type="journal"><string-name><surname>Suri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Heise</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Trachtenberg</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>. <article-title>The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2.</article-title>
<source/>Neurosci Biobehav Rev. <year>2013</year>; <volume>37</volume>:<fpage>2878</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.010</pub-id><pub-id pub-id-type="pmid">24183852</pub-id></mixed-citation>
</ref>
<ref id="r146">
<label>146</label>
<mixed-citation publication-type="journal"><string-name><surname>Gesierich</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Opherk</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rosand</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gonik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Malik</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jouvent</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hervé</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Adib-Samii</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bevan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pianese</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Silvestri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dotti</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>De Stefano</surname>
<given-names>N</given-names></string-name>, <etal>et al</etal>. <article-title>APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL.</article-title>
<source/>J Cereb Blood Flow Metab. <year>2016</year>; <volume>36</volume>:<fpage>199</fpage>–<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2015.85</pub-id><pub-id pub-id-type="pmid">25920955</pub-id></mixed-citation>
</ref>
<ref id="r147">
<label>147</label>
<mixed-citation publication-type="journal"><string-name><surname>Mueller</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fischer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gessner</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rosendahl</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Böhm</surname>
<given-names>S</given-names></string-name>, <string-name><surname>van Bömmel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Knop</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sarrazin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Witt</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Marques</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kovacs</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Schleinitz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stumvoll</surname>
<given-names>M</given-names></string-name>, <etal>et al</etal>. <article-title>Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection.</article-title>
<source/>Liver Int. <year>2016</year>; <volume>36</volume>:<fpage>1267</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1111/liv.13094</pub-id><pub-id pub-id-type="pmid">26880346</pub-id></mixed-citation>
</ref>
<ref id="r148">
<label>148</label>
<mixed-citation publication-type="journal"><string-name><surname>Wirth</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Villeneuve</surname>
<given-names>S</given-names></string-name>, <string-name><surname>La Joie</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marks</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Jagust</surname>
<given-names>WJ</given-names></string-name>. <article-title>Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.</article-title>
<source/>J Neurosci. <year>2014</year>; <volume>34</volume>:<fpage>8612</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4612-13.2014</pub-id><pub-id pub-id-type="pmid">24948815</pub-id></mixed-citation>
</ref>
<ref id="r149">
<label>149</label>
<mixed-citation publication-type="journal"><string-name><surname>Filippini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ebmeier</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>MacIntosh</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Trachtenberg</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Frisoni</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Wilcock</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Beckmann</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>. <article-title>Differential effects of the APOE genotype on brain function across the lifespan.</article-title>
<source/>Neuroimage. <year>2011</year>; <volume>54</volume>:<fpage>602</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.08.009</pub-id><pub-id pub-id-type="pmid">20705142</pub-id></mixed-citation>
</ref>
<ref id="r150">
<label>150</label>
<mixed-citation publication-type="journal"><string-name><surname>Woo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>Y</given-names></string-name>. <article-title>Cortical functional connections and fluid intelligence in adolescent APOE ε4 carriers.</article-title>
<source/>Dement Geriatr Cogn Disord. <year>2017</year>; <volume>44</volume>:<fpage>153</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1159/000479276</pub-id><pub-id pub-id-type="pmid">28848214</pub-id></mixed-citation>
</ref>
<ref id="r151">
<label>151</label>
<mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>C</given-names></string-name>. <article-title>Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults.</article-title>
<source/>Brain Struct Funct. <year>2017</year>; <volume>222</volume>:<fpage>2877</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-017-1377-3</pub-id><pub-id pub-id-type="pmid">28229235</pub-id></mixed-citation>
</ref>
<ref id="r152">
<label>152</label>
<mixed-citation publication-type="journal"><string-name><surname>Treble-Barna</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Yeates</surname>
<given-names>KO</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>HG</given-names></string-name>, <string-name><surname>Wade</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Kurowski</surname>
<given-names>BG</given-names></string-name>. <article-title>Does Apolipoprotein e4 status moderate the association of family environment with long-term child functioning following early moderate to severe traumatic brain injury? a preliminary study.</article-title>
<source/>J Int Neuropsychol Soc. <year>2016</year>; <volume>22</volume>:<fpage>859</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1017/S1355617716000631</pub-id><pub-id pub-id-type="pmid">27480909</pub-id></mixed-citation>
</ref>
<ref id="r153">
<label>153</label>
<mixed-citation publication-type="journal"><string-name><surname>Kassam</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Gagnon</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cusimano</surname>
<given-names>MD</given-names></string-name>. <article-title>Association of the APOE-ε4 allele with outcome of traumatic brain injury in children and youth: a meta-analysis and meta-regression.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2016</year>; <volume>87</volume>:<fpage>433</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2015-310500</pub-id><pub-id pub-id-type="pmid">25904811</pub-id></mixed-citation>
</ref>
<ref id="r154">
<label>154</label>
<mixed-citation publication-type="journal"><string-name><surname>Moran</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>HG</given-names></string-name>, <string-name><surname>Ganesalingam</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gastier-Foster</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Frick</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bangert</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Dietrich</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nuss</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Rusin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yeates</surname>
<given-names>KO</given-names></string-name>. <article-title>Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury.</article-title>
<source/>J Neurotrauma. <year>2009</year>; <volume>26</volume>:<fpage>1489</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2008.0767</pub-id><pub-id pub-id-type="pmid">19645623</pub-id></mixed-citation>
</ref>
<ref id="r155">
<label>155</label>
<mixed-citation publication-type="journal"><string-name><surname>Aboud</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Mrak</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Boop</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Griffin</surname>
<given-names>WS</given-names></string-name>. <article-title>Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype.</article-title>
<source/>Acta Neuropathol Commun. <year>2013</year>; <volume>1</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.1186/2051-5960-1-41</pub-id><pub-id pub-id-type="pmid">24252240</pub-id></mixed-citation>
</ref>
<ref id="r156">
<label>156</label>
<mixed-citation publication-type="journal"><string-name><surname>Busch</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Floden</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lineweaver</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Chapin</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Unnwongse</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wehner</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Diaz-Arrastia</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Najm</surname>
<given-names>IM</given-names></string-name>. <article-title>Effect of apolipoprotein ε4 allele on hippocampal and brain volume in intractable temporal lobe epilepsy.</article-title>
<source/>Epilepsy Behav. <year>2011</year>; <volume>21</volume>:<fpage>88</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2011.01.007</pub-id><pub-id pub-id-type="pmid">21317045</pub-id></mixed-citation>
</ref>
<ref id="r157">
<label>157</label>
<mixed-citation publication-type="journal"><string-name><surname>Kauffman</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Consalvo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Moron</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Lereis</surname>
<given-names>VP</given-names></string-name>, <string-name><surname>Kochen</surname>
<given-names>S</given-names></string-name>. <article-title>ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis.</article-title>
<source/>Epilepsy Res. <year>2010</year>; <volume>90</volume>:<fpage>234</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2010.05.007</pub-id><pub-id pub-id-type="pmid">20554432</pub-id></mixed-citation>
</ref>
<ref id="r158">
<label>158</label>
<mixed-citation publication-type="journal"><string-name><surname>Braga</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Borigato</surname>
<given-names>EV</given-names></string-name>, <string-name><surname>Speck-Martins</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Imamura</surname>
<given-names>EU</given-names></string-name>, <string-name><surname>Gorges</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Izumi</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Dantas</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Nunes</surname>
<given-names>LG</given-names></string-name>. <article-title>Apolipoprotein E genotype and cerebral palsy.</article-title>
<source/>Dev Med Child Neurol. <year>2010</year>; <volume>52</volume>:<fpage>666</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2009.03465.x</pub-id><pub-id pub-id-type="pmid">20002130</pub-id></mixed-citation>
</ref>
<ref id="r159">
<label>159</label>
<mixed-citation publication-type="journal"><string-name><surname>O’Callaghan</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>MacLennan</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Haan</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Dekker</surname>
<given-names>G</given-names></string-name>, and <collab>South Australian Cerebral Palsy Research Group</collab>. <article-title>The genomic basis of cerebral palsy: a HuGE systematic literature review.</article-title>
<source/>Hum Genet. <year>2009</year>; <volume>126</volume>:<fpage>149</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-009-0638-5</pub-id><pub-id pub-id-type="pmid">19238444</pub-id></mixed-citation>
</ref>
<ref id="r160">
<label>160</label>
<mixed-citation publication-type="journal"><string-name><surname>Kantarci</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lowe</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Przybelski</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Weigand</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Senjem</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Ivnik</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Preboske</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Geda</surname>
<given-names>YE</given-names></string-name>, <string-name><surname>Boeve</surname>
<given-names>BF</given-names></string-name>, <string-name><surname>Knopman</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Jack</surname>
<given-names>CR</given-names>
<suffix>Jr</suffix></string-name>. <article-title>APOE modifies the association between Aβ load and cognition in cognitively normal older adults.</article-title>
<source/>Neurology. <year>2012</year>; <volume>78</volume>:<fpage>232</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31824365ab</pub-id><pub-id pub-id-type="pmid">22189452</pub-id></mixed-citation>
</ref>
<ref id="r161">
<label>161</label>
<mixed-citation publication-type="journal"><string-name><surname>Fennema-Notestine</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Panizzon</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Eyler</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Fischl</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Franz</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Jak</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Jernigan</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Lyons</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Neale</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Seidman</surname>
<given-names>LJ</given-names></string-name>, <etal>et al</etal>. <article-title>Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.</article-title>
<source/>J Alzheimers Dis. <year>2011</year> (<issue>Suppl 3</issue>); <volume>26</volume>:<fpage>49</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-0002</pub-id><pub-id pub-id-type="pmid">21971450</pub-id></mixed-citation>
</ref>
<ref id="r162">
<label>162</label>
<mixed-citation publication-type="journal"><string-name><surname>Wishart</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Saykin</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>McAllister</surname>
<given-names>TW</given-names></string-name>, <string-name><surname>Rabin</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>McDonald</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Flashman</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Roth</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Mamourian</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Tsongalis</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Rhodes</surname>
<given-names>CH</given-names></string-name>. <article-title>Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele.</article-title>
<source/>Neurology. <year>2006</year>; <volume>67</volume>:<fpage>1221</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000238079.00472.3a</pub-id><pub-id pub-id-type="pmid">17030756</pub-id></mixed-citation>
</ref>
<ref id="r163">
<label>163</label>
<mixed-citation publication-type="journal"><string-name><surname>Westlye</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Hodneland</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Haász</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Espeseth</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lundervold</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lundervold</surname>
<given-names>AJ</given-names></string-name>. <article-title>Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe.</article-title>
<source/>Neuroimage. <year>2012</year>; <volume>63</volume>:<fpage>507</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.06.072</pub-id><pub-id pub-id-type="pmid">22796460</pub-id></mixed-citation>
</ref>
<ref id="r164">
<label>164</label>
<mixed-citation publication-type="journal"><string-name><surname>Chiang</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Schuff</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Weiner</surname>
<given-names>MW</given-names></string-name>. <article-title>White matter alterations in cognitively normal apoE ε2 carriers: insight into Alzheimer resistance?</article-title>
<source/>AJNR Am J Neuroradiol. <year>2012</year>; <volume>33</volume>:<fpage>1392</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A2984</pub-id><pub-id pub-id-type="pmid">22383234</pub-id></mixed-citation>
</ref>
<ref id="r165">
<label>165</label>
<mixed-citation publication-type="journal"><string-name><surname>Machulda</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Vemuri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>McDade</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Avula</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Przybelski</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Boeve</surname>
<given-names>BF</given-names></string-name>, <string-name><surname>Knopman</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Jack</surname>
<given-names>CR</given-names>
<suffix>Jr</suffix></string-name>. <article-title>Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects.</article-title>
<source/>Arch Neurol. <year>2011</year>; <volume>68</volume>:<fpage>1131</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2011.108</pub-id><pub-id pub-id-type="pmid">21555604</pub-id></mixed-citation>
</ref>
<ref id="r166">
<label>166</label>
<mixed-citation publication-type="journal"><string-name><surname>Trachtenberg</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Filippini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ebmeier</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Karpe</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>. <article-title>The effects of APOE on the functional architecture of the resting brain.</article-title>
<source/>Neuroimage. <year>2012</year>; <volume>59</volume>:<fpage>565</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.07.059</pub-id><pub-id pub-id-type="pmid">21851856</pub-id></mixed-citation>
</ref>
<ref id="r167">
<label>167</label>
<mixed-citation publication-type="journal"><string-name><surname>Evans</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dowell</surname>
<given-names>NG</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>King</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Hutton</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Rusted</surname>
<given-names>JM</given-names></string-name>. <article-title>Disrupted neural activity patterns to novelty and effort in young adult APOE-e4 carriers performing a subsequent memory task.</article-title>
<source/>Brain Behav. <year>2017</year>; <volume>7</volume>:<fpage>e00612</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.612</pub-id><pub-id pub-id-type="pmid">28239522</pub-id></mixed-citation>
</ref>
<ref id="r168">
<label>168</label>
<mixed-citation publication-type="journal"><string-name><surname>Su</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Schoepf</surname>
<given-names>UJ</given-names></string-name>, <string-name><surname>Varga-Szemes</surname>
<given-names>A</given-names></string-name>, <string-name><surname>West</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Qi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>LJ</given-names></string-name>. <article-title>APOE Polymorphism affects brain default mode network in healthy young adults: a STROBE Article.</article-title>
<source/>Medicine (Baltimore). <year>2015</year>; <volume>94</volume>:<fpage>e1734</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000001734</pub-id><pub-id pub-id-type="pmid">26717353</pub-id></mixed-citation>
</ref>
<ref id="r169">
<label>169</label>
<mixed-citation publication-type="journal"><string-name><surname>Perkins</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wolf</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Chavira</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Shonebarger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Meckel</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ballina</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ly</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Vallejo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jentarra</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Valla</surname>
<given-names>J</given-names></string-name>. <article-title>Altered energy metabolism pathways in the posterior cingulate in young adult Apolipoprotein E ɛ4 carriers.</article-title>
<source/>J Alzheimers Dis. <year>2016</year>; <volume>53</volume>:<fpage>95</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-151205</pub-id><pub-id pub-id-type="pmid">27128370</pub-id></mixed-citation>
</ref>
<ref id="r170">
<label>170</label>
<mixed-citation publication-type="journal"><string-name><surname>Suri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Germuska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tunbridge</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Frisoni</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Ebmeier</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Bulte</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Filippini</surname>
<given-names>N</given-names></string-name>. <article-title>Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele.</article-title>
<source/>Alzheimers Dement. <year>2015</year>; <volume>11</volume>:<fpage>648</fpage>–<lpage>57.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2014.05.1755</pub-id><pub-id pub-id-type="pmid">25160043</pub-id></mixed-citation>
</ref>
<ref id="r171">
<label>171</label>
<mixed-citation publication-type="journal"><string-name><surname>Love</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Siew</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Dawbarn</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wilcock</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Ben-Shlomo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>SJ</given-names></string-name>. <article-title>Premorbid effects of APOE on synaptic proteins in human temporal neocortex.</article-title>
<source/>Neurobiol Aging. <year>2006</year>; <volume>27</volume>:<fpage>797</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.04.008</pub-id><pub-id pub-id-type="pmid">15979210</pub-id></mixed-citation>
</ref>
<ref id="r172">
<label>172</label>
<mixed-citation publication-type="journal"><string-name><surname>Kok</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Haikonen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Luoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Huhtala</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Goebeler</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Haapasalo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Karhunen</surname>
<given-names>PJ</given-names></string-name>. <article-title>Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.</article-title>
<source/>Ann Neurol. <year>2009</year>; <volume>65</volume>:<fpage>650</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21696</pub-id><pub-id pub-id-type="pmid">19557866</pub-id></mixed-citation>
</ref>
<ref id="r173">
<label>173</label>
<mixed-citation publication-type="journal"><string-name><surname>Teasdale</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>GD</given-names></string-name>, <string-name><surname>Nicoll</surname>
<given-names>JA</given-names></string-name>. <article-title>The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study.</article-title>
<source/>Brain. <year>2005</year>; <volume>128</volume>:<fpage>2556</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh595</pub-id><pub-id pub-id-type="pmid">16033781</pub-id></mixed-citation>
</ref>
<ref id="r174">
<label>174</label>
<mixed-citation publication-type="journal"><string-name><surname>Merritt</surname>
<given-names>VC</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Sorg</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Evangelista</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>Werhane</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Bondi</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Schiehser</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Delano-Wood</surname>
<given-names>L</given-names></string-name>. <article-title>Apolipoprotein E (APOE) ε4 genotype is associated with reduced neuropsychological performance in military veterans with a history of mild traumatic brain injury.</article-title>
<source/>J Clin Exp Neuropsychol. <year>2018</year>; <volume>40</volume>:<fpage>1050</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1080/13803395.2018.1508555</pub-id><pub-id pub-id-type="pmid">30124361</pub-id></mixed-citation>
</ref>
<ref id="r175">
<label>175</label>
<mixed-citation publication-type="journal"><string-name><surname>Main</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Villapol</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sloley</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Barton</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Parsadanian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Agbaegbu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Stefos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>McCann</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Washington</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Rodriguez</surname>
<given-names>OC</given-names></string-name>, <string-name><surname>Burns</surname>
<given-names>MP</given-names></string-name>. <article-title>Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury.</article-title>
<source/>Mol Neurodegener. <year>2018</year>; <volume>13</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/s13024-018-0249-5</pub-id><pub-id pub-id-type="pmid">29618365</pub-id></mixed-citation>
</ref>
<ref id="r176">
<label>176</label>
<mixed-citation publication-type="journal"><string-name><surname>Kadotani</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kadotani</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Peppard</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Finn</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Colrain</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>GM</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Mignot</surname>
<given-names>E</given-names></string-name>. <article-title>Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults.</article-title>
<source/>JAMA. <year>2001</year>; <volume>285</volume>:<fpage>2888</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1001/jama.285.22.2888</pub-id><pub-id pub-id-type="pmid">11401610</pub-id></mixed-citation>
</ref>
<ref id="r177">
<label>177</label>
<mixed-citation publication-type="journal"><string-name><surname>Tranah</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Yaffe</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nievergelt</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Parimi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Glymour</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Ensrud</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Cauley</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mariani</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, and <collab>Osteoporotic Fractures in Men Study (MrOS) Research Group</collab>. <article-title>APOEε4 and slow wave sleep in older adults.</article-title>
<source/>PLoS One. <year>2018</year>; <volume>13</volume>:<fpage>e0191281</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0191281</pub-id><pub-id pub-id-type="pmid">29370207</pub-id></mixed-citation>
</ref>
<ref id="r178">
<label>178</label>
<mixed-citation publication-type="journal"><string-name><surname>Hwang</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Byun</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Choe</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Yi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>DY</given-names></string-name>, and <collab>KBASE Research Group</collab>. <article-title>Moderating effect of APOE ε4 on the relationship between sleep-wake cycle and brain β-amyloid.</article-title>
<source/>Neurology. <year>2018</year>; <volume>90</volume>:<fpage>e1167</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000005193</pub-id><pub-id pub-id-type="pmid">29490913</pub-id></mixed-citation>
</ref>
<ref id="r179">
<label>179</label>
<mixed-citation publication-type="journal"><string-name><surname>Pawlikowska</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Poon</surname>
<given-names>KY</given-names></string-name>, <string-name><surname>Achrol</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>McCulloch</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Ha</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lum</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zaroff</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Ko</surname>
<given-names>NU</given-names></string-name>, <string-name><surname>Johnston</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Sidney</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marchuk</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Lawton</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Kwok</surname>
<given-names>PY</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>WL</given-names></string-name>. <article-title>Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.</article-title>
<source/>Neurosurgery. <year>2006</year>; <volume>58</volume>:<fpage>838</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1227/01.NEU.0000209605.18358.E5</pub-id><pub-id pub-id-type="pmid">16639317</pub-id></mixed-citation>
</ref>
<ref id="r180">
<label>180</label>
<mixed-citation publication-type="journal"><string-name><surname>St George-Hyslop</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Tanzi</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Polinsky</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Haines</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Nee</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Watkins</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Myers</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Feldman</surname>
<given-names>RG</given-names></string-name>, <string-name><surname>Pollen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Drachman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>al</surname></string-name>. <article-title>The genetic defect causing familial Alzheimer’s disease maps on chromosome 21.</article-title>
<source/>Science. <year>1987</year>; <volume>235</volume>:<fpage>885</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1126/science.2880399</pub-id><pub-id pub-id-type="pmid">2880399</pub-id></mixed-citation>
</ref>
<ref id="r181">
<label>181</label>
<mixed-citation publication-type="journal"><string-name><surname>Michaelson</surname>
<given-names>DM</given-names></string-name>. <article-title>APOE ε4: the most prevalent yet understudied risk factor for Alzheimer’s disease.</article-title>
<source/>Alzheimers Dement. <year>2014</year>; <volume>10</volume>:<fpage>861</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2014.06.015</pub-id><pub-id pub-id-type="pmid">25217293</pub-id></mixed-citation>
</ref>
<ref id="r182">
<label>182</label>
<mixed-citation publication-type="journal"><string-name><surname>Berge</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sando</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Rongve</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aarsland</surname>
<given-names>D</given-names></string-name>, <string-name><surname>White</surname>
<given-names>LR</given-names></string-name>. <article-title>Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2014</year>; <volume>85</volume>:<fpage>1227</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2013-307228</pub-id><pub-id pub-id-type="pmid">24639435</pub-id></mixed-citation>
</ref>
<ref id="r183">
<label>183</label>
<mixed-citation publication-type="journal"><string-name><surname>Srinivasan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Davidson</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gibbons</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Payton</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Richardson</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Varma</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Julien</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Stopford</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Horan</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Pendleton</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Pickering-Brown</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Neary</surname>
<given-names>D</given-names></string-name>, <etal>et al</etal>. <article-title>The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2006</year>; <volume>77</volume>:<fpage>154</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2005.063966</pub-id><pub-id pub-id-type="pmid">16421115</pub-id></mixed-citation>
</ref>
<ref id="r184">
<label>184</label>
<mixed-citation publication-type="journal"><string-name><surname>Davidson</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gibbons</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pritchard</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hardicre</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wren</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stopford</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Julien</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Payton</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pickering-Brown</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Pendleton</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Horan</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Burns</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>. <article-title>Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer’s disease.</article-title>
<source/>Dement Geriatr Cogn Disord. <year>2007</year>; <volume>23</volume>:<fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1159/000097038</pub-id><pub-id pub-id-type="pmid">17108687</pub-id></mixed-citation>
</ref>
<ref id="r185">
<label>185</label>
<mixed-citation publication-type="journal"><string-name><surname>Geschwind</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Karrim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>B</given-names></string-name>. <article-title>The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.</article-title>
<source/>Ann Neurol. <year>1998</year>; <volume>44</volume>:<fpage>134</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410440122</pub-id><pub-id pub-id-type="pmid">9667603</pub-id></mixed-citation>
</ref>
<ref id="r186">
<label>186</label>
<mixed-citation publication-type="journal"><string-name><surname>Lovati</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Galimberti</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Albani</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bertora</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Venturelli</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cislaghi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Guidi</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fenoglio</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cortini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Clerici</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Finazzi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Forloni</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Scarpini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mariani</surname>
<given-names>C</given-names></string-name>. <article-title>APOE ε2 and ε4 influence the susceptibility for Alzheimer’s disease but not other dementias.</article-title>
<source/>Int J Mol Epidemiol Genet. <year>2010</year>; <volume>1</volume>:<fpage>193</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">21537391</pub-id></mixed-citation>
</ref>
<ref id="r187">
<label>187</label>
<mixed-citation publication-type="journal"><string-name><surname>Corder</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Saunders</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Strittmatter</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Schmechel</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Gaskell</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Small</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Roses</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Haines</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Pericak-Vance</surname>
<given-names>MA</given-names></string-name>. <article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.</article-title>
<source/>Science. <year>1993</year>; <volume>261</volume>:<fpage>921</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1126/science.8346443</pub-id><pub-id pub-id-type="pmid">8346443</pub-id></mixed-citation>
</ref>
<ref id="r188">
<label>188</label>
<mixed-citation publication-type="journal"><string-name><surname>Frisoni</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Louhija</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Geroldi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Trabucchi</surname>
<given-names>M</given-names></string-name>. <article-title>Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study.</article-title>
<source/>J Gerontol A Biol Sci Med Sci. <year>2001</year>; <volume>56</volume>:<fpage>M75</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/56.2.M75</pub-id><pub-id pub-id-type="pmid">11213279</pub-id></mixed-citation>
</ref>
<ref id="r189">
<label>189</label>
<mixed-citation publication-type="journal"><string-name><surname>Tindale</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Leach</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ushey</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Daley</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Brooks-Wilson</surname>
<given-names>AR</given-names></string-name>. <article-title>Rare and common variants in the Apolipoprotein E gene in healthy oldest old.</article-title>
<source/>Neurobiol Aging. <year>2014</year>; <volume>35</volume>:<fpage>727.e1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.09.010</pub-id><pub-id pub-id-type="pmid">24126160</pub-id></mixed-citation>
</ref>
<ref id="r190">
<label>190</label>
<mixed-citation publication-type="journal"><string-name><surname>Packard</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Westendorp</surname>
<given-names>RG</given-names></string-name>, <string-name><surname>Stott</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Caslake</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Shepherd</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Blauw</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Bollen</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Buckley</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Cobbe</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Ford</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Gaw</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>, and <collab>Prospective Study of Pravastatin in the Elderly at Risk Group</collab>. <article-title>Association between apolipoprotein E4 and cognitive decline in elderly adults.</article-title>
<source/>J Am Geriatr Soc. <year>2007</year>; <volume>55</volume>:<fpage>1777</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01415.x</pub-id><pub-id pub-id-type="pmid">17979899</pub-id></mixed-citation>
</ref>
<ref id="r191">
<label>191</label>
<mixed-citation publication-type="journal"><string-name><surname>Scheller</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Peter</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schumacher</surname>
<given-names>LV</given-names></string-name>, <string-name><surname>Lahr</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mader</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kaller</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Klöppel</surname>
<given-names>S</given-names></string-name>. <article-title>APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults.</article-title>
<source/>Neurobiol Aging. <year>2017</year>; <volume>56</volume>:<fpage>127</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.04.015</pub-id><pub-id pub-id-type="pmid">28528773</pub-id></mixed-citation>
</ref>
<ref id="r192">
<label>192</label>
<mixed-citation publication-type="journal"><string-name><surname>Reiter</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nielson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Durgerian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Woodard</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Seidenberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Rao</surname>
<given-names>SM</given-names></string-name>. <article-title>Five-year longitudinal brain volume change in healthy elders at genetic risk for Alzheimer’s Disease.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>55</volume>:<fpage>1363</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160504</pub-id><pub-id pub-id-type="pmid">27834774</pub-id></mixed-citation>
</ref>
<ref id="r193">
<label>193</label>
<mixed-citation publication-type="journal"><string-name><surname>Nagy</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Esiri</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Jobst</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Johnston</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Litchfield</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sim</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>AD</given-names></string-name>. <article-title>Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer’s disease.</article-title>
<source/>Neuroscience. <year>1995</year>; <volume>69</volume>:<fpage>757</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(95)00331-C</pub-id><pub-id pub-id-type="pmid">8596645</pub-id></mixed-citation>
</ref>
<ref id="r194">
<label>194</label>
<mixed-citation publication-type="journal"><string-name><surname>Boudreau</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Scheer</surname>
<given-names>WD</given-names></string-name>, <string-name><surname>Malcom</surname>
<given-names>GT</given-names></string-name>, <string-name><surname>Mulvad</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Pedersen</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Jul</surname>
<given-names>E</given-names></string-name>. <article-title>Apolipoprotein E and atherosclerosis in Greenland Inuit.</article-title>
<source/>Atherosclerosis. <year>1999</year>; <volume>145</volume>:<fpage>207</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9150(99)00067-2</pub-id><pub-id pub-id-type="pmid">10428312</pub-id></mixed-citation>
</ref>
<ref id="r195">
<label>195</label>
<mixed-citation publication-type="journal"><string-name><surname>Crawford</surname>
<given-names>FC</given-names></string-name>, <string-name><surname>Vanderploeg</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Freeman</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Waisman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Michaels</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Abdullah</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Warden</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lipsky</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Salazar</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mullan</surname>
<given-names>MJ</given-names></string-name>. <article-title>APOE genotype influences acquisition and recall following traumatic brain injury.</article-title>
<source/>Neurology. <year>2002</year>; <volume>58</volume>:<fpage>1115</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.58.7.1115</pub-id><pub-id pub-id-type="pmid">11940706</pub-id></mixed-citation>
</ref>
<ref id="r196">
<label>196</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Hauser</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Booze</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Walter</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Nance</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Hubble</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Koller</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Pahwa</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Stern</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Hiner</surname>
<given-names>BC</given-names></string-name>, <etal>et al</etal>. <article-title>Apolipoprotein E controls the risk and age at onset of Parkinson disease.</article-title>
<source/>Neurology. <year>2004</year>; <volume>62</volume>:<fpage>2005</fpage>–<lpage>09</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000128089.53030.AC</pub-id><pub-id pub-id-type="pmid">15184605</pub-id></mixed-citation>
</ref>
<ref id="r197">
<label>197</label>
<mixed-citation publication-type="journal"><string-name><surname>Konialis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Spengos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Iliopoulos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Karapanou</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gialafos</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hagnefelt</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Vemmos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zakopoulos</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Pangalos</surname>
<given-names>C</given-names></string-name>. <article-title>The APOE E4 allele confers increased risk of ischemic stroke among greek carriers.</article-title>
<source/>Adv Clin Exp Med. <year>2016</year>; <volume>25</volume>:<fpage>471</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.17219/acem/38841</pub-id><pub-id pub-id-type="pmid">27629735</pub-id></mixed-citation>
</ref>
<ref id="r198">
<label>198</label>
<mixed-citation publication-type="journal"><string-name><surname>Holmes</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Esterlis</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Mazure</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Ames</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rainey-Smith</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Martins</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Salvado</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Dore</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Villemagne</surname>
<given-names>VL</given-names></string-name>, <string-name><surname>Rowe</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Laws</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Masters</surname>
<given-names>CL</given-names></string-name>, <etal>et al</etal>, and <collab>Australian Imaging, Biomarkers, Lifestyle Research Group</collab>. <article-title>β-Amyloid, APOE and BDNF genotype, and depressive and anxiety symptoms in cognitively normal older women and men.</article-title>
<source/>Am J Geriatr Psychiatry. <year>2016</year>; <volume>24</volume>:<fpage>1191</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.jagp.2016.08.007</pub-id><pub-id pub-id-type="pmid">27742526</pub-id></mixed-citation>
</ref>
<ref id="r199">
<label>199</label>
<mixed-citation publication-type="journal"><string-name><surname>Kypreos</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Karagiannides</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fotiadou</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Karavia</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Brinkmeier</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Giakoumi</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Tsompanidi</surname>
<given-names>EM</given-names></string-name>. <article-title>Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.</article-title>
<source/>FEBS J. <year>2009</year>; <volume>276</volume>:<fpage>5720</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07301.x</pub-id><pub-id pub-id-type="pmid">19754875</pub-id></mixed-citation>
</ref>
<ref id="r200">
<label>200</label>
<mixed-citation publication-type="journal"><string-name><surname>Yao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Figueroa</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Barochia</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Levine</surname>
<given-names>SJ</given-names></string-name>. <article-title>Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.</article-title>
<source/>Am J Respir Cell Mol Biol. <year>2016</year>; <volume>55</volume>:<fpage>159</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2016-0060TR</pub-id><pub-id pub-id-type="pmid">27073971</pub-id></mixed-citation>
</ref>
<ref id="r201">
<label>201</label>
<mixed-citation publication-type="journal"><string-name><surname>Coto-Segura</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Coto</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Alvarez</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Morales</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Soto-Sánchez</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Corao</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>Santos-Juanes</surname>
<given-names>J</given-names></string-name>. <article-title>Apolipoprotein epsilon4 allele is associated with psoriasis severity.</article-title>
<source/>Arch Dermatol Res. <year>2010</year>; <volume>302</volume>:<fpage>145</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/s00403-009-1002-2</pub-id><pub-id pub-id-type="pmid">19911187</pub-id></mixed-citation>
</ref>
<ref id="r202">
<label>202</label>
<mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Chi</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>G</given-names></string-name>. <article-title>Neglected but important role of Apolipoprotein E exchange in Hepatitis C virus infection.</article-title>
<source/>J Virol. <year>2016</year>; <volume>90</volume>:<fpage>9632</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01353-16</pub-id><pub-id pub-id-type="pmid">27535051</pub-id></mixed-citation>
</ref>
<ref id="r203">
<label>203</label>
<mixed-citation publication-type="journal"><string-name><surname>Masuda</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shimazawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kojima</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Suemori</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mochizuki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kawakami</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kawase</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hara</surname>
<given-names>H</given-names></string-name>. <article-title>Apolipoprotein E2 and E3, but Not E4, promote retinal pathologic neovascularization.</article-title>
<source/>Invest Ophthalmol Vis Sci. <year>2017</year>; <volume>58</volume>:<fpage>1208</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.16-20539</pub-id><pub-id pub-id-type="pmid">28241308</pub-id></mixed-citation>
</ref>
<ref id="r204">
<label>204</label>
<mixed-citation publication-type="journal"><string-name><surname>Zokaei</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Giehl</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sillence</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Neville</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Karpe</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Nobre</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Husain</surname>
<given-names>M</given-names></string-name>. <article-title>Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife.</article-title>
<source/>Cortex. <year>2017</year>; <volume>88</volume>:<fpage>98</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.cortex.2016.12.016</pub-id><pub-id pub-id-type="pmid">28086184</pub-id></mixed-citation>
</ref>
<ref id="r205">
<label>205</label>
<mixed-citation publication-type="journal"><string-name><surname>Lancaster</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rusted</surname>
<given-names>J</given-names></string-name>. <article-title>The APOE paradox: do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline.</article-title>
<source/>Neurobiol Aging. <year>2016</year>; <volume>48</volume>:<fpage>114</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.08.015</pub-id><pub-id pub-id-type="pmid">27661410</pub-id></mixed-citation>
</ref>
<ref id="r206">
<label>206</label>
<mixed-citation publication-type="journal"><string-name><surname>Osuntokun</surname>
<given-names>BO</given-names></string-name>, <string-name><surname>Sahota</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ogunniyi</surname>
<given-names>AO</given-names></string-name>, <string-name><surname>Gureje</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Baiyewu</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Adeyinka</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Oluwole</surname>
<given-names>SO</given-names></string-name>, <string-name><surname>Komolafe</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Unverzagt</surname>
<given-names>FW</given-names></string-name>, <string-name><surname>Hui</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hendrie</surname>
<given-names>HC</given-names></string-name>. <article-title>Lack of an association between apolipoprotein E epsilon 4 and Alzheimer’s disease in elderly Nigerians.</article-title>
<source/>Ann Neurol. <year>1995</year>; <volume>38</volume>:<fpage>463</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410380319</pub-id><pub-id pub-id-type="pmid">7668835</pub-id></mixed-citation>
</ref>
<ref id="r207">
<label>207</label>
<mixed-citation publication-type="journal"><string-name><surname>Gureje</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Ogunniyi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Baiyewu</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Unverzagt</surname>
<given-names>FW</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Smith-Gamble</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Hendrie</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Murrell</surname>
<given-names>JR</given-names>
<suffix>Jr</suffix></string-name>. <article-title>APOE epsilon4 is not associated with Alzheimer’s disease in elderly Nigerians.</article-title>
<source/>Ann Neurol. <year>2006</year>; <volume>59</volume>:<fpage>182</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20694</pub-id><pub-id pub-id-type="pmid">16278853</pub-id></mixed-citation>
</ref>
<ref id="r208">
<label>208</label>
<mixed-citation publication-type="journal"><string-name><surname>Tang</surname>
<given-names>MX</given-names></string-name>, <string-name><surname>Stern</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Marder</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gurland</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Lantigua</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Andrews</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Tycko</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mayeux</surname>
<given-names>R</given-names></string-name>. <article-title>The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.</article-title>
<source/>JAMA. <year>1998</year>; <volume>279</volume>:<fpage>751</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1001/jama.279.10.751</pub-id><pub-id pub-id-type="pmid">9508150</pub-id></mixed-citation>
</ref>
<ref id="r209">
<label>209</label>
<mixed-citation publication-type="journal"><string-name><surname>Lipnicki</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Crawford</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Dutta</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thalamuthu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kochan</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Andrews</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lima-Costa</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Castro-Costa</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Brayne</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>Stephan</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Lipton</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Katz</surname>
<given-names>MJ</given-names></string-name>, <etal>et al</etal>, and <collab>Cohort Studies of Memory in an International Consortium (COSMIC)</collab>. <article-title>Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study.</article-title>
<source/>PLoS Med. <year>2017</year>; <volume>14</volume>:<fpage>e1002261</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002261</pub-id><pub-id pub-id-type="pmid">28323832</pub-id></mixed-citation>
</ref>
<ref id="r210">
<label>210</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Loewenstein</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Duara</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Cabrerizo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barker</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Adjouadi</surname>
<given-names>M</given-names></string-name>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>. <article-title>The relationship of brain amyloid load and APOE status to regional cortical thinning and cognition in the ADNI Cohort.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>59</volume>:<fpage>1269</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-170286</pub-id><pub-id pub-id-type="pmid">28731444</pub-id></mixed-citation>
</ref>
<ref id="r211">
<label>211</label>
<mixed-citation publication-type="journal"><string-name><surname>Fouquet</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Besson</surname>
<given-names>FL</given-names></string-name>, <string-name><surname>Gonneaud</surname>
<given-names>J</given-names></string-name>, <string-name><surname>La Joie</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chételat</surname>
<given-names>G</given-names></string-name>. <article-title>Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.</article-title>
<source/>Neuropsychol Rev. <year>2014</year>; <volume>24</volume>:<fpage>290</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1007/s11065-014-9263-8</pub-id><pub-id pub-id-type="pmid">25146994</pub-id></mixed-citation>
</ref>
<ref id="r212">
<label>212</label>
<mixed-citation publication-type="journal"><string-name><surname>Goryawala</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Duara</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Loewenstein</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cabrerizo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barker</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Adjouadi</surname>
<given-names>M</given-names></string-name>. <article-title>Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.</article-title>
<source/>Conf Proc IEEE Eng Med Biol Soc. <year>2014</year>; <volume>2014</volume>:<fpage>2468</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1109/EMBC.2014.6944122</pub-id><pub-id pub-id-type="pmid">25570490</pub-id></mixed-citation>
</ref>
<ref id="r213">
<label>213</label>
<mixed-citation publication-type="journal"><string-name><surname>Herrmann</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Hanf</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kaffarnik</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Motzny</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Reissner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Steinmetz</surname>
<given-names>A</given-names></string-name>. <article-title>The influence of apolipoprotein E polymorphism on plasma concentrations of apolipoprotein B and A-I during the first year of life.</article-title>
<source/>Pediatrics. <year>1994</year>; <volume>93</volume>:<fpage>296</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">8121744</pub-id></mixed-citation>
</ref>
<ref id="r214">
<label>214</label>
<mixed-citation publication-type="journal"><string-name><surname>Nadkarni</surname>
<given-names>NK</given-names></string-name>, <string-name><surname>Perera</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Snitz</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Mathis</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Williamson</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>DeKosky</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Klunk</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Lopez</surname>
<given-names>OL</given-names></string-name>. <article-title>Association of brain Amyloid-β with slow gait in elderly individuals without dementia: influence of cognition and Apolipoprotein E ε4 genotype.</article-title>
<source/>JAMA Neurol. <year>2017</year>; <volume>74</volume>:<fpage>82</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.3474</pub-id><pub-id pub-id-type="pmid">27842173</pub-id></mixed-citation>
</ref>
<ref id="r215">
<label>215</label>
<mixed-citation publication-type="journal"><string-name><surname>Wirth</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Villeneuve</surname>
<given-names>S</given-names></string-name>, <string-name><surname>La Joie</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marks</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Jagust</surname>
<given-names>WJ</given-names></string-name>. <article-title>Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.</article-title>
<source/>J Neurosci. <year>2014</year>; <volume>34</volume>:<fpage>8612</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4612-13.2014</pub-id><pub-id pub-id-type="pmid">24948815</pub-id></mixed-citation>
</ref>
<ref id="r216">
<label>216</label>
<mixed-citation publication-type="journal"><string-name><surname>Martin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Jazwinski</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Davey</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Macdonald</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Margrett</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Siegler</surname>
<given-names>IC</given-names></string-name>, <string-name><surname>Arnold</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Woodard</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <etal>et al</etal>, and <collab>For The Georgia Centenarian Study</collab>. <article-title>APOE ϵ4, rated life experiences, and affect among centenarians.</article-title>
<source/>Aging Ment Health. <year>2014</year>; <volume>18</volume>:<fpage>240</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1080/13607863.2013.827624</pub-id><pub-id pub-id-type="pmid">23998924</pub-id></mixed-citation>
</ref>
<ref id="r217">
<label>217</label>
<mixed-citation publication-type="journal"><string-name><surname>Asada</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yamagata</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Kinoshita</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kinoshita</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kariya</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Asaka</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kakuma</surname>
<given-names>T</given-names></string-name>. <article-title>Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan.</article-title>
<source/>J Am Geriatr Soc. <year>1996</year>; <volume>44</volume>:<fpage>151</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/j.1532-5415.1996.tb02431.x</pub-id><pub-id pub-id-type="pmid">8576504</pub-id></mixed-citation>
</ref>
<ref id="r218">
<label>218</label>
<mixed-citation publication-type="journal"><string-name><surname>Ossenkoppele</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Pijnenburg</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Perry</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Cohn-Sheehy</surname>
<given-names>BI</given-names></string-name>, <string-name><surname>Scheltens</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Vogel</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kramer</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>van der Vlies</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>La Joie</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rosen</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>van der Flier</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Grinberg</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Rozemuller</surname>
<given-names>AJ</given-names></string-name>, <etal>et al</etal>. <article-title>The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features.</article-title>
<source/>Brain. <year>2015</year>; <volume>138</volume>:<fpage>2732</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv191</pub-id><pub-id pub-id-type="pmid">26141491</pub-id></mixed-citation>
</ref>
<ref id="r219">
<label>219</label>
<mixed-citation publication-type="journal"><string-name><surname>Murray</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Graff-Radford</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>OA</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Duara</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dickson</surname>
<given-names>DW</given-names></string-name>. <article-title>Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study.</article-title>
<source/>Lancet Neurol. <year>2011</year>; <volume>10</volume>:<fpage>785</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(11)70156-9</pub-id><pub-id pub-id-type="pmid">21802369</pub-id></mixed-citation>
</ref>
<ref id="r220">
<label>220</label>
<mixed-citation publication-type="journal"><string-name><surname>Gordon</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Blazey</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Fagan</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Holtzman</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Benzinger</surname>
<given-names>TL</given-names></string-name>. <article-title>Longitudinal β-Amyloid deposition and hippocampal volume in preclinical Alzheimer Disease and suspected non-alzheimer disease pathophysiology.</article-title>
<source/>JAMA Neurol. <year>2016</year>; <volume>73</volume>:<fpage>1192</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.2642</pub-id><pub-id pub-id-type="pmid">27548756</pub-id></mixed-citation>
</ref>
<ref id="r221">
<label>221</label>
<mixed-citation publication-type="journal"><string-name><surname>Schreiber</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schreiber</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lockhart</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Horng</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bejanin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Landau</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Jagust</surname>
<given-names>WJ</given-names></string-name>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>. <article-title>Alzheimer Disease signature neurodegeneration and APOE genotype in mild cognitive impairment with suspected non-alzheimer disease pathophysiology.</article-title>
<source/>JAMA Neurol. <year>2017</year>; <volume>74</volume>:<fpage>650</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.5349</pub-id><pub-id pub-id-type="pmid">28319241</pub-id></mixed-citation>
</ref>
<ref id="r222">
<label>222</label>
<mixed-citation publication-type="journal"><string-name><surname>Mehta</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Watts</surname>
<given-names>GD</given-names></string-name>, <string-name><surname>Adamson</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Hutton</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Umberger</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ramdeen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lovell</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Kimonis</surname>
<given-names>VE</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>CD</given-names></string-name>. <article-title>APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).</article-title>
<source/>Genet Med. <year>2007</year>; <volume>9</volume>:<fpage>9</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1097/GIM.0b013e31802d830d</pub-id><pub-id pub-id-type="pmid">17224685</pub-id></mixed-citation>
</ref>
<ref id="r223">
<label>223</label>
<mixed-citation publication-type="journal"><string-name><surname>Chiò</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brunetti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barberis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iazzolino</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Montuschi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ilardi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cammarosano</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Canosa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Moglia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Calvo</surname>
<given-names>A</given-names></string-name>. <article-title>The Role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis.</article-title>
<source/>JAMA Neurol. <year>2016</year>; <volume>73</volume>:<fpage>425</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2015.4773</pub-id><pub-id pub-id-type="pmid">26903389</pub-id></mixed-citation>
</ref>
<ref id="r224">
<label>224</label>
<mixed-citation publication-type="journal"><string-name><surname>Bras</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Guerreiro</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Darwent</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Parkkinen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ansorge</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Escott-Price</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Hernandez</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Nalls</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Honig</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Marder</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Van Der Flier</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Lemstra</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>. <article-title>Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.</article-title>
<source/>Hum Mol Genet. <year>2014</year>; <volume>23</volume>:<fpage>6139</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu334</pub-id><pub-id pub-id-type="pmid">24973356</pub-id></mixed-citation>
</ref>
<ref id="r225">
<label>225</label>
<mixed-citation publication-type="journal"><string-name><surname>Berge</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sando</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Rongve</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aarsland</surname>
<given-names>D</given-names></string-name>, <string-name><surname>White</surname>
<given-names>LR</given-names></string-name>. <article-title>Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.</article-title>
<source/>J Neurol Neurosurg Psychiatry. <year>2014</year>; <volume>85</volume>:<fpage>1227</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2013-307228</pub-id><pub-id pub-id-type="pmid">24639435</pub-id></mixed-citation>
</ref>
<ref id="r226">
<label>226</label>
<mixed-citation publication-type="journal"><string-name><surname>Anttila</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bulik-Sullivan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Finucane</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Walters</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Bras</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Duncan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Escott-Price</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Falcone</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Gormley</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Malik</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Patsopoulos</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Ripke</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Z</given-names></string-name>, <etal>et al</etal>, and <collab>Brainstorm Consortium</collab>. <article-title>Analysis of shared heritability in common disorders of the brain.</article-title>
<source/>Science. <year>2018</year>; <volume>360</volume>:<fpage>8757</fpage>. <pub-id pub-id-type="doi">10.1126/science.aap8757</pub-id><pub-id pub-id-type="pmid">29930110</pub-id></mixed-citation>
</ref>
<ref id="r227">
<label>227</label>
<mixed-citation publication-type="journal"><string-name><surname>Uhl</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Drgon</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Contoreggi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hess</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Naiman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>QR</given-names></string-name>. <article-title>Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify “connectivity constellation” and drug target genes with pleiotropic effects.</article-title>
<source/>Ann N Y Acad Sci. <year>2008</year>; <volume>1141</volume>:<fpage>318</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1441.018</pub-id><pub-id pub-id-type="pmid">18991966</pub-id></mixed-citation>
</ref>
<ref id="r228">
<label>228</label>
<mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>. <article-title>Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer’s Disease risk reduction and early intervention.</article-title>
<source/>J Neurosci. <year>2018</year>; <volume>38</volume>:<fpage>6665</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2262-17.2018</pub-id><pub-id pub-id-type="pmid">29967007</pub-id></mixed-citation>
</ref>
<ref id="r229">
<label>229</label>
<mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases.</article-title>
<source/>Neurobiol Dis. <year>2014</year>; <volume>72</volume>:<fpage>3</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.08.025</pub-id><pub-id pub-id-type="pmid">25173806</pub-id></mixed-citation>
</ref>
<ref id="r230">
<label>230</label>
<mixed-citation publication-type="journal"><string-name><surname>Keeney</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Ibrahimi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>. <article-title>Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer’s prevention and early intervention. </article-title><source/>JAD. <year>2015</year>; <volume>48</volume>:<fpage>411</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150348</pub-id><pub-id pub-id-type="pmid">26402005</pub-id></mixed-citation>
</ref>
<ref id="r231">
<label>231</label>
<mixed-citation publication-type="journal"><string-name><surname>Berlau</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Corrada</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Head</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kawas</surname>
<given-names>CH</given-names></string-name>. <article-title>APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.</article-title>
<source/>Neurology. <year>2009</year>; <volume>72</volume>:<fpage>829</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000343853.00346.a4</pub-id><pub-id pub-id-type="pmid">19255410</pub-id></mixed-citation>
</ref>
<ref id="r232">
<label>232</label>
<mixed-citation publication-type="journal"><string-name><surname>Shinohara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kanekiyo</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Linthicum</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shinohara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Frisch-Daiello</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Fryer</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>. <article-title>APOE2 eases cognitive decline during Aging: clinical and preclinical evaluations.</article-title>
<source/>Ann Neurol. <year>2016</year>; <volume>79</volume>:<fpage>758</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24628</pub-id><pub-id pub-id-type="pmid">26933942</pub-id></mixed-citation>
</ref>
<ref id="r233">
<label>233</label>
<mixed-citation publication-type="journal"><string-name><surname>Suri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Heise</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Trachtenberg</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>. <article-title>The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2.</article-title>
<source/>Neurosci Biobehav Rev. <year>2013</year>; <volume>37</volume>:<fpage>2878</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.010</pub-id><pub-id pub-id-type="pmid">24183852</pub-id></mixed-citation>
</ref>
<ref id="r234">
<label>234</label>
<mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Raghavachari</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Arbeeva</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ukraintseva</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yashin</surname>
<given-names>AI</given-names></string-name>. <article-title>Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study.</article-title>
<source/>Biogerontology. <year>2016</year>; <volume>17</volume>:<fpage>893</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-016-9659-3</pub-id><pub-id pub-id-type="pmid">27447179</pub-id></mixed-citation>
</ref>
<ref id="r235">
<label>235</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Montine</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Keene</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Montine</surname>
<given-names>TJ</given-names></string-name>. <article-title>Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.</article-title>
<source/>FASEB J. <year>2015</year>; <volume>29</volume>:<fpage>1754</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-262683</pub-id><pub-id pub-id-type="pmid">25593125</pub-id></mixed-citation>
</ref>
<ref id="r236">
<label>236</label>
<mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Verghese</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Chakraborty</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Joung</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hyman</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Ulrich</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Holtzman</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Barres</surname>
<given-names>BA</given-names></string-name>. <article-title>Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes.</article-title>
<source/>Proc Natl Acad Sci USA. <year>2016</year>; <volume>113</volume>:<fpage>10186</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1609896113</pub-id><pub-id pub-id-type="pmid">27559087</pub-id></mixed-citation>
</ref>
<ref id="r237">
<label>237</label>
<mixed-citation publication-type="journal"><string-name><surname>Woody</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ibrahimi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>. <article-title>Human ApoE ε2 promotes regulatory mechanisms of bioenergetic and synaptic function in female brain: a focus on V-type H+-ATPase. </article-title><source/>JAD. <year>2016</year>; <volume>53</volume>:<fpage>1015</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160307</pub-id><pub-id pub-id-type="pmid">27340853</pub-id></mixed-citation>
</ref>
<ref id="r238">
<label>238</label>
<mixed-citation publication-type="journal"><string-name><surname>Alata</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>St-Amour</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Vandal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Calon</surname>
<given-names>F</given-names></string-name>. <article-title>Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.</article-title>
<source/>J Cereb Blood Flow Metab. <year>2015</year>; <volume>35</volume>:<fpage>86</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2014.172</pub-id><pub-id pub-id-type="pmid">25335802</pub-id></mixed-citation>
</ref>
<ref id="r239">
<label>239</label>
<mixed-citation publication-type="journal"><string-name><surname>Sen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Alkon</surname>
<given-names>DL</given-names></string-name>. <article-title>ApoE isoforms differentially regulates cleavage and secretion of BDNF.</article-title>
<source/>Mol Brain. <year>2017</year>; <volume>10</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/s13041-017-0301-3</pub-id><pub-id pub-id-type="pmid">28569173</pub-id></mixed-citation>
</ref>
<ref id="r240">
<label>240</label>
<mixed-citation publication-type="journal"><string-name><surname>Cooper</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Krawczak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Polychronakos</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tyler-Smith</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kehrer-Sawatzki</surname>
<given-names>H</given-names></string-name>. <article-title>Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.</article-title>
<source/>Hum Genet. <year>2013</year>; <volume>132</volume>:<fpage>1077</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1331-2</pub-id><pub-id pub-id-type="pmid">23820649</pub-id></mixed-citation>
</ref>
<ref id="r241">
<label>241</label>
<mixed-citation publication-type="journal"><string-name><surname>Lew</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Kellermayer</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Sule</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Szigeti</surname>
<given-names>K</given-names></string-name>. <article-title>Copy number variations in adult-onset neuropsychiatric diseases.</article-title>
<source/>Curr Genomics. <year>2018</year>; <volume>19</volume>:<fpage>420</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.2174/1389202919666180330153842</pub-id><pub-id pub-id-type="pmid">30258274</pub-id></mixed-citation>
</ref>
<ref id="r242">
<label>242</label>
<mixed-citation publication-type="journal"><string-name><surname>Mahley</surname>
<given-names>RW</given-names></string-name>. <article-title>Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism.</article-title>
<source/>Arterioscler Thromb Vasc Biol. <year>2016</year>; <volume>36</volume>:<fpage>1305</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307023</pub-id><pub-id pub-id-type="pmid">27174096</pub-id></mixed-citation>
</ref>
<ref id="r243">
<label>243</label>
<mixed-citation publication-type="journal"><string-name><surname>Tisato</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Zuliani</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vigliano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Longo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Franchini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Secchiero</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Zauli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Paraboschi</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Vikram Singh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Serino</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Ortolani</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zurlo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bosi</surname>
<given-names>C</given-names></string-name>, <etal>et al</etal>. <article-title>Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.</article-title>
<source/>PLoS One. <year>2018</year>; <volume>13</volume>:<fpage>e0193867</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0193867</pub-id><pub-id pub-id-type="pmid">29518107</pub-id></mixed-citation>
</ref>
<ref id="r244">
<label>244</label>
<mixed-citation publication-type="journal"><string-name><surname>Vélez</surname>
<given-names>JI</given-names></string-name>, <string-name><surname>Lopera</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sepulveda-Falla</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Johar</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Chuah</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tobón</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rivera</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Villegas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cai</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arkell</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Castellanos</surname>
<given-names>FX</given-names></string-name>, <etal>et al</etal>. <article-title>APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease.</article-title>
<source/>Mol Psychiatry. <year>2016</year>; <volume>21</volume>:<fpage>916</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.177</pub-id><pub-id pub-id-type="pmid">26619808</pub-id></mixed-citation>
</ref>
<ref id="r245">
<label>245</label>
<mixed-citation publication-type="journal"><string-name><surname>Gomar</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Conejero-Goldberg</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Huey</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Goldberg</surname>
<given-names>TE</given-names></string-name>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>. <article-title>Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer’s disease.</article-title>
<source/>Neurobiol Aging. <year>2016</year>; <volume>39</volume>:<fpage>165</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.12.004</pub-id><pub-id pub-id-type="pmid">26923413</pub-id></mixed-citation>
</ref>
<ref id="r246">
<label>246</label>
<mixed-citation publication-type="journal"><string-name><surname>Blanchard</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ramin-Mangata</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Billon-Crossouard</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Aguesse</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Durand</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chemello</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nativel</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Flet</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chétiveaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jacobi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bard</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ouguerram</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lambert</surname>
<given-names>G</given-names></string-name>, <etal>et al</etal>. <article-title>Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.</article-title>
<source/>J Lipid Res. <year>2018</year>; <volume>59</volume>:<fpage>892</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.P083576</pub-id><pub-id pub-id-type="pmid">29540575</pub-id></mixed-citation>
</ref>
<ref id="r247">
<label>247</label>
<mixed-citation publication-type="journal"><string-name><surname>Martínez-Morillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Batruch</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Drabovich</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Begcevic</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Lopez</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Minthon</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mattsson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Portelius</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hansson</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Diamandis</surname>
<given-names>EP</given-names></string-name>. <article-title>Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.</article-title>
<source/>J Proteome Res. <year>2014</year>; <volume>13</volume>:<fpage>1077</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1021/pr401060x</pub-id><pub-id pub-id-type="pmid">24392642</pub-id></mixed-citation>
</ref>
<ref id="r248">
<label>248</label>
<mixed-citation publication-type="journal"><string-name><surname>Nishimura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Satoh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nishimura</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kakinuma</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sato</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sawai</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tsuchida</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kazama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Matsushita</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kado</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kodera</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nomura</surname>
<given-names>F</given-names></string-name>. <article-title>Human apolipoprotein e resequencing by proteomic analysis and its application to serotyping.</article-title>
<source/>PLoS One. <year>2014</year>; <volume>9</volume>:<fpage>e85356</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085356</pub-id><pub-id pub-id-type="pmid">24454848</pub-id></mixed-citation>
</ref>
<ref id="r249">
<label>249</label>
<mixed-citation publication-type="journal"><string-name><surname>Iacono</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Markesbery</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Gross</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pletnikova</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Rudow</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zandi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Troncoso</surname>
<given-names>JC</given-names></string-name>. <article-title>The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.</article-title>
<source/>Neurology. <year>2009</year>; <volume>73</volume>:<fpage>665</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b01077</pub-id><pub-id pub-id-type="pmid">19587326</pub-id></mixed-citation>
</ref>
<ref id="r250">
<label>250</label>
<mixed-citation publication-type="journal"><string-name><surname>Bapat</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Narayana</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Parikh</surname>
<given-names>NA</given-names></string-name>. <article-title>Magnetic resonance spectroscopy at term-equivalent age in extremely preterm infants: association with cognitive and language development.</article-title>
<source/>Pediatr Neurol. <year>2014</year>; <volume>51</volume>:<fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.03.011</pub-id><pub-id pub-id-type="pmid">24938140</pub-id></mixed-citation>
</ref>
<ref id="r251">
<label>251</label>
<mixed-citation publication-type="journal"><string-name><surname>Simões</surname>
<given-names>RV</given-names></string-name>, <string-name><surname>Muñoz-Moreno</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cruz-Lemini</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Eixarch</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bargalló</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Sanz-Cortés</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gratacós</surname>
<given-names>E</given-names></string-name>. <article-title>Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome.</article-title>
<source/>Am J Obstet Gynecol. <year>2017</year>; <volume>216</volume>:<fpage>62.e1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2016.09.089</pub-id><pub-id pub-id-type="pmid">27667762</pub-id></mixed-citation>
</ref>
<ref id="r252">
<label>252</label>
<mixed-citation publication-type="journal"><string-name><surname>Pogribna</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Burson</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lasky</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Narayana</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Parikh</surname>
<given-names>NA</given-names></string-name>. <article-title>Role of diffusion tensor imaging as an independent predictor of cognitive and language development in extremely low-birth-weight infants.</article-title>
<source/>AJNR Am J Neuroradiol. <year>2014</year>; <volume>35</volume>:<fpage>790</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A3725</pub-id><pub-id pub-id-type="pmid">24052505</pub-id></mixed-citation>
</ref>
<ref id="r253">
<label>253</label>
<mixed-citation publication-type="journal"><string-name><surname>Wright</surname>
<given-names>RO</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Silverman</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Tsaih</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bellinger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Palazuelos</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Hernandez-Avila</surname>
<given-names>M</given-names></string-name>. <article-title>Apolipoprotein E genotype predicts 24-month bayley scales infant development score.</article-title>
<source/>Pediatr Res. <year>2003</year>; <volume>54</volume>:<fpage>819</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000090927.53818.DE</pub-id><pub-id pub-id-type="pmid">12930912</pub-id></mixed-citation>
</ref>
<ref id="r254">
<label>254</label>
<mixed-citation publication-type="journal"><string-name><surname>Chapman</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Benedict</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Roy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Porteinsson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Szigeti</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Federoff</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mapstone</surname>
<given-names>M</given-names></string-name>. <article-title>Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.</article-title>
<source/>Int J Geriatr Psychiatry. <year>2018</year>; <volume>33</volume>:<fpage>332</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1002/gps.4748</pub-id><pub-id pub-id-type="pmid">28612377</pub-id></mixed-citation>
</ref>
<ref id="r255">
<label>255</label>
<mixed-citation publication-type="journal"><string-name><surname>Dar-Nimrod</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Chapman</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Robbins</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Porsteinsson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mapstone</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Duberstein</surname>
<given-names>PR</given-names></string-name>. <article-title>Gene by neuroticism interaction and cognitive function among older adults.</article-title>
<source/>Int J Geriatr Psychiatry. <year>2012</year>; <volume>27</volume>:<fpage>1147</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/gps.3759</pub-id><pub-id pub-id-type="pmid">23042108</pub-id></mixed-citation>
</ref>
<ref id="r256">
<label>256</label>
<mixed-citation publication-type="journal"><string-name><surname>Caselli</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Dueck</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Locke</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Henslin</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Woodruff</surname>
<given-names>BK</given-names></string-name>, <string-name><surname>Hoffman-Snyder</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Geda</surname>
<given-names>YE</given-names></string-name>. <article-title>Impact of personality on cognitive aging: a prospective cohort study.</article-title>
<source/>J Int Neuropsychol Soc. <year>2016</year>; <volume>22</volume>:<fpage>765</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1017/S1355617716000527</pub-id><pub-id pub-id-type="pmid">27346168</pub-id></mixed-citation>
</ref>
<ref id="r257">
<label>257</label>
<mixed-citation publication-type="journal"><string-name><surname>Altschul</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Starr</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Deary</surname>
<given-names>IJ</given-names></string-name>. <article-title>Cognitive function in early and later life is associated with blood glucose in older individuals: analysis of the Lothian Birth Cohort of 1936.</article-title>
<source/>Diabetologia. <year>2018</year>; <volume>61</volume>:<fpage>1946</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-018-4645-8</pub-id><pub-id pub-id-type="pmid">29860628</pub-id></mixed-citation>
</ref>
<ref id="r258">
<label>258</label>
<mixed-citation publication-type="journal"><string-name><surname>Sinclair</surname>
<given-names>LI</given-names></string-name>, <string-name><surname>Pleydell-Pearce</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>IN</given-names></string-name>. <article-title>Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life.</article-title>
<source/>Neurobiol Learn Mem. <year>2017</year>; <volume>146</volume>:<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2017.10.008</pub-id><pub-id pub-id-type="pmid">29032015</pub-id></mixed-citation>
</ref>
<ref id="r259">
<label>259</label>
<mixed-citation publication-type="journal"><string-name><surname>Smith</surname>
<given-names>JD</given-names></string-name>. <article-title>Apolipoprotein E4: an allele associated with many diseases.</article-title>
<source/>Ann Med. <year>2000</year>; <volume>32</volume>:<fpage>118</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.3109/07853890009011761</pub-id><pub-id pub-id-type="pmid">10766403</pub-id></mixed-citation>
</ref>
<ref id="r260">
<label>260</label>
<mixed-citation publication-type="journal"><string-name><surname>Mueller</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fischer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gessner</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rosendahl</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Böhm</surname>
<given-names>S</given-names></string-name>, <string-name><surname>van Bömmel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Knop</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sarrazin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Witt</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Marques</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kovacs</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Schleinitz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stumvoll</surname>
<given-names>M</given-names></string-name>, <etal>et al</etal>. <article-title>Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection.</article-title>
<source/>Liver Int. <year>2016</year>; <volume>36</volume>:<fpage>1267</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1111/liv.13094</pub-id><pub-id pub-id-type="pmid">26880346</pub-id></mixed-citation>
</ref>
<ref id="r261">
<label>261</label>
<mixed-citation publication-type="journal"><string-name><surname>Sapkota</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wiebe</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Small</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Dixon</surname>
<given-names>RA</given-names></string-name>. <article-title>Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.</article-title>
<source/>Int J Geriatr Psychiatry. <year>2016</year>; <volume>31</volume>:<fpage>502</fpage>–<lpage>09</lpage>. <pub-id pub-id-type="doi">10.1002/gps.4355</pub-id><pub-id pub-id-type="pmid">26343804</pub-id></mixed-citation>
</ref>
<ref id="r262">
<label>262</label>
<mixed-citation publication-type="journal"><string-name><surname>Yamazaki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Painter</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kanekiyo</surname>
<given-names>T</given-names></string-name>. <article-title>Apolipoprotein E as a therapeutic target in Alzheimer’s Disease: a review of basic research and clinical evidence.</article-title>
<source/>CNS Drugs. <year>2016</year>; <volume>30</volume>:<fpage>773</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1007/s40263-016-0361-4</pub-id><pub-id pub-id-type="pmid">27328687</pub-id></mixed-citation>
</ref>
<ref id="r263">
<label>263</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Allington</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Prelli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Martá-Ariza</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scholtzova</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Biswas</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Verghese</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Mehta</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Kwon</surname>
<given-names>YU</given-names></string-name>, <string-name><surname>Wisniewski</surname>
<given-names>T</given-names></string-name>. <article-title>Targeting Apolipoprotein E/Amyloid β binding by peptoid CPO_Aβ17-21 P ameliorates Alzheimer’s Disease related pathology and cognitive decline.</article-title>
<source/>Sci Rep. <year>2017</year>; <volume>7</volume>:<fpage>8009</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-08604-8</pub-id><pub-id pub-id-type="pmid">28808293</pub-id></mixed-citation>
</ref>
<ref id="r264">
<label>264</label>
<mixed-citation publication-type="journal"><string-name><surname>Harper</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Nayee</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Topol</surname>
<given-names>EJ</given-names></string-name>. <article-title>Protective alleles and modifier variants in human health and disease.</article-title>
<source/>Nat Rev Genet. <year>2015</year>; <volume>16</volume>:<fpage>689</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1038/nrg4017</pub-id><pub-id pub-id-type="pmid">26503796</pub-id></mixed-citation>
</ref>
<ref id="r265">
<label>265</label>
<mixed-citation publication-type="journal"><string-name><surname>Mattsson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Eriksson</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Lindberg</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Schöll</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lampinen</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Nilsson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Insel</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Lautner</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Strandberg</surname>
<given-names>O</given-names></string-name>, <string-name><surname>van Westen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zetterberg</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Blennow</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Palmqvist</surname>
<given-names>S</given-names></string-name>, <etal>et al</etal>. <article-title>Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer’s disease.</article-title>
<source/>Neurobiol Aging. <year>2018</year>; <volume>71</volume>:<fpage>81</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.07.003</pub-id><pub-id pub-id-type="pmid">30107289</pub-id></mixed-citation>
</ref>
<ref id="r266">
<label>266</label>
<mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Iijima</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Goto</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sakai</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ishii</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kondo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Saeki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yamamoto</surname>
<given-names>T</given-names></string-name>. <article-title>Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain.</article-title>
<source/>J Biol Chem. <year>1996</year>; <volume>271</volume>:<fpage>8373</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.14.8373</pub-id><pub-id pub-id-type="pmid">8626535</pub-id></mixed-citation>
</ref>
<ref id="r267">
<label>267</label>
<mixed-citation publication-type="journal"><string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>. <article-title>The LDL receptor gene family: (un)expected signal transducers in the brain.</article-title>
<source/>Neuron. <year>2001</year>; <volume>29</volume>:<fpage>571</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00234-3</pub-id><pub-id pub-id-type="pmid">11301018</pub-id></mixed-citation>
</ref>
<ref id="r268">
<label>268</label>
<mixed-citation publication-type="journal"><string-name><surname>Gotthardt</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Trommsdorff</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nevitt</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Shelton</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Richardson</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Stockinger</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Nimpf</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>. <article-title>Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.</article-title>
<source/>J Biol Chem. <year>2000</year>; <volume>275</volume>:<fpage>25616</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M000955200</pub-id><pub-id pub-id-type="pmid">10827173</pub-id></mixed-citation>
</ref>
<ref id="r269">
<label>269</label>
<mixed-citation publication-type="journal"><string-name><surname>D’Arcangelo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Homayouni</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Keshvara</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Sheldon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Curran</surname>
<given-names>T</given-names></string-name>. <article-title>Reelin is a ligand for lipoprotein receptors.</article-title>
<source/>Neuron. <year>1999</year>; <volume>24</volume>:<fpage>471</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80860-0</pub-id><pub-id pub-id-type="pmid">10571240</pub-id></mixed-citation>
</ref>
<ref id="r270">
<label>270</label>
<mixed-citation publication-type="journal"><string-name><surname>Jossin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ignatova</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hiesberger</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lambert de Rouvroit</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Goffinet</surname>
<given-names>AM</given-names></string-name>. <article-title>The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development.</article-title>
<source/>J Neurosci. <year>2004</year>; <volume>24</volume>:<fpage>514</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3408-03.2004</pub-id><pub-id pub-id-type="pmid">14724251</pub-id></mixed-citation>
</ref>
<ref id="r271">
<label>271</label>
<mixed-citation publication-type="journal"><string-name><surname>Bosch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Masachs</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Exposito-Alonso</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Martínez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Teixeira</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Fernaud</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Pujadas</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ulloa</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Comella</surname>
<given-names>JX</given-names></string-name>, <string-name><surname>DeFelipe</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Merchán-Pérez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Soriano</surname>
<given-names>E</given-names></string-name>. <article-title>Reelin regulates the maturation of dendritic spines, synaptogenesis and glial ensheathment of newborn granule cells.</article-title>
<source/>Cereb Cortex. <year>2016</year>; <volume>26</volume>:<fpage>4282</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw216</pub-id><pub-id pub-id-type="pmid">27624722</pub-id></mixed-citation>
</ref>
<ref id="r272">
<label>272</label>
<mixed-citation publication-type="journal"><string-name><surname>Krstic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rodriguez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Knuesel</surname>
<given-names>I</given-names></string-name>. <article-title>Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators.</article-title>
<source/>PLoS One. <year>2012</year>; <volume>7</volume>:<fpage>e47793</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047793</pub-id><pub-id pub-id-type="pmid">23082219</pub-id></mixed-citation>
</ref>
<ref id="r273">
<label>273</label>
<mixed-citation publication-type="journal"><string-name><surname>Mata-Balaguer</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Cuchillo-Ibañez</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Calero</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ferrer</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Sáez-Valero</surname>
<given-names>J</given-names></string-name>. <article-title>Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer’s disease.</article-title>
<source/>FASEB J. <year>2018</year>; <volume>32</volume>:<fpage>3536</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700736RR</pub-id><pub-id pub-id-type="pmid">29442527</pub-id></mixed-citation>
</ref>
<ref id="r274">
<label>274</label>
<mixed-citation publication-type="journal"><string-name><surname>Benveniste</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Koundal</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sanggaard</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wardlaw</surname>
<given-names>J</given-names></string-name>. <article-title>The glymphatic system and waste clearance with brain aging: a review.</article-title>
<source/>Gerontology. <year>2018</year>;:<fpage>1</fpage>–<lpage>14</lpage>; <comment>Epub ahead of print</comment>. <pub-id pub-id-type="doi">10.1159/000490349</pub-id><pub-id pub-id-type="pmid">29996134</pub-id></mixed-citation>
</ref>
<ref id="r275">
<label>275</label>
<mixed-citation publication-type="journal"><string-name><surname>Louveau</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Herz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Alme</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Salvador</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>MQ</given-names></string-name>, <string-name><surname>Viar</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Herod</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Knopp</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Setliff</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Lupi</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Da Mesquita</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Frost</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Gaultier</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>. <article-title>CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature.</article-title>
<source/>Nat Neurosci. <year>2018</year>; <volume>21</volume>:<fpage>1380</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0227-9</pub-id><pub-id pub-id-type="pmid">30224810</pub-id></mixed-citation>
</ref>
<ref id="r276">
<label>276</label>
<mixed-citation publication-type="journal"><string-name><surname>Belinson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kariv-Inbal</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Kayed</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Masliah</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Michaelson</surname>
<given-names>DM</given-names></string-name>. <article-title>Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration.</article-title>
<source/>J Alzheimers Dis. <year>2010</year>; <volume>22</volume>:<fpage>959</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-101008</pub-id><pub-id pub-id-type="pmid">20858958</pub-id></mixed-citation>
</ref>
<ref id="r277">
<label>277</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Linares</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>. <article-title>ApoE4 accelerates early seeding of amyloid pathology.</article-title>
<source/>Neuron. <year>2017</year>; <volume>96</volume>:<fpage>1024</fpage>–<lpage>1032.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.11.013</pub-id><pub-id pub-id-type="pmid">29216449</pub-id></mixed-citation>
</ref>
<ref id="r278">
<label>278</label>
<mixed-citation publication-type="journal"><string-name><surname>Robert</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Button</surname>
<given-names>EB</given-names></string-name>, <string-name><surname>Yuen</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gilmour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bahrabadi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stukas</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kulic</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Wellington</surname>
<given-names>CL</given-names></string-name>. <article-title>Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels.</article-title>
<source/>eLife. <year>2017</year>; <volume>6</volume>:<fpage>e29595</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.29595</pub-id><pub-id pub-id-type="pmid">28994390</pub-id></mixed-citation>
</ref>
<ref id="r279">
<label>279</label>
<mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yamada</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Liddelow</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Spina</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grinberg</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Rojas</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Gallardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Roh</surname>
<given-names>J</given-names></string-name>, <etal>et al</etal>, and <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>. <article-title>ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.</article-title>
<source/>Nature. <year>2017</year>; <volume>549</volume>:<fpage>523</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/nature24016</pub-id><pub-id pub-id-type="pmid">28959956</pub-id></mixed-citation>
</ref>
<ref id="r280">
<label>280</label>
<mixed-citation publication-type="journal"><string-name><surname>Dafnis</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Argyri</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sagnou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tzinia</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tsilibary</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Stratikos</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Chroni</surname>
<given-names>A</given-names></string-name>. <article-title>The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.</article-title>
<source/>Sci Rep. <year>2016</year>; <volume>6</volume>:<fpage>30654</fpage>. <pub-id pub-id-type="doi">10.1038/srep30654</pub-id><pub-id pub-id-type="pmid">27476701</pub-id></mixed-citation>
</ref>
<ref id="r281">
<label>281</label>
<mixed-citation publication-type="journal"><string-name><surname>Kakuda</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Miyasaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Iwasaki</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Nirasawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wada-Kakuda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Takahashi-Fujigasaki</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Murayama</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ihara</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ikegawa</surname>
<given-names>M</given-names></string-name>. <article-title>Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry.</article-title>
<source/>Acta Neuropathol Commun. <year>2017</year>; <volume>5</volume>:<fpage>73</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-017-0477-x</pub-id><pub-id pub-id-type="pmid">29037261</pub-id></mixed-citation>
</ref>
<ref id="r282">
<label>282</label>
<mixed-citation publication-type="journal"><string-name><surname>Mori</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yasuda</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kazui</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hirono</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Matsui</surname>
<given-names>M</given-names></string-name>. <article-title>Accelerated hippocampal atrophy in Alzheimer’s disease with apolipoprotein E epsilon4 allele.</article-title>
<source/>Ann Neurol. <year>2002</year>; <volume>51</volume>:<fpage>209</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10093</pub-id><pub-id pub-id-type="pmid">11835377</pub-id></mixed-citation>
</ref>
<ref id="r283">
<label>283</label>
<mixed-citation publication-type="journal"><string-name><surname>Basso</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gelernter</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>MacAvoy</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Varma</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bronen</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>van Dyck</surname>
<given-names>CH</given-names></string-name>. <article-title>Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer’s disease.</article-title>
<source/>Neurobiol Aging. <year>2006</year>; <volume>27</volume>:<fpage>1416</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.08.002</pub-id><pub-id pub-id-type="pmid">16182410</pub-id></mixed-citation>
</ref>
<ref id="r284">
<label>284</label>
<mixed-citation publication-type="journal"><string-name><surname>Filippini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>MacIntosh</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Hough</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Goodwin</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Frisoni</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Beckmann</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Mackay</surname>
<given-names>CE</given-names></string-name>. <article-title>Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.</article-title>
<source/>Proc Natl Acad Sci USA. <year>2009</year>; <volume>106</volume>:<fpage>7209</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0811879106</pub-id><pub-id pub-id-type="pmid">19357304</pub-id></mixed-citation>
</ref>
<ref id="r285">
<label>285</label>
<mixed-citation publication-type="journal"><string-name><surname>Persico</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>D’Agruma</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zelante</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Militerni</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bravaccio</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Melmed</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Trillo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Montecchi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Elia</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Palermo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rabinowitz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pascucci</surname>
<given-names>T</given-names></string-name>, <etal>et al</etal>. <article-title>Enhanced APOE2 transmission rates in families with autistic probands.</article-title>
<source/>Psychiatr Genet. <year>2004</year>; <volume>14</volume>:<fpage>73</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1097/01.ypg.0000128768.37838.17</pub-id><pub-id pub-id-type="pmid">15167692</pub-id></mixed-citation>
</ref>
<ref id="r286">
<label>286</label>
<mixed-citation publication-type="journal"><string-name><surname>Burnham</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ittenbach</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>Stallings</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Gerdes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zackai</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bernbaum</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Clancy</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Gaynor</surname>
<given-names>JW</given-names></string-name>. <article-title>Genetic factors are important determinants of impaired growth after infant cardiac surgery.</article-title>
<source/>J Thorac Cardiovasc Surg. <year>2010</year>; <volume>140</volume>:<fpage>144</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2010.01.003</pub-id><pub-id pub-id-type="pmid">20381076</pub-id></mixed-citation>
</ref>
<ref id="r287">
<label>287</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Van Ingelgom</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Linares</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kurti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Heckman</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Diehl</surname>
<given-names>NN</given-names></string-name>, <string-name><surname>Shinohara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Martens</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Attrebi</surname>
<given-names>ON</given-names></string-name>, <string-name><surname>Petrucelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fryer</surname>
<given-names>JD</given-names></string-name>, <etal>et al</etal>. <article-title>APOE ε2 is associated with increased tau pathology in primary tauopathy.</article-title>
<source/>Nat Commun. <year>2018</year>; <volume>9</volume>:<fpage>4388</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-06783-0</pub-id><pub-id pub-id-type="pmid">30348994</pub-id></mixed-citation>
</ref>
<ref id="r288">
<label>288</label>
<mixed-citation publication-type="journal"><string-name><surname>White</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Nicoll</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Roses</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Horsburgh</surname>
<given-names>K</given-names></string-name>. <article-title>Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.</article-title>
<source/>Neurobiol Dis. <year>2001</year>; <volume>8</volume>:<fpage>611</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.2001.0401</pub-id><pub-id pub-id-type="pmid">11493026</pub-id></mixed-citation>
</ref>
<ref id="r289">
<label>289</label>
<mixed-citation publication-type="journal"><string-name><surname>Ji</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Beach</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Holtzman</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Wisniewski</surname>
<given-names>T</given-names></string-name>. <article-title>Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer’s disease patients.</article-title>
<source/>Neuroscience. <year>2003</year>; <volume>122</volume>:<fpage>305</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.08.007</pub-id><pub-id pub-id-type="pmid">14614898</pub-id></mixed-citation>
</ref>
<ref id="r290">
<label>290</label>
<mixed-citation publication-type="journal"><string-name><surname>Nwabuisi-Heath</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Rebeck</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Ladu</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>C</given-names></string-name>. <article-title>ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro.</article-title>
<source/>ASN Neuro. <year>2014</year>; <volume>6</volume>:<fpage>e00134</fpage>. <pub-id pub-id-type="doi">10.1042/AN20130043</pub-id><pub-id pub-id-type="pmid">24328732</pub-id></mixed-citation>
</ref>
<ref id="r291">
<label>291</label>
<mixed-citation publication-type="journal"><string-name><surname>Bloss</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Delis</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Salmon</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Bondi</surname>
<given-names>MW</given-names></string-name>. <article-title>APOE genotype is associated with left-handedness and visuospatial skills in children.</article-title>
<source/>Neurobiol Aging. <year>2010</year>; <volume>31</volume>:<fpage>787</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.05.021</pub-id><pub-id pub-id-type="pmid">18606479</pub-id></mixed-citation>
</ref>
<ref id="r292">
<label>292</label>
<mixed-citation publication-type="journal"><string-name><surname>Marchant</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>King</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Tabet</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rusted</surname>
<given-names>JM</given-names></string-name>. <article-title>Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.</article-title>
<source/>Neuropsychopharmacology. <year>2010</year>; <volume>35</volume>:<fpage>1090</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.214</pub-id><pub-id pub-id-type="pmid">20072115</pub-id></mixed-citation>
</ref>
<ref id="r293">
<label>293</label>
<mixed-citation publication-type="journal"><string-name><surname>Filippini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rao</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wetten</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gibson</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Borrie</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guzman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kertesz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Loy-English</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nichols</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Whitcher</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>PM</given-names></string-name>. <article-title>Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer’s disease.</article-title>
<source/>Neuroimage. <year>2009</year>; <volume>44</volume>:<fpage>724</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.10.003</pub-id><pub-id pub-id-type="pmid">19013250</pub-id></mixed-citation>
</ref>
<ref id="r294">
<label>294</label>
<mixed-citation publication-type="journal"><string-name><surname>Boros</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Greathouse</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Gearing</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Herskowitz</surname>
<given-names>JH</given-names></string-name>. <article-title>Dendritic spine remodeling accompanies Alzheimer’s disease pathology and genetic susceptibility in cognitively normal aging.</article-title>
<source/>Neurobiol Aging. <year>2019</year>; <volume>73</volume>:<fpage>92</fpage>–<lpage>103</lpage>; <comment>Epub ahead of print</comment>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.09.003</pub-id><pub-id pub-id-type="pmid">30339964</pub-id></mixed-citation>
</ref>
<ref id="r295">
<label>295</label>
<mixed-citation publication-type="journal"><string-name><surname>Trull</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Widiger</surname>
<given-names>TA</given-names></string-name>. <article-title>Dimensional models of personality: the five-factor model and the DSM-5.</article-title>
<source/>Dialogues Clin Neurosci. <year>2013</year>; <volume>15</volume>:<fpage>135</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">24174888</pub-id></mixed-citation>
</ref>
<ref id="r296">
<label>296</label>
<mixed-citation publication-type="journal"><string-name><surname>Servaas</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Geerligs</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Renken</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Marsman</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Ormel</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Riese</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Aleman</surname>
<given-names>A</given-names></string-name>. <article-title>Connectomics and neuroticism: an altered functional network organization.</article-title>
<source/>Neuropsychopharmacology. <year>2015</year>; <volume>40</volume>:<fpage>296</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.169</pub-id><pub-id pub-id-type="pmid">25005250</pub-id></mixed-citation>
</ref>
<ref id="r297">
<label>297</label>
<mixed-citation publication-type="journal"><string-name><surname>Mulders</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Llera</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tendolkar</surname>
<given-names>I</given-names></string-name>, <string-name><surname>van Eijndhoven</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Beckmann</surname>
<given-names>C</given-names></string-name>. <article-title>Personality profiles are associated with functional brain networks related to cognition and emotion.</article-title>
<source/>Sci Rep. <year>2018</year>; <volume>8</volume>:<fpage>13874</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-32248-x</pub-id><pub-id pub-id-type="pmid">30224828</pub-id></mixed-citation>
</ref>
<ref id="r298">
<label>298</label>
<mixed-citation publication-type="journal"><string-name><surname>Hsu</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Rosenberg</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Scheinost</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Constable</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Chun</surname>
<given-names>MM</given-names></string-name>. <article-title>Resting-state functional connectivity predicts neuroticism and extraversion in novel individuals.</article-title>
<source/>Soc Cogn Affect Neurosci. <year>2018</year>; <volume>13</volume>:<fpage>224</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nsy002</pub-id><pub-id pub-id-type="pmid">29373729</pub-id></mixed-citation>
</ref>
<ref id="r299">
<label>299</label>
<mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ai</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>. <article-title>The Effects of an APOE promoter polymorphism on human white matter connectivity during non-demented aging.</article-title>
<source/>J Alzheimers Dis. <year>2017</year>; <volume>55</volume>:<fpage>77</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160447</pub-id><pub-id pub-id-type="pmid">27636845</pub-id></mixed-citation>
</ref>
<ref id="r300">
<label>300</label>
<mixed-citation publication-type="journal"><string-name><surname>Korthauer</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ajilore</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Leow</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Driscoll</surname>
<given-names>I</given-names></string-name>. <article-title>Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers.</article-title>
<source/>Neuroimage. <year>2018</year>; <volume>178</volume>:<fpage>295</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.05.052</pub-id><pub-id pub-id-type="pmid">29803958</pub-id></mixed-citation>
</ref>
<ref id="r301">
<label>301</label>
<mixed-citation publication-type="journal"><string-name><surname>Tautvydaitė</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kukreja</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Antonietti</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Henry</surname>
<given-names>H</given-names></string-name>, <string-name><surname>von Gunten</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Popp</surname>
<given-names>J</given-names></string-name>. <article-title>Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology modulates cognitive performance.</article-title>
<source/>Alzheimers Res Ther. <year>2017</year>; <volume>9</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-017-0235-0</pub-id><pub-id pub-id-type="pmid">28153054</pub-id></mixed-citation>
</ref>
<ref id="r302">
<label>302</label>
<mixed-citation publication-type="journal"><string-name><surname>Bessi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mazzeo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Padiglioni</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Piccini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Nacmias</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sorbi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bracco</surname>
<given-names>L</given-names></string-name>. <article-title>From Subjective Cognitive Decline to Alzheimer’s Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.</article-title>
<source/>J Alzheimers Dis. <year>2018</year>; <volume>63</volume>:<fpage>1523</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-171180</pub-id><pub-id pub-id-type="pmid">29782316</pub-id></mixed-citation>
</ref>
<ref id="r303">
<label>303</label>
<mixed-citation publication-type="journal"><string-name><surname>Tangwongchai</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Supasitthumrong</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hemrunroj</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tunvirachaisakul</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chuchuen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Houngngam</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Snabboon</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tawankanjanachot</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Likitchareon</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Phanthumchindad</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Maes</surname>
<given-names>M</given-names></string-name>. <article-title>In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer’s Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.</article-title>
<source/>Mol Neurobiol. <year>2018</year>; <volume>55</volume>:<fpage>6449</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-017-0848-0</pub-id><pub-id pub-id-type="pmid">29307083</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>